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CHAPTER I GENERAL INTRODUCTION 
Dissertation Organization 
This dissertation is written in an alternative thesis format, as permitted by the 
Graduate College. It includes a research objective, background and literature review, 
rationale and an experimental part of four manuscripts to be published, general 
discussion, general summary, list of references cited in the general introduction, 
rationale, and general discussion, and acknowledgements. 
This dissertation contains the experimental results obtained by the author during his 
graduate study under the supervision of his major professor. Dr. Walter H, Hsu. 
Research Objectives 
Insulin secretion from pancreatic y?-cells is essential for life and homeostasis of the 
concentration of glucose in the blood. Elevation of blood glucose causes insulin release 
through ATP-mediated cell depolarization, opening of voltage-dependent Ca^^ channels 
(VDCCs) and an increase in intracellular free Ca^^ concentration ([Ca^^lj). For the 
studies of the physiology and pharmacology of pancreatic ;?-cells, pancreatic tissue 
has been used. However, it is difficult to get pure i9-cells from pancreatic islets of 
which ;ff-cells comprise 60 - 75%. Therefore, clonal insulin-secreting cell lines have 
been established, and RINmSF cells are one of the cell lines which are established from 
the transplantable irradiation-induced NEDH rat insulinoma. The RINm5F cell line has 
facilitated numerous studies on ;9-cell function, including regulatory receptors, insulin 
gene expression, glucose transport and metabolism, ATP-sensitive K'^ channels, the 
regulation of [Ca^^], and insulin release. Despite the proven utility of RINmSF cells, 
insulin secretion is gradually decreased and the morphology change from a 
differentiated state (with neuron-like processes) to an undifferentiated state (with round 
shape) as the culture continues. The extent to which these changes are a genuine 
feature of the cells or merely a consequence of long-term maintenance is 
undetermined. 
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Insulin, with 51 amino acids, is made up of two chains of amino acids joined 
together by two disulfide linkages. The rat pancreas secretes equal amounts of two 
types of insulin, designated as rat insulin I and II; however, RINm5F cells have been 
found to express only rat insulin type I. In our preliminary study, undifferentiated 
RINm5F cells were demonstrated to produce a novel insulin-like immunoreactivity due 
to neither rat insulin I nor II, which has never been reported. 
Epinephrine inhibits insulin release from pancreatic )ff-cells through activation of a^-
adrenergic receptors (ARs). When aj-ARs are blocked, epinephrine increases insulin 
release by activating Despite the numerous studies on aj-adrenergic 
mechanisms of insulin release in RINmSF cells, ^-ARs/adenylyl cyclase-mediated insulin 
release has not been studied as much as aj-AR-mediated insulin release. This may be 
attributable to the lack of information on the number of passages and the morphology 
(differentiated vs. undifferentiated state) of RINmBF cells which are appropriate for the 
study of (72- or iff-AR-mediated insulin release. Passage- and morphology-dependent 
changes of a- and ^S-ARs and adenylyl cyclase can be observed in these cells. The 
effect of epinephrine on insulin release was compared in order to characterize 
functional distribution of these receptors in RINmSF cells in the differentiated and 
undifferentiated state. In addition, the activities of adenylyl cyclase, phosphodiesterase 
(PDE), and cAMP-dependent protein kinase (protein kinase A) were characterized in 
RINmSF cells. 
Ca^*^ plays a central role in stimulus-secretion coupling in pancreatic ;3-cells and p-
cell lines including RINmSF. The insulin secretagogue which triggers cell depolarization 
opens VDCCs leading to Ca^*^ influx and insulin secretion. VDCCs have been classified 
into subclasses, i.e. T-, N-, L-, P-, and Q-type. RINmSF cells appear to have T-, L-, and 
Q-like-types mediating Ca^'^ currents, but the presence of N-, P-, and Q-type VDCCs is 
still controversial. By utilizing two morphological features (differentiated and 
undifferentiated state), the presence of VDCCs that mediate Ca^^ currents, Ca^^ influx, 
and insulin release was characterized in RINmSF cells. 
In summary, the purpose of this research was to characterize an insulin secreting 
clonal yff-cell line RINmSF with regards to 1) a novel insulin-like immunoreactivity, 2) the 
ffi-, 02-, and /ff-ARs, 3) adenylyl cyclase, PDE and protein kinase A, and 4) VDCCs in a 
passage- and morphology-dependent manner. 
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Background and Literature Review 
The objective of this section is to provide concise background information for the 
study of 1) a novel insulin-like immunoreactivity, 2) the a,-, a^-, and ^-ARs, 3) adenylyl 
cyclase, PDE and protein kinase A, and 4) VDCCs with a passage- and morphology-
dependent manner in RINmBF cells. 
The pancreatic islets 
Anatomy 
The pancreas is an exocrine and endocrine organ which is located in the upper right 
quadrant of the abdominal cavity in close association with the duodenum. The 
exocrine pancreas secretes pancreatic juice which consists of digestive enzymes 
required for the digestion of food. The endocrine glands of the pancreas, which are 
called islets of Langerhans, contain four types of endocrine cells. These cells are the A 
( or a) cells which secrete glucagon, the B (or P) cells which secrete insulin, the D (or 6) 
cells which secrete somatostatin, and F cells which secrete pancreatic polypeptide 
(Pelletier, 1977). These cells are not randomly distributed throughout the organ but are 
fairly well organized. The B cells are located in the center of islets and the A cells are 
located in the periphery of islets. The D cells are located between the A and B cells. 
The F cells are usually located near the A cells but are few in number and are not 
always found in the islets. The A cells comprise 20 - 30% of the islet cells, the B cells 
60 - 75%, D cells 3 -10%, and F cells < 2% (Karam, 1992). The A, B, D, and F cells 
make up 95 - 98% of islets volume (Larsson, 1980). 
The islets of Langerhans are richly vascularized and both the islet cells and blood 
vessels are intimately associated with a variety of autonomic nerves. The origin of 
parasympathetic preganglionic neurons that distribute to the pancreas is in the brain 
stem, and that of the sympathetic system is in the spinal cord. Stimulation of 
parasympathetic nerves increases insulin secretion (Kaneto et al., 1967), whereas 
stimulation of the sympathetic nerves decreases insulin secretion (Miller, 1981). 
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Pa thoph ysiology 
Insulin and glucagon are the key hormones for maintaining glucose concentration in 
the blood (Hsu and Crump, 1989). Insulin decreases the concentration of blood 
glucose by facilitating the transport of glucose across the cell membrane. However, 
glucagon increases blood glucose concentration by increasing hepatic glycogenolysis 
and gluconeogenesis. In addition, insulin inhibits glucagon release, whereas glucagon 
stimulates insulin release. Somatostatin inhibits the release of insulin and glucagon. 
The role of pancreatic polypeptide, however, has not been clearly demonstrated in the 
regulation of insulin release. 
Diminished rates of insulin secretion or tissue sensitivity to insulin cause diabetes 
mellitus classified as 1) insulin-dependent diabetes mellitus (IDDM) and 2) non-insulin-
dependent diabetes mellitus (NIDDM). An estimated 8.3 million people in the USA are 
known to have diabetes, and 600,000 have the insulin-dependent type (Karam, 1992). 
Insulin 
Chemistry of insulin 
Insulin with a M.W. of 56 KDa has two peptide chains (A chain with 21 amino 
acids and B chain with 30 amino acids) joined together by two disulfide bonds. The 
amino acid sequence of insulin is established (Sanger, 1960). The structures of 
human, porcine, and bovine insulins are shown in Fig. 1. Pancreatic 0-ce\\s synthesize 
insulin from a single-chain precursor, proinsulin, which consists of A and B subunits 
joined by the C-peptide (Orci et al., 1986). Proinsulin precursor is synthesized in the 
endoplasmic reticulum as preproinsulin, a precursor of proinsulin, which has at least 23 
amino acids more at the N terminal than proinsulin (Chan et al., 1976). Conversion of 
proinsulin to insulin occurs by removing four amino acids and the C-peptide and is 
catalyzed by type I and type II carboxypeptidase H (Halban and Irminger, 1994). 
Insulin exists as a monomer, a dimer and a hexamer but the biologically active form 
of insulin is a monomer. Hexameric zinc insulin is the storage form in the granules of 
jff-cells. Three forms of insulin hexamers are present; Tg (two zinc insulin hexamer), 
T3R3 (4 zinc insulin hexamer) and Rg (a phenol-induced two zinc insulin hexamer with a 
high concentration of chloride ion). The Tg hexamer has two zinc ions located 15.9 A 
apart on the threefold symmetry axis, each in an octahedral array. The conversion 
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Connecting peptide 
peptide) 
Porcine: 
^30 • Alanine 
Bovine; 
B30 • •- Alanine 
Ag * •- Alanine 
AIQ * •- Valine 
Fig. 1. The structure of human insulin. Insulin is shown as the shaded polypeptide A 
and B chains. Comparisons of human, porcine, and bovine C-peptides show 
considerable differences between species, with only about 40% homology. Species 
differences in the A and B chains are noted in the inset (from Karam, 1992). 
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from Tg to Rg occurs by changing from an extended B chain to a helix conformation and 
by positioning two zinc ions within the interior of the hexamer. The T3R3 hexamer is a 
stable intermediate between Tg and Rg conformational transition. The alternative 
conformations suggest that comparable conformational events may occur during 
biochemical signalling processes within the receptor-insulin complex. However, little is 
known about the relationship between the ligand-mediated conformational changes in 
the hexamer and the behavior of the insulin monomer in vivo (Brader and Dunn, 1991). 
Genetic contra! of insulin 
The expression of the insulin gene is regulated through both transcriptional and 
post-translational processes in pancreatic /9-cells. Glucose rapidly increases the rate of 
transcription, an effect that may partly be mediated through cAMP (Nielsen et al., 
1985; Welsh et al., 1986a), and stimulates translation (Itoh and Okamoto, 1980). 
Glucose-stimulated islets have greater amounts of insulin-specific mRNA in the 
membrane bound polysomes (Cordell et al., 1982). Post-transcriptional processes in 
insulin gene expression are enhanced by glucose which reduces degradation of insulin 
mRNA. In addition, translation of insulin is enhanced by glucose which increases 
initiation and elongation of signal recognition particle (SRP)-mediated transferral of 
cytosolic insulin mRNA to the rough endoplasmic reticulum (Welsh et al., 1986a). 
Leucine and 2-ketoisocaproate also play a stimulatory role in insulin gene expression 
(Welsh et al., 1986b). Glucocorticoids increase pancreatic islet mRNA content, but 
Ca^^ and a phorbol ester, an activator of protein kinase C, do not regulate insulin gene 
expression (Welsh et al., 1988). 
Secretion of insulin 
Insulin secretion is modulated by secretagogues in a regulated pathway, which 
allows for rapid and massive discharge of insulins stored in granules at the 
physiologically appropriate moments. The cytoskeletons, microtubules and 
microfilaments, in the yS-cells link some of the granules to the cell membrane and 
provide internal pathways of controlled movement of the granules within the cells. The 
granules fuse with the membrane, rupture and liberate the content into the extracellular 
space (Lacy et al., 1968). Exocytosis from the constitutive pathway is a continuous 
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process limited only by the availability of product. The constitutive pathway is 
responsible for delivery of integral proteins to the cell surface (Halban and Irminger, 
1994). In the regulated pathway, the secretory granules are formed in the trans-Go\g'\ 
network (TGN) and coated with a protein called clathrin. The immature, clathrin-coated 
granules are where the conversion to proinsulin occurs. The maturation of secretory 
granules involves progressive acidification, proinsulin conversion and loss of the 
clathrin coat. The enzymes responsible for proinsulin conversion, type 1 and type II 
carboxypeptidase H and PAM (peptidyl a-amidating mono-oxidase), are present in 
secretory granules (Orel et al., 1985; Christie et al., 1991). However, rat proinsulin II 
and human proinsulin can be cleaved within the cells which contain only the 
constitutive pathway of secretion. Cleavage occurs at the C-A junction with tetrabasic 
sequence, Arg-X-(Lys/Arg)-Arg. This cleavage is likely due to the endogenous, Golgi-
anchored, processing enzyme, furin or PACE4, which is present in the constitutive 
pathway of the cells (Groskreutz et al., 1994). 
Species differences 
Insulins of various mammals show a high degree of homology but species 
differences do exist. These differences involve amino acid residues 8, 9 and 10 of the 
A chain and amino acid residue 30 of the B chain (Fig. 1). The structure of porcine 
insulin is closest to human with the major difference being the presence of an alanine 
residue at the C-terminal of the human B chain. Bovine insulin differs from porcine 
insulin at A8 (Threonine -* Alanine) and at A10 (lleucine -• Valine). Guinea pig insulin 
differs from porcine insulin in 10 residues of the B chain and 7 residues of the A chain. 
However, canine and fin whale insulins have a identical sequence with porcine insulin 
(Nicole and Smith, 1960; Smith, 1966). In addition to species differences, more than 
one insulin may exist in the same species. In rats, mice and fish, two different insulins 
have been isolated (Smith, 1966; Clark and Steiner, 1969; Markussen, 1971). The A 
chain of rat insulin has the same sequence and differs from porcine insulin at A4 
glutamic acid. Rat insulin I B chain differs from porcine insulin at B3 (Asparagine 
Lysine) and at B9 (Serine -*• Proline). Rat insulin II B chain differs from porcine insulin at 
83 (Asparagine -* Lysine) and at 829 (Lysine -* Methionine) (Clark and Steiner, 1969). 
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Two different rat insulin cDNAs (mRNAs) have been isolated (Ullrich et al., 1977) 
and two nonallelic genes have been isolated and completely sequenced in the rat 
genome (Cordell et al., 1979). Insulin genes I and II are equally expressed and equal 
amounts of insulin I and II are secreted. However, insulin gene II is the ancestral gene 
in normal rat pancreatic ;S-cells (Bell et al., 1980). Equivalent amounts of insulin genes 
I and II are transcribed and mature mRNAs are present in RIN cells. However, rat 
preproinsulin I and II are 10-fold higher for insulin gene I than insulin gene II in RIN cells 
(Cordell et al., 1982). The presence of stable insulin gene II mRNAs in the cytoplasm 
which are not translated may be attributable to a cap-specific binding protein that 
differentially stimulates the translation of fully capped mRNAs compared with 
uncapped mRNAs (Sonenberg et al., 1980). RINmSF cells are suggested to have only 
rat insulin I mRNA (Fiedorek et al., 1990). 
Mechanisms of insulin action 
Effect of insulin on metabolism 
Insulin controls blood glucose by stimulating glucose uptake and glycogen synthesis 
in muscle and adipocytes and by inhibiting gluconeogenesis and lipolysis in the liver 
and adipocytes. Furthermore, insulin modifies the expression or activity of a variety of 
enzymes and transport systems in nearly all cells (White and Kahn, 1994). Pyruvate 
dehydrogenase, a mitochondrial enzyme, is also dephosphorylated by insulin to oxidize 
pyruvate to fat reducing the formation of glucose from pyruvate (Reed et al., 1980). 
The activity of lipoprotein lipase is increased by insulin, which in turn makes fatty acids 
derived from circulating lipoproteins available to the cells (Steinberg, 1983). In protein 
metabolism, insulin increases amino acid uptake and protein synthesis and inhibits 
protein degradation (Draznin and Trowbridge, 1982). K* uptake is also promoted by 
insulin through stimulation of Na'^, K'^-ATPase (Resh et al., 1980). 
Effect of insulin on glucose transport 
Glucose is a major source of metabolic energy, and a transport system for glucose 
is present in all animal cells. The energy independent transport of glucose is mediated 
by the facilitative glucose transporter (GLUT) family that are present on the surface of 
the cells. The facilitative transport of glucose is saturable, stereoselective, and 
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Fig. 2. Schematic representation of model showing two-dimensional membrane 
topology of the prototypical facilitative glucose transporter GLUTl, Putative 
membrane-spanning a-helices are labelled Ml - M12. M7, MB, and Mil have been 
putatively assigned as hydrophilic channels and M9 and M10 as the hydrophobic clefts 
(from Silverman, 1991). 
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bidirectional. The second family of glucose transporter (present in the lumen of the 
small intestine and nephron) is the intestinal Na"^/glucose cotransporter, SGLT1, which 
utilizes the electrochemical sodium gradient to transport glucose and galactose against 
their concentration gradient (Bell et al., 1993). 
The rate of glucose transport is dramatically increased in muscle and fat when the 
circulating concentrations of insulin is high (Gould and Bell, 1990). GLUT1 
(erythrocyte-type) is an integral membrane glycoprotein with a M.W. of 45 - 55 KDa 
and 12 transmembrane domains present in fetal tissues, brain, kidney, and colon (Fig. 
2). With insulin challenge, the translocation of GLUT1 is not sufficient to account for 
the full stimulation of transport by insulin. GLUT2 (liver-type) is present in liver, 
pancreatic ;9-cells, small intestine and kidney but does not play a role in the increase of 
the rate of glucose uptake caused by insulin. The topological organization of GLUT2 is 
identical to that of GLUT1. GLUT2 in pancreatic ;S-cells plays a role in regulating insulin 
secretion and is important in maintaining blood glucose levels working in conjunction 
with glucokinase. 
GLUT3 (brain-type) is present in brain, kidney and placenta but relatively low in 
adult muscle suggesting that this transporter is not the major one responsible for 
glucose uptake by muscle. The topological organization of GLUTS is identical to that of 
GLUT1. GLUT4 (muscle-type) is found in skeletal muscle, heart and white and brown 
adipose tissues. Insulin causes a 20- to 30-fold increase in the rate of glucose 
transport through GLUT4 in adipocytes. The insulin-stimulated increase in glucose 
transport is due to the translocation of a latent pool of GLUT4 from intracellular 
locations to the plasma membrane. GLUT4 has 65%, 54% and 58% homology with 
GLUT1, 2, and 3, respectively. 
GLUT5 (small intestine-type) is a fructose transporter expressed at highest levels in 
small intestine. However, it is unknown whether GLUT5 transports glucose or is a 
carrier for another sugar or other small polar molecule. GLUT5 has 42%, 40%, 39% 
and 42% homology with GLUT1, 2, 3 and 4, respectively. GLUT6 is a non-functional 
pseudogene and has been identified only in human. GLUT7 (microsomal-type) is a 
microsomal glucose transporter in liver. It comprises part of the glucose-6-phosphatase 
complex and mediates glucose release from the endoplasmic reticulum (ER). 
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Insulin 
receptor 
MAP 
kinase 
Signal? Signal? 
Phosphoinositides 3-phosphorylated 
phosphoinositides 
kinase 
kinase 
Other 
SH2-containing 
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Mitogenic signal 
Fig. 3. Mechanisms of action through insulin receptor. IRS-1 is required for activation 
of PI 3'-kinase and p70 S6 kinase. The insulin receptor also mediates the 
phosphorylation of She on tyrosine and activation of small G-protein Ras and MAP 
kinase in the absence of IRS-1. The interaction of IRS-1 and Grb-2 can also play a role 
in MAP kinase signalling. PI 3'-kinase is suggested to be involved in movement of 
GLUT4-containing vesicles and activation of p70 S6 kinase (Myers et al., 1994). 
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Of the GLUT family, GLUT1 and 4 are responsible for increased glucose uptake 
through the stimulation of insulin, whereas other GLUTs do not need insulin to activate 
the glucose uptake (Gould and Bell, 1990; Silverman, 1991; Bell et al., 1993). GLUT1 
regulates basal glucose uptake, however, GLUT4 is associated with an increased rate 
of glucose uptake in response to insulin stimulation. The effect of insulin on GLUT4 is 
acute, occurring with a half time of two or three minutes, and in the absence of new 
protein synthesis (Gould et al., 1994). Small G-proteins are believed to be involved in 
insulin-stimulated GLUT4 translocations from the observation that these G-proteins are 
colocalized with GLUT4 and GTPKS (a nonhydrolyzable GTP analog) and stimulate 
GLUT4 translocations (Etgen, Jr. et al., 1993). 
Signal transduction through insulin receptor 
The B25 phenylalanine of insulin plays a major role in directing the interaction of 
insulin with its receptor (Nakagawa and Tager, 1986). In addition, the A3 valine of 
insulin is also necessary for binding to the insulin receptor (Nanjo et al., 1986). Insulin 
action is mediated through the insulin receptor, a glycoprotein with intrinsic protein 
kinase activity, which has a kinase activity also found in receptors for EGF and PDGF 
(DeFronzo et al., 1992). The mechanism of insulin action is summarized in Fig. 3. 
Insulin receptors have two a subunits each with a M.W. of 125 KDa and two y? 
subunits each a with M.W. of 90 KDa, joined together by two disulfide bonds. 
Activation of the receptor by insulin-induced dimerization stimulates 
autophosphorylation of tyrosine residues of the j9-subunit (Ullrich et al., 1985; Myers et 
al., 1994). The activated receptor phosphorylates insulin receptor substrate-1 (IRS-1) 
with multiple tyrosine residues, which in turn binds to Src homology 2 domains (SH2 
proteins) of phosphatidylinositol (P\) 3'-kinase, growth factor receptor-bound protein 2 
(Grb-2), SH-PTP-2, and Nek (Backer et al., 1992; Skolnik et a!., 1993). In addition to 
IRS-1, insulin stimulates tyrosine phosphorylation of She, a 52 KDa SH2-containing 
protein with a tyrosine phosphorylation site that associates with Grb-2. Regulation of 
Ras and the activation of MAP kinase can occur through at least two pathways: an 
IRS-1 dependent pathway and an She-dependent pathway (Myers et al., 1994). 
In addition, insulin decreases intracellular cAMP concentrations by stimulating PDE 
and inhibiting adenylyl cyclase (Houslay et al., 1984) and lowers the affinity of protein 
13 
kinase A to cAMP without changing intracellular cAMP concentrations (Lamer et al., 
1982). 
A clonal /g-cell line. RINm5F 
Establishment of RIN-m cell line 
RINmBF cells were derived from a transplantable islet tumor induced by x-ray 
irradiation in an inbred NEDH (New England Deaconess Hospital) rat (Chick et al., 
1977). The islet tumor was initiated and maintained by serially transplanting nine-
times into NEDH rats (Gazdar et al., 1980). The tumor was again transplanted into 
athymic nude mice. The cell lines from the rat transplant were designated as RIN-r and 
from the nude mouse transplant as RIN-m. The RIN-m cell line was established after 
transplanting four times in nude mice. RIN-m cells was classified into 5 clones; 
designated as clone 1 to 5, RINmBF was one of the clones of RIN-m cells. The cells 
were further cultured in Dulbecco's modification of Eagles's minimal essential medium 
(DMEM) or RPMi-1640 medium supplemented with 10% fetal bovine serum. 
Population doubling times were 60 - 80 hr and varied with the culture medium and 
duration of culture. Growth rates were faster in DMEM than in RPMI-1640 medium 
and were also faster at later than at earlier passages. 
Both epithelioid and fibroblastoid cells were present, but fibroblastoid cells of 
murine origin were completely eliminated by exposing the cells to cystine-free medium 
for 16 h. However, epithelioid cells were progressively grown in both media, with 
more rapid growth in the DMEM. RIN-m cells consisted of epithelioid cells without 
apparent fibroblastoid contamination (Gazdar et al., 1980), which was confirmed by 
isoenzyme analysis. The cells were free of contamination with mycoplasma and 
murine leukemia virus. 
Characterization of the RIN-m cell line 
Functional characterizations 
The RINmSF cells secrete both insulin and somatostatin (Gazdar et al., 1980; Oie et 
al., 1983). The amount of insulin secreted is varied depending upon medium and 
duration of culture. There is an inverse relationship between proliferation and function. 
Maximal insulin secretion occurs by day 2 when cell growth is in a lag phase and a fall 
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in insulin secretion occurs when the cells rapidly proliferate post day 2 - 3 
(Bartholomeusz et al., 1990). The changes in insulin production during culture may be 
due to changes in insulin mRNA stability (Muschel et al., 1986). Cells maintained in 
DMEM and RPMI-1640 media release relatively high levels of insulin (Gazdar et al., 
1980). However, the level of insulin in DMEM is decreased and is not detectable after 
190 days. In RPMI-1640 medium, insulin secretion decreases during the first 100 days 
but stabilizes at 150 - 250//U/million cells per 24 hr. Moreover, the cells in RPMI-
1640 medium keep secreting insulin for more than 400 days; although the insulin 
content of the cells is only 1 % compared to pancreatic ^ff-cells (Halban et al., 1983; 
Praz et al., 1983). 
The level of somatostatin secreted did not widely fluctuate with culture time or 
type of medium and ranged from 3,150 - 8,700 pg/million cells per 24 hr. Therefore, 
variations in insulin secretion during culture may be influenced by the simultaneous 
secretion of somatostatin, an inhibitor of insulin secretion (Basabe et al., 1977). 
Biochemical characterizations 
RINmSF cells are not responsive to glucose but are responsive to glyceraldehyde-
stimulated insulin release (Lenzen et al., 1987; Thomas et al., 1989). Glucose 
utilization is hyperbolic and reaches maximal rates at glucose concentrations of 3 - 5 
mM (Halban et al., 1983). The ratios for glucose utilization and lactate/pyruvate output 
are much lower in RINm5F cells than in normal islet cells (Giroix et al., 1985). 
The glucose insensitivity of the cells has been attributed to a lack of glucokinase 
and the presence of low (hexokinase-like) glucose-phosphorylating activity (Halban 
et al., 1983; Lenzen et al., 1987; Vischer et al., 1987), and/or the reduced amounts of 
GLUT2 (Thorens et al., 1988). Although RINmBF cells do not have glucokinase, the 
cells are reported to have a glucokinase mRNA that is similar to the one in pancreatic 
islets (Fernandez-Mejia and Davidson, 1990). In addition, RINmSF cells have reduced 
amounts of GLUT2 compared to normal islets, and increased levels of GLUT1 
(presumably as a result of the transformed phenotype). Since the for glucose of 
GLUT1 is considerably lower than GLUT2, the rate of glucose entry into RINm5F cells 
is quite low compared to the cells expressing only GLUT2 (Thorens et al., 1988). In 
fact, the transfection of GLUT2 cDNA improves glucose transportation and glucose-
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stimulated insulin secretion in RINm5F cells (Tiedge et al., 1993). However, 
contradictory findings have been reported on GLUT in RINmSF cells. The loss of 
glucose sensitivity is not due to the alteration of hexose transport because the cells 
have a passive glucose transport system with high capacity and low affinity 
(Trautmann and Wollheim, 1987). 
The in vivo transplantation of ceils markedly enhances the rate of glucose uptake 
(Hoenig et al., 1984; Flatt et al., 1988), however, such an effect is very rapidly lost in 
tissue culture (Flatt et al., 1988). In addition, basal insulin release and insulin release in 
response to pancreatic fi-ceW secretagogues (i.e. arginine, leucine, and KCI) are 
increased by in vivo transplantation but lost during subsequent cell culture (Flatt et al., 
1988). This suggests that long-term maintenance in the physiological condition may 
enhance responsiveness of the cells by inducing glucokinase and other undetermined 
factors (Lenzen et al., 1987). 
The cell lines resemble the APUD cells series in biochemical, functional, and 
morphological features (Pearse, 1980). RIN cells secrete polypeptide hormone, have 
high levels of L-dopa decarboxylase, aromatic L-amino acid decarboxylase, and exhibit 
fluorescence after being exposed to formaldehyde (Oie et al., 1983). 
Immunological characterizations 
RINmBF cells have been frequently employed as a model of islet cell growth and 
differentiation in that they are relatively undifferentiated compared to normal adult islet 
cells (Halban et al., 1988; Bartholomeusz et al., 1990; Polak et al., 1993). The 
differentiation of RINmSF cells has been characterized by using monoclonal antibodies 
(A2B5, 3G5, and R2D6) against gangliosides which are expressed on the plasma 
membrane. A2B5 and 3G5 are monoclonal antibodies which recognize gangliosides on 
many cells including 0-ce\\s. R2D6 is a monoclonal antibody to a ganglioside which is 
only expressed on the surface of pancreatic i9-cells. increased insulin gene expression 
accompanies increased expression of A2B5-reactive ganglioside, which is associated 
with p-ceW differentiation (Halban et al., 1988; Bartholomeusz et al., 1990). A2B5-
reactive ganglioside is expressed more in functional, more differentiated cells than in 
less differentiated RINmBF cells. In fact, fully differentiated adult islets are identified 
by reactivity with A2B5 (Eisenbarth et al., 1982). However, more 3G5 - but less 
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A2B5-reactive ganglioside is expressed in less differentiated cells than in more 
differentiated RINmSF cells. The expression of R2D6-reactive ganglioside is also 
expressed in RINmSF cells. Its expression is higher in cells at 1 • 2 days after 
subculture than those at 5 days after subculture, suggesting that cellular confluence or 
cell cycle may be a factor in differentiated surface antigen (Halban et al., 1988). 
The differentiation of RINmSF cells has also been characterized by the expression of 
major histocompatibility complex (MHO proteins. MHC is a glycoprotein expressed on 
the surface of nucleated cells of many tissues and classified into class I and class II 
MHC. It serves as a specific antigen of the cells which is responsible for immune 
rejection following allograft transplantation. More differentiated RINmBF cells exhibit 
reduced expression of class I MHC proteins suggesting that the expression of class I 
MHC proteins may be related to the state of islet cell differentiation (Bartholomeusz et 
al., 1990). RINmSF cells do not have detectable class II MHC proteins (Setum and 
Hegre, 1990). However, the expression of class I MHC is increased by reovirus 
infection (Campbell et al., 1988), and the expression of both class I and II MHCs is 
enhanced by interferon-gamma (IFNk) (Varey et al., 1988). 
Morphological changes of cells in vitro 
Cells in culture usually undergo gross morphological changes. Cells attached to the 
substratum which is coated to the bottom of the culture flask grow neuron-like 
processes (differentiated) or completely flatten against the underlying surface. These 
cells become round (undifferentiated) during long-term culture (Willingham, 1976). 
Stimulators of cellular processes 
Cellular processes are either formed spontaneously or are induced by elevation of 
cAMP, phenylethyl alcohol, sodium butyrate, and nerve growth factor (NGF). cAMP 
appears to induce neuron-like processes in serum-free media (Nabika et al., 1988; 
Chaldakov et al., 1989) or in serum-contained media (Baorto et al., 1992). Increased 
intracellular cAMP concentration changes cell morphology in culture to look more like 
the normal parent cell, which is more spindly rather than round (Willingham, 1976). 
Dibutyryl cAMP (BtjCAMP), an analogue of cAMP, induces elongation of CHO (Chinese 
hamster ovary) cells (Hsie and Puck, 1971), Swiss 3T3 cells (Johnson and Pastan, 
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1972), cultured iris epithelial cells (Ortiz et al., 1973), cultured vascular smooth muscle 
cells (Nabika et al., 1988), primary cultured astrocytes (Baorto et al., 1992), NG 108-
15 cells (Bergamaschi et al., 1992), NCB-20 cells (Mienville, 1992) and BHK21 cells 
(Edwards et al., 1993). N®-substituted derivatives of adenosine can produce the 
processes without affecting cAMP levels. This raises the possibility that morphological 
changes may not be due to alteration of cAMP levels, but may act through the same 
effector mechanisms that cAMP regulates under normal conditions. However, protein 
kinase A is responsible for cAMP-dependent morphological transformation because 
microinjection of the catalytic subunit of protein kinase A triggers morphological 
changes from the differentiated to the undifferentiated state in thyroid epithelial cells 
(Roger et al., 1988). 
Phenylethyl alcohol and sodium butyrate, a short-chain carboxylic acid, produce 
process elongation in CHO cells (Wright, 1973). The mechanisms of sodium butyrate-
induced differentiation are reported to raise intracellular cAMP concentrations (Wright, 
1973), to arrest proliferation at late G1 phase of cell cycle (Toscani, et al., 1988), and 
to decrease cellular content of polyamine (Sjohoim, 1993). NGF promotes neurits 
outgrowth and alters cellular morphology not through activating a protein kinase A but 
through activating tyrosine kinase in PC 12 cells (Greene and Tischler, 1976; Chijiwa et 
al., 1990) and in RINmSF cells (Polak et al., 1993). In addition, NGF and BtjCAMP 
synergistically stimulate neurite outgrowth in PCI 2 cells suggesting divergent 
pathways of action of NGF and cAMP in growth of cellular processes (Heidemann et 
al., 1985). 
Inhibitors of cellular processes 
Fetal bovine serum, platelet-derived growth factor (PDGF), epidermal growth factor 
(EGF), bombesin, insulin, and lysophosphatidic acid (LPA) have been shown to inhibit 
the formation of the cell processes which are formed by elongation of cytoplasm 
around cytoskeletal elements (Baorto et al., 1992). Reorganization of actin filaments 
forms stress fibers and in turn retracts processes (Ridley and Hall, 1992). POGF, EGF, 
bombesin and insulin induce stress fiber formation in serum-starved Swiss 3T3 cells 
(Ridley et al., 1992; Ridley and Hall, 1992). LPA, bombesin and serum induce rapid 
stress fiber assembly (within 2 min), however, PDGF, EGF and insulin induce it more 
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slowly (5 to 10 min). 
Serum decreases cAMP-induced process formation in BHK21, NIH-3T3 and CHO 
cells. However, factors present in serum whicii inhibit stellation are presently unknown 
(Edwards et al., 1993). It has been suggested that serum can be replaced by LPA to 
inhibit process formation (van Corven et a!,, 1992; Ridley and Hall, 1992). The effect 
of LPA on the inhibition of cAMP-induced process formation may suggest the 
reorganization of actin components of the cytoskeleton (Edwards et al., 1993). LPA in 
fibroblasts lowers cAMP accumulation (van Corven et al., 1989), but stimulates 
phosphoinositide hydrolysis which leads to a transient increase in [Ca^^], (van Corven 
et al., 1989). However, LPA-induced increase in [Ca^"^], is not likely to activate stress 
fiber formation (Ridley and Hall, 1992). 
There is a possibility that small GTP-binding proteins (G-proteins) are involved in the 
formation of stress fibers. The intracellular target for LPA has been reported to be 
rhoGAP, a GTPase-activating protein (Tsai et al., 1989). However, it is unclear 
whether LPA acts through a transmembrane receptor or an intracellular target. LPA, 
PDGF, and other growth factors presumably induce G-protein-dependent responses. 
They increase the level of GTP-bound rho and rac small G-proteins or inhibit rhoGAP 
which enhances GTP hydrolysis leading to actin filament accumulation in the plasma 
.membrane of the cells (Ridley et al., 1992; Ridley and Hall, 1992). In fact, the rac and 
rho small G-proteins, which are approximately 60% identical, are essential components 
for organization of polymerized actin (Ridley et al., 1992). 
The role of protein kinase C in the formation of stress fiber is still not clear. A 
phorbol ester, PMA (phorbol 12-myristate 13-acetate) which is an activator of protein 
kinase C, stimulates the accumulation of polymerized actin which leads to retract 
processes in serum starved Swiss 3T3 cells (Ridley et al., 1992). In addition, PMA 
prevents isoproterenol-induced process formation through activation of protein kinase C 
in vascular smooth muscle cells (Nabika et al., 1988). However, PMA causes cells to 
form long narrow processes in fibroblasts (Brown et al., 1989) and macrophages 
(Phaire-Washington et al., 1980). 
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Effect of cytoskeletal system on cellular processes 
Effect of microtubules on cellular processes 
Microtubules present in all eukaryotic cells are formed by polymerization of tubulin. 
The tubulin subunits are arranged in 13 parallel rows called protofilaments. Each 
protofilament is composed of repeating tubulin dimers linked head to tail with each 
dimer containing one a- and one /^-tubulin molecule. Individual microtubules associated 
with intermediated filaments form a stable cytoskeleton and act as guides along which 
protein particles and organelles move up and down. In cultured cells, most 
microtubules radiate from the microtubule-organizing center (MTOC) and are 
consistently disassembling and reassembling into new ones (Amos and Baker, 1979; 
Mandelkow et al., 1986; Vale, 1987). 
The morphological transformation of CHO cells in vitro by elevating intracellular 
cAMP concentration is related to the degree of organization, possibly increasing 
microtubular population (Ortiz et al., 1973). Agents that interfere with microtubuiar 
function, such as colchicine, prevent most of the morphological changes due to 
elevated cAMP levels (Hsie and Puck, 1971) and BtjCAMP treatment redistributes or 
increases microtubular structures (Willingham and Pastan, 1975). 
Background information of actin 
Actin microfilaments play a role in many cellular functions, including motility, 
chemotaxis, cell division, endocytosis and secretion (Ridley and Hall, 1992). 
Microfilaments, called F actin, are polymers of a globular protein subunit (a M.W. of 42 
KDa) called globular actin, or G actin. Long bundles of filaments are termed stress 
fibers. Each actin subunit has a defined polarity, and the subunits polymerize head to 
tail. Most cellular actin is in microfilaments; although such filaments can grow and 
shrink. Actin filaments are much less likely to depolymerize than are microtubules. 
Under steady-state conditions the actin monomers are polymerized to microfilaments 
within cells. 
A ras-related GTP-binding proteins (small G-proteins), rho and rac, stimulate the 
formation of stress fibers and focal adhesions in Swiss 3T3 cells. Stress fibers, which 
are contractile, are involved in the attachment of cultured cells to a substratum and in 
generation of the tension that produces the flattened shape of fibroblasts. Stress 
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Fig. 4. Mechanisms of the cell process formation through increased intracellular cAMP 
concentration. ©: Inhibitory effect. *: Active MLCK binds Ca^'^/CaM strongly but 
inactive MLCK binds Ca^'^/CaM poorly. Ca^'^/CaM activates MLCK which in turn 
activates myosin. Activated myosin can bind to actin and actin microfilaments are 
stabilized. When actin microfilaments are stabilized, stress fibers are formed and the 
cell processes retract (summarized from the text). 
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fibers are located in the cytoplasm adjacent to the plasma membrane and contain 
myosin, a-actin, tropomyosin and myosin light chain kinase (MLCK) (Byers and 
Fujiwara, 1982; Pollard, 1986; Korn et al., 1987; Mitchison and Kirschner, 1988; 
Small 1988; Ridley and Hall, 1992). 
Background information of myosin 
Myosin proteins have a long rodlike tail and two globular heads at the one end. A 
myosin molecule has two identical heavy chains, each with a M.W. of 230 KDa and 
two pairs of light chains, each with a M.W. of 20 KDa. Type I myosin is present only 
in nonmuscle cells and contains the globular actin-binding region but lacks the fibrous 
tail. The fibrous tails are composed of 300 - 400 myosin dimers packed together to 
form a specific bipolar aggregate termed the thick filament. Type II myosin is present 
in muscle and in nonmuscle cells and contains a globular region that binds actin and a 
fibrous segment that allows it to aggregate into filaments (Tokunaga et al., 1987; 
Davis, 1988). Myosin has an ATPase activity. The SI fragment retains all of the actin-
stimulated ATPase activity of intact myosin. Binding of myosin SI fragments to actin 
fibers reflects the directionality and helicity of the actin filaments (Tokunaga et al., 
1987). 
Effect of microfilaments on cellular processes 
By elevating intracellular cAMP concentration, the subcellular distribution of 
microfilaments is changed (Fig. 4) (Willingham and Pastan, 1975). The process 
formation induced by increasing intracellular cAMP concentration can also be induced 
by cytochalasin, an agent that interferes with the function of microfilaments 
(Chaldakov et al., 1989). This suggests that actin microfilaments participate in the 
formation of the neuron-like processes. The cell processes induced by elevating cAMP 
are accompanied by depletion of actin microfilaments, particularly loss of stress fibers 
(Chaldakov et al., 1989; Baorto et al., 1992). Loss of F-actin can lead plasma 
membrane to form cellular processes (Edwards et al., 1993). In addition, the 
outgrowth of processes of BHK21 cells is accompanied by a high amount of F-actin at 
the tips of growing processes, indicating that the effect of elevated cAMP is selective 
for different subsets of microfilaments (Edwards et al., 1993). The relationship 
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between stellation and disappearance of sub-membrane actin empliasizes the 
importance of microtubule stabilization in neurite outgrowth (Heidemann et al., 1985). 
However, neurite outgrowth of PCI 2 cells happens in the absence of microtubules 
(Lamoureux et al., 1990). 
The effect of cAMP on microfilaments may come from phosphorylation of MLCK 
through activating protein kinase A, which lowers the binding affinity of MLCK for the 
Ca^"^-calmodulin complex. As a result, myosin-dependent tension is relaxed and 
microfilaments are destabilized (Baorto et al., 1992). In addition, inhibitors of MLCK 
(ML-9 and KT 5926) and a calmodulin antagonist (W7) can induce the formation of cell 
processes by dephosphorylating a 19 KDa actin depolymerizing factor implicating 
MLCK as a control point in process initiation (Baorto et al., 1992). 
Catecholamines 
Chemistry 
Catecholamines, sympathomimetic drugs, are derived from phenylethylamine by 
substituting positions 3 and 4 of the benzene ring with -OH groups. The structure of 
catecholamines and their biosynthesis pathways are illustrated in Fig. 4. Substitutions 
of phenylethylamine on the terminal amino group, of the benzene ring, and on the a or 
P carbons change affinity of the drugs for a- and yff-ARs and influence the intrinsic 
activity to the receptors (Hoffman, 1992). For example, substitutions on the amino 
groups of phenylethylamine with alkyi or isopropyl groups increase yJ-AR activity; e.g., 
epinephrine and isoproterenol. The activities of catecholamines on a- and ;?-ARs are 
maximal when -OH groups are present at the 3 and 4 positions. The absence of one of 
these -OH group markedly decreases the potency of the drugs but makes them more 
resistant to catechol-O-methyltransferase (COMT) which methylates epinephrine or 
norepinephrine to metanephrine or normetanephrine, respectively. In addition, 
substitution on the a-carbon blocks oxidation by monoamine oxidase (MAO) and 
prolongs the action. Substitution of the OH group on the P carbon decreases lipid 
solubility but enhances agonistic activity both at a- and /ff-ARs. Catecholamines 
include epinephrine, norepinephrine, isoproterenol, and dopamine. Non-catecholamines 
include phenylephrine, methoxamine, ephedrine, amphetamine, and tyramine (Hoffman, 
1992). 
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Fig. 5. Biosynthesis of catecholanriines. The alternative pathways are shown by the 
dashed arrows. Phenylethylannine with the indication oi a or 0 carbons is noted in the 
inset (from Katzung, 1992). 
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Synthesis of catecholamine 
Catecholamines are syntliesized from tyrosine by the hydroxylation of the phenolic 
ring, decarboxylation of the lateral ring, hydroxylation of the lateral ring, and N-
methylation (Fig. 5). The major enzymes involved are tyrosine hydroxylase, L-aromatic 
amino acid decarboxylase, dopamine ^-hydroxylase and phenylethanolamine-N-
methyltransferase. Dopamine /S-hydroxylase is found only in the granules but other 
enzymes are present in the cytosol of the chromaffin cells (Katzung, 1992). 
Tyrosine, a precursor of catecholamine, is actively transported into the cells or 
derived from the hydroxylation of phenylalanine. Tyrosine is converted to DOPA (3,4-
dihydroxy phenylalanine) by the tyrosine hydroxylase. The rate-limiting step in the 
biosynthesis of catecholamines is the hydroxylation of tyrosine. There are two forms 
of the tyrosine hydroxylase; a non-phosphorylated form which is only slightly active 
and a highly active phosphorylated form. The phosphorylation of tyrosine hydroxylase 
is a process of activation by protein kinase A and Ca^^-activated protein kinase 
following stimulation of adrenergic nerves and the adrenal medulla (Yamauchi et al., 
1981). In addition, the activity of tyrosine hydroxylase is inhibited by catechol 
compounds (competitive with the pterin receptor of tyrosine hydroxylase), a-
methyltyrosine, and 3-iodotyrosine and its metabolites, all considered as feedback 
inhibition (Hanoune, 1990). DOPA is converted to dopamine by dopamine 
decarboxylase. Dopamine is transported to neuronal vesicles where the synthesis and 
the storage of norepinephrine take place. Hydroxylation of dopamine to norepinephrine 
is catalyzed by dopamine/ff-hydroxylase, in the presence of , ascorbic acid and 
molecular oxygen. Norepinephrine is stored in the granules of adrenergic nerve 
terminals (Ganong, 1991). 
Release of catecholamine 
Catecholamines are released from adrenergic fibers and the adrenal medulla by 
exocytosis. In the adrenal medulla, acetylcholine from the preganglionic fibers interact 
with nicotinic receptors to depolarize membrane potentials and to increase Ca^*^ influx. 
Increase in [Ca^*^]! results in exocytosis of the granular content, including epinephrine, 
ATP, some neuroactive peptides and their precursors, chromogranins and dopamine-iff-
hydroxylase (Winkler et al., 1981). In adrenergic nerve terminals, Ca^*^ also plays a 
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role in coupling the nerve impulse with norepinephrine (Burn and Gibbons, 1965). 
Adreneroic receptors 
Classification of adrenergic receptors 
Catecholamines, epinephrine and norepinephrine, exert their effects on target tissue 
through direct binding with surface receptors, adrenergic receptors (ARs) (Fig. 6). 
Ahlquist (1948) proposed the two different subtypes (a and fi) of ARs based on 
different rank of orders of potency with natural and synthetic agonists. This 
subclassification is also consistent when the sensitivity of ARs is tested with 
antagonists. Finally, this subclassification was proven by a partial agonist, 
dichloroisoproterenol, which was the first agent antagonizing 0- but not a-AR-mediated 
responses (Powell and Slater, 1957). 
A-ARs are further classified into subtypes, A,- and otz-ARs on an anatomical, 
functional, and pharmacological basis. Langer (1974) suggested that ARs which 
mediate effector organ responses through postjunctional cr-AR be termed a,-ARs and 
ARs which mediate neurotransmitter release through prejunctional a-AR be termed Oz-
ARs. This anatomical classification, however, can not explain the phenomena that 
postjunctional events are mediated by agonists which are highly selective for Oj-AR. 
Berthelsen and Pettinger (1977) proposed a functional classification of a-ARs; ARs 
which mediate stimulatory responses be called a,-ARs, and ARs which mediate 
inhibitory responses be called aj-ARs. However, the vasoconstriction induced by 
norepinephrine is inhibited by both prazosin and yohimbine suggesting that 
postjunctional stimulation is mediated through both and Cj (Drew and Whiting, 
1979). Therefore, anatomical and functional characterizations can not reliably be used 
to classify a-ARs. Pharmacological classification is based on the relative potency of 
agonists and antagonists. a-ARs that are activated by methoxamine, cirazoline, or 
phenylephrine and are blocked by low concentration of prazosin, WB-4101, or 
corynanthine are classified as a,-ARs. a-ARs that are activated by a-
methylnorepinephrine, UK-14,304, B-HT 920, or B-HT 933 and are blocked by low 
concentrations of yohimbine, rauwolscine, or idazoxan is classified as aj-ARs (Table 1) 
(Ruffolo, Jr., et al., 1991). 
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Fig. 6. Primary structure of the human Oj-AR. The amino acid sequence is represented 
by the one letter code. The arrangement of the receptor structure within the 
membrane is based on a model for rhodopsin and is thought to be general for other G-
protein-coupled receptors (Ruffolo, Jr. et a!., 1991). 
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Table 1. Relative selectivity of a-agonists and -antagonists 
agonists antagonists 
or, selective 
a•^ and aj 
02 selective 
phenylephrine, methoxamine, 
cirazoline, amidephrine, 
Sgd 101/75 
epinephrine, norepinephrine 
clonidine, UK-14,304, 
B-HT 920, B-HT 933 
a-methylnorepinephrine 
prazosin, phenoxybenzamine, 
WB-4101, corynanthine 
phentolamine, tolazoline 
yohimbine, rauwolscine, 
idazoxan 
Modified from Buffalo, R.R. Jr. et al: Structure and function of or-adrenoceptors. 
Pharmacol. Rev. 43: 475-505, 1991. 
Table 2. Relative selectivity of ;ff-agonists and -antagonists 
agonists antagonists 
selective 
yff, and 02 
P2 selective 
P2 selective 
norepinephrine, dobutamine, 
prenalterol, xamoterol, 
denopamine 
isoproterenol, epinephrine 
fenoterol, albuterol, terbutaline, 
metaproterenol, salbutamol, 
salmeterol 
BRL 37344, CGP 12177*, 
ICI 198157, CL 316243 
metoprolol, acebutolol, 
practolol, alprenolol, atenolol, 
esmolol, betaxolol, 
bisoprolol, CGP 20712A 
propranolol, timolol, nadolol, 
pindolol, CGP 12177 
butoxamine, ICI 118551 
SR 59230A 
* Partial agonistic activity. 
Modified from Bylund, D.B. et al.: IV. International union of pharmacology 
nomenclature of adrenoceptors. Pharmacol. Rev. 46: 121-136, 1994. 
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yff-ARs have been subdivided into P2- and p^-AHs on the basis of the relative 
selectivity of effects of both agonists and antagonists {Table 1) (Bylund et al., 1994). 
Heterogeneity of /ff-ARs will be reviewed in page 28 in detail. 
Heterogeneity of a-adrenergic receptors 
or,-Adrenergic receptors 
a,-ARs are subclassified as ^ib'' and ot^q-ARs based on functional, radioligand 
binding, and molecular biology technique (Table 3) (Hieble et al., 1995). 
Subclassification between a^f^- and o,b-ARs is based on the receptor dissociation 
constants for 5-methylurapidil or (+ )-niguldipine and on sensitivity to irreversible 
inactivation by chloroethylclonidine. 5-Methylurapidil and ( + )-niguldipine are at least 
100-fold more selective for the oti^^-ARs than Oib'ARs. in addition, indoramin and its 
analog, SNAP-1069, have approximately 10-fold selectivity for or,^-ARs compared with 
the other two c/i-AR subtypes (Forray et al., 1994). Chloroethylclonidine selectively 
alkylates the aig-ARs. There is no currently no competitive antagonist for Oig-ARs, but 
spiperone is reported to have a 10-fold higher affinity for 0,3- ARs than ai^-ARs (Michel 
et al., 1989). a^D-ARs have affinity for 5-methylurapidil that is intermediate between 
a,A" and a^a'ARs. In addition, a,D-ARs have 50- to 100-fold selectivity for antagonists, 
BMY 7378 and SK&F 105854, and are alkylated by chloroethylclonidine (Hieble et al., 
1995). 
o,-ARs are also subclassified as a,g-, and a^^-ARs by using recombinant 
technique. ffia-AR is a seven transmembrane spanning, G-protein-coupled receptor and 
pharmacologically represents </ia-AR (Lomasney et al., 1991; Hieble et al., 1995). 
AR is a G-protein-coupled receptor and pharmacologically represents a^B-AR (Ramarao 
et al., 1992). The chromosomal locations of ai^-, and a^o-ARs are C8, C5, and 
C20 in human, respectively. 
ffj-Adrenergic receptors 
Oj-ARs are subclassified into 4 subtypes which can be blocked by yohimbine and 
rauwolscine with different affinities (Table 4). Oja-ARs have a low affinity for prazosin 
but higher affinity for oxymetazoline and BRL 44408 than CTzb-ARs. The rank order of 
potency for oTja'ARs is RX 821002 > yohimbine = rauwolscine oxymetazoline > 
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Table 3. Pharmacological properties of the a,-adrenergic receptor subtypes 
Subtypes Clone Human chromosomal Chloroethylclonidine 
location selective selectivity antagonist 
"lA Ou C8 ± SNAP-5089 { + ) niguldipine 
5-methylurapidil 
indoramin 
C5 + + + + ? 
Old C20 + + + BMY 7378 
SK&F 105854 
Modified from Hieble, J.P. et al.: International union of pharmacology. 
X. Recommendation for nomenclature of ff,-adrenoceptors: consensus update. 
Pharmacol. Rev. 47: 267-270, 1995 
Table 4. Pharmacological properties of the 02-adrenergic receptor subtypes 
Subtypes Clone Rank order of potency 
02A OjCIO RX 821002 > yohimbine = rauwolscine » oxymetazoline > 
phentolamine » idazoxan > prazosin » chlorpromazine » ARC 
239 
O2C2 rauwolscine > yohimbine > ARC 239 = prazosin » idazoxan = 
phentolamine > chlorpromazine = oxymetazoline 
Ozc ar2C4 rauwolscine > yohimbine > phentolamine « prazosin = ARC 
239 s oxymetazoline > chlorpromazine 
O2D 7 RX 821002 > oxymetazoline » phentolamine » idazoxan > 
yohimbine = rauwolscine > prazosin « chlorpromazine «= ARC 
239 
l\/Iodified from Remaury, A. and Paris, H. : The insulin-secreting cell line, RINm5F, 
expresses an alpha-2D adrenoceptor and nonadrenergic idazoxan-binding sites. J. 
Pharmacol. Exp. Ther. 260: 417-425, 1990. 
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phentolamine « idazoxan > > prazosin « chlorpromazine « ARC 239. Ojb-ARs have 
high affinity for prazosin and selective affinity for ARC 239, spiroxatrine, and imiloxan 
(Young et al., 1989). The rank order of potency for azg-ARs is rauwolscine > 
yohimbine > ARC 239 = prazosin » idazoxan » phentolamine > chlorpromazine -
oxymetazoline. The ajc-ARs are similar to the aje-ARs regarding the relatively high 
affinity for prazosin, ARC 239, and spiroxatrine, but it has higher affinity for 
rauwolscine. The ranl< order of potency for otzc'ARs is rauwolscine > yohimbine > 
phentolamine = prazosin » ARC 239 » oxymetazoline > chlorpromazine. ajc-ARs 
are present in opossum kidney tissue and Y 79 cells. Cjo-ARs, present in bovine and rat 
tissues, have a low affinity for prazosin, ARC 239 and spiroxatrine, and have a lower 
affinity for rauwolscine and yohimbine than Ozc-ARs. The rank order of potency for 
oTzq-ARs is RX 821002 > oxymetazoline = phentolamine « idazoxan > yohimbine = 
rauwolscine > prazosin » chlorpromazine = ARC 239. Ojd-ARs are the rat and bovine 
homologs of the human otza-ARs {Byiund and Ray-Prenger, 1989; Remaury and Paris, 
1992; Byiund et al., 1994). 
aj-ARs are also subclassified as O2CIO, O2C2, and a2C4 in human by using 
recombinant technique. The otjCIO and a2C2 clones pharmacologically represent 
AR and a2B"AR, respectively. The a2C4 clone has pharmacological characteristics of 
the ff2c-AR. The clone which represents CTzd'ARs has not been clearly demonstrated, 
however, rat RG20 clone is suggested to have characteristics of ff2D-ARs (Lomasney et 
al., 1990; Byiund et al., 1992; Byiund et al., 1994). Cloned Oj-ARs in the rat are 
designated as pAjd, RG10, cA2-47 and RG 20. However, mice have a high degree of 
homology with human OjCIO, a^l, and a2C4 (Byiund et al., 1994). 
Heterogeneity of ^-adrenergic receptors 
iS-ARs are subclassified into three subtypes; P2 ^3 (Table 2). The three 
subtypes of fi-ARs are activated by norepinephrine and epinephrine with differential 
affinities (Byiund et al., 1994). Norepinephrine and epinephrine are equally potent for 
yffi-AR, but epinephrine has 100-fold more selectivity for ^j'AR than for/?i-AR. In 
contrast, norepinephrine has higher affinity for /ffj-AR than epinephrine. The synthetic 
catecholamine, isoproterenol, is a potent agonist with equal selectivity for all )S-ARs. 
Selective agonists (denopamine, Ro 363 and xamoterol) for i?,-ARs have low selectivity 
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and efficacy, however, selective agonists (terbutaline, salbutamol, salmeterol and 
zintero!) for ^j-ARs have high selectivity. Selective agonists for jffg-ARs are BRL 37344, 
ICI 198157 and CL 316243, however, CGP 12177, a /ff,/yS2-AR antagonist, is a partial 
agonist for yffj-AR. 
Highly selective antagonists for /?,-ARs include metoprolol, practolol, atenolol, 
betaxolol and CGP 20712A. Highly selective antagonists for^ffj-ARs are butoxamine 
and ICI 118551 (Dooley et a!., 1986; O'Donneil and Wanstall, 1980; Emorine et al., 
1992). In addition, propranolol is a potent antagonist for and yffz'ARs, but much 
less selective for (Bylund et al., 1994). SR 59230A is the selective antagonist 
foryffg-ARs (Manara et al., 1995). 
All of the yff-ARs subclassified in pharmacological profile have been cloned and 
expressed. The pharmacologic characteristics of the recombinant receptors correspond 
well with those of three receptor subtypes, although there are some differences in 
ARs. Although the clone is derived from a human genomic library, BRL 37344, a ;?3-AR 
agonist, corresponds more closely to those of the rat adipocyte than those of human 
adipocyte . This may reflect species differences in the ySa-AR density (Zaagsma and 
Nahorski, 1990). 
Adrenergic receptors in pancreatic P-cell 
Insulin secretion is modulated by the sympathetic and parasympathetic nervous 
systems, although glucose and other substrates are the principal regulators of insulin 
secretion. The parasympathetic preganglionic neurons are originated from the brain 
stem, and the sympathetic system is from the spinal cord. Stimulation of 
parasympathetic nerves increases insulin secretion (Kaneto et al., 1967), whereas 
stimulation of the sympathetic nerves decreases insulin secretion (Miller, 1981). Both 
ffa" and p-ARs have been demonstrated on pancreatic islets (Ahren, et al., 1984), but 
the presence of a^-ARs is still controversial. An a,-AR agonist, amidephrine mesylate, 
fails to affect glucose-stimulated insulin release in rat pancreatic )?-cells (Malaisse and 
Moratinos, 1986), but an a,-AR agonist, phenylephrine, causes a slight but significant 
increases of insulin release in RINm5F cells (Ullrich and Wollheim, 1985). In porcine 
pancreatic islet, however, an a^-AR agonist, phenylephrine, inhibits insulin release, and 
the inhibitory effect of epinephrine is abolished by an a^-AR antagonist, prazosin, but 
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not inhibited by an aj-AR antagonist, idazoxan (Gregersen et al., 1991). In pancreatic 
yff-cells, there are separate imidazoline binding sites, which are not Oz-ARs. New 
selective oj-antagonists of imidazoline family, phentolamine and idazoxan, can 
stimulate insulin secretion by binding to these sites. 
Glucose-induced insulin secretion is inhibited by Oz-aQori'sts and stimulated by yS-
agonists. i?-ARs are i?2-subtype and aj-ARs are ajo-subtype in rats (Remaury and Paris, 
1992). have also been suggested as OjA-subtype in rat pancreas (Niddam et al., 
1990), however, this observation was made without considering the presence of otjo-
subtype. In fact, ffjo'Subtype is suggested as a rat homologue of az^-subtype. 
Voltage-dependent Ca^'^ channels (VDCCs) 
VDCCs in general 
VDCCs are classified as L (long-lasting), T (transient or tiny), N (neither L nor T) and 
P (Purkinje cells) according to their activation and inactivation kinetics, conductance, 
ion specificities, and sensitivity to drugs and toxins (Table 5). in addition, the Q-type 
channel has been characterized in the brain (Spedding and Paoletti, 1992; Hofmann et 
a!., 1994). 
T-type VDCC 
The T-type (low voltage-activated or slow-deactivating) channel is activated at 
membrane potentials of around -50 mV and exhibits a voltage-dependent inactivation, 
which may be important for pacemaker activity in several tissues. The T-type channels 
are present in the sinoatrial node, the atrioventricular node, smooth muscle cells, and 
neurons where they are responsible for burst firing (White et al., 1989). There are no 
specific blockers for T-type channels, however, Ni^"^, ethosuximlde, tetrandine and 
felodipine show some selectivity for blocking T-type channels. 
L-type VDCC 
The L-type (high-voltage activated or fast-deactivating) channel is activated at 
membrane potentials of around -40 mV and reaches its maximum at -10 to 0 mV, and 
the inactivation of the calcium current is Ca^'^-dependent (Polio et al., 1993). The L-
type channel is characterized by its sensitivity to dihydropyridines (DHP), being 
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Fig. 7, Structural model of L-type Ca^"^ channel. Upper panel: subunit structure of an 
L-type Ca^"^ channel. P, phosphorylation site. Lower panel: proposed folding patterns 
of the polypeptide components of an L-type channel as predicted from the amino 
acid sequences deduced from cDNA cloning and sequencing (from Catterali and 
Striessnig, 1 992). 
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inhibited by the DHP antagonist, nimodipine, and activated by a DHP agonist, Bay K 
8644, (Smith et al., 1993). DHPs have a high affinity for the inactivated state of the 
channel and low affinity for other states (activated and resting). 40 mM KCI shifts the 
equilibrium to the inactivated state in approximately 70% of cardiac muscle cells and 
increases the affinity of DHPs to produce pharmacological effects (Bean, 1984). 
Changes in membrane potentials are critical in the potency of DHPs, therefore, a wide 
range of holding potentials, stimulation frequencies, charge carriers, etc. should be 
performed in electrophysiological studies (Catterall and Striessnig, 1992; Spedding and 
Paoletti, 1992). 
L-type channels consist of five subunits; o,, aj, jff, y and 6.  The a, subunit, with a 
M.W. of 165 KDa, contains sites for phosphorylation and binding sites for L-type 
channel agonists and antagonists. The subunit has four repeating units (I to IV), each 
containing six membrane-spanning domains (SI to S6), of which the S4 is a voltage 
sensor (Fig. 7). The subunit has 55% homology with sodium channels, therefore, 
selective drugs have affinity for both sodium channels and L-type channels. The 
subunit forms an ion-selective pore and binding sites for DHPs, phenylalkylamines and 
benzodiazepines. The DHP-binding site is localized close to the SSI - SS2 region of 
repeat III and to a sequence following the IVS6 (Hofmann et al., 1994). The az'Subunit 
does not participate in channel formation and serves as sites for drug binding. The 
subunit increases the rate of activation and inactivation of the channel and modifies 
DHP binding to the a, subunit. The structure of k subunit has been determined but the 
function is still unknown. The 6 subunit is linked to the aj'Subunit by sulfhydryl bonds. 
There appears to be 4 isoforms of the L-type channel; distinguished as LI to L4 
(Spedding and Paoletti, 1992). 
N-, P-, and Q-type VDCCs 
The N-type channels, which are coupled to neurotransmitter release, are sensitive 
to w-conotoxin GVIA but not sensitive to L-type channel blockers. Some N-type 
channels are predominantly voltage activated, but others may be modulated by 
receptor-linked second messenger systems such as G-proteins (Kongsamut et al., 
1989). The P-type channels, present in cerebellar Purkinje cells and squid giant axons, 
are sensitive to a;-agatoxin IVA but not sensitive to either DHPs or w-conotoxin GVIA 
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Table 5. Classes of voltage-dependent calcium channels 
N 
Channel types 
T P 
Conductance 25 pS 12-20 pS 8 pS 10-12 pS 
Activation High voltage High voltage Low voltage Moderate High voltage 
high voltage 
Inactivation Slov\/ Moderate Transient Very Slow Fast 
Location/ Widespread, Neuronal Widespread, Neuronal, Neuronal 
function muscle, transmitter pacemaker purkinje 
nerve release 
Blockers DHP, w-CTX GVIA Flunarizine? w-Aga IVA w-Aga IVA 
calciseptine, w-CTX MVIIC 
phenylalkylamines 
Abbreviations: CTX; conotoxin, Aga: agatoxin, DHP; dihydropyridine. 
Modified from Spedding, M. and Paoletti, R.: III. Classification of calcium channels and 
the sites of action of drugs modifying channel function. Pharmacol. Rev. 44: 363-376, 
1992. And also summarized from Olivia, B.M. et al.: Calcium channel diversity and 
neurotransmitter release: The w-conotoxins and w-agatoxins. Ann. Rev. Biochem. 63: 
823-867, 1994. 
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{Regan et al., 1991). These channels fornn a larger portion of Ca^* channels in the 
brain and are responsible for neurotransmitter release. The Q-type channels, present in 
the brain, are blocked by a higher concentration of w-agatoxin IVA than the P-type 
channels, and are also blocked by w-conotoxin MVIIC (Hofmann et al., 1994). 
VDCCs in pancreatic p-ceils 
VDCCs are characterized as T- and L-types in pancreatic /?-cells and in /ff-cell lines 
including RINm5F (Wollheim and Pozzan, 1984; Ashcroft et al., 1990). In addition, the 
presence of N-, P-, and Q-types has been suggested (Magneili et a!., 1995). The o, 
subunit of L-type VDCCs has been cloned in human pancreatic ^ff-cells and shares 65%, 
64%, and 41 % homology with the a, subunit of rabbit heart, skeletal muscle and brain, 
respectively (Seino et al., 1992). The properties of L- and T-type channels in 
pancreatic i?-cells are similar to those of skeletal and cardiac muscle and neurons. The 
L-type channels control voltage-dependent insulin release, but the significance of T-
type channels remains to be determined. With the patch-clamp technique, the 
additional presence of DHP-resistant high voltage activated (HVA) channels is 
suggested in RINm5F cells (Polio et al., 1993; Magneili et al., 1995). The L-type 
channels contribute to approximately 50% of the HVA current, the N-type channels to 
15%, Q-like-channels (kinetically similar to the P- and N-type channels) to 30% and the 
R-type channels to the remainder of the HVA currents. KCI-induced increases in [Ca^'^J, 
and insulin release are completely inhibited by DHP antagonists in rat islet cells and in 
RINm5F cells, but are not attenuated by w-conotoxin GVIA (Komatsu et al., 1989). 
Therefore, irrespective of the presence of other types of VDCCs or hormone-regulated 
Ca^"^ channels, only the L-type channels appear to be involved in the mechanism of 
depolarization-induced insulin release. However, contradictory finding has been 
suggested. D-glyceraldehyde and alanine-induced Ca^'^-dependent insulin release is 
attenuated by oz-conotoxin GVIA in RINm5F cells (Sher et al., 1992). This raises a 
possibility that depolarization-induced increases in [Ca^^], have differential signal 
transduction pathways from D-glyceraldehyde and alanine-induced increases in [Ca^"^],. 
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Fig. 8. Regulatory cycle of a G-protein. Squares and semisquares represent inactive 
conformations of the G-protein as they relate to modulation of effector functions. 
Circles and semicircles represent activated forms of the G-protein. Activation is both 
GTP and dependent and is stabilized by subunit dissociation to give an G,*-GTP 
complex and the G^ dimer. Hydrolysis of GTP by the G^ subunit deactivates it, 
increases its affinity for G^, and leads to reassociation to give an inactive holo-G-
protein with GDP bound to it (from Birnbaumer, 1990) 
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GTP-bindina proteins (G-oroteinsl 
G-proteins in signal transduction 
G-proteins consist of three subunits named a, 0 and y in order of decreasing 
molecular size. The a-subunits have a single, high affinity binding site for GTP or GDP. 
The 0- and j^-subunits are tightly associated and function as a unit. The GDP-bound 
form of the a-subunit is an inactive state and is bound tightly to the Py subunit, which 
stabilizes the GDP-bound form of the a-subunit. When GTP binds to an a-subunit, the 
a-subunit is dissociated from the 0y subunit and functions as a regulator of effector 
proteins (Fig. 8). In addition, the a-subunit has an intrinsic GTPase activity and 
hydrolyses the terminal phosphate of GTP to GDP and a free phosphate. Bacterial 
toxins covalently modify specific residues of the o-subunit. Cholera toxin (CTX), an 
87 KDa protein with one A and five B subunits, covalently modifies the a-subunit of 
CTX-sensitive-G-proteins (G^ and Gq,,) amplifying hormonal mechanisms. The A, 
subunit of CTX catalyses the transfer of an ADP-ribose unit from NAD"^ to a specific 
arginine side chain. This ADP-ribosylation of CTX-sensitive-G-proteins block their 
capacity to hydrolyze bound GTP to GDP. Pertussis toxin (PTX) ADP-ribosylates a 
specific cysteine residue of the a-subunit and prevents receptor-mediated activation of 
G-proteins. The ADP-ribosylation of PTX-sensitive G-proteins (G,, G^, and G,) blocks 
their capability to bind to GTP by releasing GDP. Consequently, both CTX and PTX 
play a role in increasing levels of cAMP depending on cell type. G-proteins are bound 
to the plasma membrane by anchoring K-subunits of G-proteins to a lipid molecule 
called an isoprenoid or by anchoring a-subunits to a lipid called myristic acid (Hepler 
and Gillman, 1992). Therefore, lipid modifications can change the affinity of G-proteins 
to the membrane and the affinity of the a-subunit for the 0y subunit (Birnbaumer, 
1990; Hepler and Gillman, 1992). 
Four G-protein families exist based on amino acid sequence relationships; Gg, G„ G^ 
and Gi2 (Hepler and Gilman, 1992). The a-subunit of the G^ family (G^ and Go,,) 
stimulates adenylyl cyclase and enhances the rate of cAMP synthesis. The Gs„-proteins 
stimulate DHP-sensitive VDCCs (L-type) in skeletal muscle (Mattera et al., 1989) and 
inhibit Na^ channels in cardiac muscle (Schubert et al., 1989). The a subunit of the G, 
family (G,, G^, G,, Gg and G^) inhibits adenylyl cyclase or Ca^+ channels. The Py 
subunits from G, may inhibit adenylyl cyclase indirectly by interaction with G^^ (Gilman, 
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1984). The CTX- and PTX-insensitive G, family (G,, G„, G14, 0,5 and G,6) activates 
phospholipase C which catalyses hydrolysis of phosphoinositol 4,5-bisphosphate (PIPj) 
to form inositol 1,4,5-trisphosphate (IP3) and diacylglycerol (DAG). The G12 family (0,2 
and G13) is present ubiquitously in tissues but its role is still unclear. 
G-proteins in pancreatic P-cells 
G-proteins link many hormone receptors to adenylyl cyclase, ion channels, 
phospholipase C, and exocytotic apparatus in pancreatic y9-cells. j?-ARs are coupled to 
the Gj-proteins to stimulate adenylyl cyclase and increase cAMP and insulin release 
(Sharp, 1979). Two molecular forms of G^^-proteins are present in HIT cells (derived 
from hamster islets with Simian virus-40 infection): with one form at 45 KDa and the 
other form at 52 KDa (Walseth et al., 1989), The 45 KDa form is more efficacious 
than the 52 KDa form as an activator of cAMP. Epinephrine inhibits insulin release 
through CT2-ARs, which are coupled to Gfproteins. PTX pretreatment (initially termed as 
islet activating protein) prevents the inhibitory effect of epinephrine by lowering cAMP 
(Katada and Ui, 1979; Hsu et al., 1991a). Five PTX substrates are found as three 
forms of Gi (Gj,, G12 and G^) and two forms of Go (G^, and G02) in RINm5F cells (Gillison 
and Sharp, 1994). In addition, three forms Grproteins and two forms of G^-proteins 
are found in HIT cells (Robertson et al., 1991). Two molecular forms of Gj^-proteins are 
present in RINm5F cells: with one form at 39 KDa and the other form at 42 KDa 
(Gillison and Sharp, 1994). 
The effects of prostaglandin Ej, somatostatin and galanin depend on the activation 
of a G,-protein (Robertson et al., 1987; Hsu et al., 1991b; Gillison and Sharp, 1994). 
All inhibitory effects of somatostatin are mediated by a PTX-sensitive mechanism, but 
the inhibitory effect of epinephrine is mediated through both PTX-sensitive and -
insensitive mechanisms (Roberson et al., 1991). The PTX-sensitive G-proteins on the 
effect of epinephrine are known as Gfproteins which inhibit adenylyl cyclase and 
proposed as Gefproteins which exert their effects by directly coupling to exocytotic 
apparatus (Ullrich and Wollheim, 1988). The PTX-insensitive G-proteins which mediate 
the inhibitory effect of epinephrine are not clear. However, the PTX-insensitive 
mechanism of epinephrine is suggested as Gj-proteins (Freissmuth et al., 1989; 
Robertson et al., 1991). 
40 
6S 
GOP, 
.  iGTPase 
N . \  
ATP 
CAMP 
PDE 
5'AMP 
GTP 
DP, 
PKA 
PKA* 
Fig. 9. iVIolecuiar mechanism of /S-AR activation of adenylyl cyclase and protein kinase 
A. Panel A shows stimulatory components of the complex in the inactive state. (A) 
represents yff-agonist, (G,) the stimulatory G-protein and (C) the catalytic component. 
Panel B shows activation of G^ by an agonist-bound receptor and GTP and the 
formation of the transient high-affinity complex. Panel C shows activated G^* which in 
turn activates C*. Gj* is subsequently deactivated by GTPase activity inherent within 
the G-protein. Increased cAMP concentration stimulates protein kinase A activity. 
cAMP is degraded to AMP by PDE (from Maier et al., 1989) 
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Adenvlvl cyclase 
Chemistry of adenylyl cyclase 
The formation of cAMP from ATP is catalyzed by adenylyl cyclase, an enzyme 
associated with the plasma membrane in mammalian cells. The six mammalian 
isoenzymes of adenylyl cyclase (AC I to AC VI) differ in tissue distribution and mode of 
regulation (Tang and Oilman, 1992). Eight adenylyl cyclases have been cloned; six of 
these (types I - VI) are from mammalian cells and two others (types VII and VIII) are 
products of Drosophila and Dictyostellium. Adenylyl cyclase is thought to be either a 
dimer or tetramer with a M.W. of 120 KDa. There are at least three classes of 
membrane-bound adenylyl cyclases. The most common motif in higher eukaryotes has 
one amino-terminal domain (N) and two cytoplasmic domains (CI and C2), connected 
by two hydrophobic transmembrane domains (Ml and M2). Ml and M2 have a six 
transmembrane helix. The hydrophobic domains may serve as a site for activation by 
forskolin, an activator of adenylyl cyclase. Among the eight adenylyl cyclases, CI a 
and C2a domains (portions of CI and C2 domains, respectively) have 50% - 92% 
homology among mammalian enzymes. The catalytic activity of adenylyl cyclases 
requires both C1a and C2a domains. 
Physiology of adenylyl cyclase 
Adenylyl cyclase is regulated by hormones and neurotransmitters, acting through 
both receptors (generally with seven transmembrane domains) and G-proteins. 
Adenylyl cyclase is stimulated by GTP-bound Ggo-proteins and inactivated by hydrolysis 
of GTP from Gj^-protein (Fig. 9). Inhibition of adenylyl cyclase is mediated by the a 
subunit of G, protein. The Py subunits also inhibit type I adenylyl cyclase by binding to 
stimulated a subunits of Gj-proteins, thereby blocking their access to adenylyl cyclase. 
Therefore, the inhibition by py subunits occurs only when Gg is present. By engaging 
the stimulatory a subunit, the inhibitory fiy subunits prevent Gg^-proteins from 
interacting with adenylyl cyclase. However, the fiy subunits greatly potentiate the 
stimulatory effect of G^^-protein on types II and IV. The concentration of the py 
subunits required to regulate the activity of adenylyl cyclase is greater than that of the 
a subunit of G^ protein. Thus, the Gg-protein may not be the source of the fiy subunits 
for such regulation. Rather, the necessary concentrations of the Py subunits may be 
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contributed by G-proteins such as G, and Go, which are more abundant than G^ (Hepler 
and Gillman, 1992). Although all the isoenzymes are stimulated by the GTP-bound a-
subunits of G^-proteins, they differentially respond to other regulators such as Ca^^ and 
calmodulin (CaM). Types I and III adenylyl cyclase are stimulated by Ca^''/CaM, while 
types II and IV are not sensitive to Ca^'^/CaM (Lustig et al., 1993). 
Adenylyl cyclase in pancreatic P-cells 
Adenylyl cyclase in pancreatic islets is regulated by Ca^"^-CaM (Thams et al„ 1982). 
Intracellular Ca^"^ may affect adenylyl cyclase to control cellular cAMP levels by 1) 
stimulating adenylyl cyclase via CaM, 2) directly inhibiting adenylyl cyclase, 3) 
stimulating cAMP-dependent PDE via CaM and 4) stimulating CaM-dependent kinase or 
protein kinase C-mediated effects on adenylyl cyclase (Caldwell et al., 1992). In 
RINm5F cells, Ca^^ stimulates adenylyl cyclase via a CaM-dependent mechanism. Ca^"^ 
inhibits adenylyl cyclase activity in the absence of CaM but stimulates adenylate 
cyclase in the presence of CaM. Maximal stimulation is achieved by 1 fjM [Ca^'^ljin the 
presence of 1 /jM CaM (Caldwell et al., 1992). Inhibitors of Ca^"^-calmodulin kinase II, 
KN-62 and KN-93, inhibit forskolin-stimulated insulin release, suggesting the possible 
involvement of Ca^'^-calmodulin kinase II in the control of insulin release after adenylyl 
cyclase is activated (Niki et a!., 1993). The differences in the response of Ca^+/CaM-
dependent adenylyl cyclase between cell types may reflect the relative distribution of 
the CaM-dependent and CaM-independent forms of adenylyl cyclase. However, in 
pancreatic islets, subtypes of adenylyl cyclase have not been demonstrated. 
Adenylyl cyclase in pancreatic islets is also regulated by Na"^ . /9-AR- and forskoin-
stimulated activation of adenylyl cyclase is enhanced by Na"^ suggesting that Na*^ can 
play a role in regulating Gg-proteins/adenylyl cyclase system (Watson et al., 1989). 
cAMP-deoendent protein kinase (protein kinase A) 
Chemistry of protein kinase A 
cAMP primarily activates protein kinase A to control diverse phenomena such as 
metabolism, gene transcription, and memory (Krebs and Bevo, 1979). Protein kinase A 
is present in all mammalian cells at a cellular level of 0.2 - 2 yuM. In the absence of 
cAMP, protein kinase A is an inactive tetramer composed of two regulatory subunits 
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and two catalytic subunits. Two isoforms of regulatory subunits (I and II with M.W. 
of 43 and 45 KDa, respectively) are products of different genes. Because regulatory 
subunits I and II isoforms have a complex with the same catalytic subunit isoforms, the 
release and activation of catalytic subunit from either holoenzyme would target the 
same substrates (Doskeland et al., 1993). The regulatory subunits are homodimers 
formed through interactions of monomers near the amino termini, although 
heterodimers also occur (Jahnsen et al., 1986). 
Three isoforms of the catalytic subunit (a, and y with a M.W. of 40 KDa) are the 
products of separate genes. In the absence of cAMP, the regulatory homodimer is 
combined with any of the catalytic subunit isoenzyrrjes with a concentration of 0.2 //M. 
The catalytic activity of the catalytic subunit is latent because of the inhibition by the 
inhibitory domain of regulatory subunits. When two cAMP molecules bind per 
regulatory subunit, the affinity of regulatory subunit for catalytic subunit decreases 
10,000 - 100,000-foid. Tetrameric protein kinase A dissociates into dimeric regulatory 
subunits and two monomers of catalytic subunits, and inhibition of catalytic subunit by 
regulatory subunit is concomitantly released (Francis and Corbin, 1994). After the 
catalytic subunit is activated, it catalyzes the transfer of the K-phosphate of ATP to 
protein or peptide substrates containing the -RRXSX- substrate consensus amino acid 
sequence (Yeaman et al., 1977). 
The regulatory subunits of protein kinase A are classified into type I and type II 
based on the order of holoenzyme elutes in anion exchange resins (Corbin et al., 1975) 
and their amino acid sequence (Takio et al., 1984). In addition, type I and type II 
holoenzymes can functionally be distinguished on the basis of their potential for 
autophosphorylation and interaction with MgATP. The type II holoenzyme contains an 
autophosphorylation site on the regulatory subunit, whereas the type I holoenzyme is 
not autophosphorylated but has a high affinity binding site for MgATP (Hoffmann et al., 
1975). The isoenzymes are equally activated because MgATP stabilizes type I protein 
kinase A, and autophosphorylation stabilize type II protein kinase A. 
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Physiology of protein kinase A 
Protein l<inase A, primarily the type II isoform, is associated with the cytoskeleton, 
Golgi complex, and microtubule organizing centers (Bregman et al., 1989; Bregman et 
al., 1991). In neurons, more than 70% of protein kinase A is localized to the 
postsynaptic densities and dendritic cytoskeletal elements. Proteins that interact with 
regulatory subunit li to anchor the catalytic subunits or regulatory subunits to 
subcellular compartments have been called A kinase Anchoring Proteins (AKAPs). 
AKAPs vary in size, amino acid sequence and relative affinities for either regulatory 
subunits \\a or 11^ (Meinkoth et al., 1990). AKAPs may specifically localize protein 
kinase A to regions/substrates for which rapid regulatory control is important. 
Regulation of cellular processes by protein kinase A occurs over a narrow range of 
activities, because two- to three-fold increases in cAMP produce maximum 
physiological responses in most tissues. One mechanism for limiting cAMP elevation is 
through negative feedback control to regulate its own steady-state activity. The 
activated protein kinase A phosphorylates and activates a PDE, which accelerates the 
rate of cAMP degradation (Gettys et al., 1987). This PDE is designated as low PDE, 
cGMP-inhibited PDE or type III PDE. 
Protein kinase A in pancreatic P-celis 
Two isoforms of protein kinase A are present in pancreatic /ff-cells (Sugden et al., 
1979) and several islet proteins are phosphorylated in the presence of cAMP {Harrison 
et al., 1984). Although protein kinase A phosphorylates some substrates, the nature 
of the substrates and their role in cAMP-mediated responses remains unclear. In HIT 
cells, protein kinase A increases Ca^"^ influx through voltage-dependent Ca^"^ channels 
by phosphorylating Ca^"^ channels or closely associated proteins (Rajan et al., 1989). 
However, in pancreatic ^ff-cells and RINmSF cells, forskolin potentiates glucose-induced 
insulin release without changing [Ca^*^], (Wollheim et al., 1984; Rorsman and 
Abrahamsson, 1985). Furthermore, forskolin stimulates insulin release while [Ca^^l, is 
held constant (Tamagawa et al., 1985). Thus, the potentiating effect of cAMP on 
glucose-stimulated insulin secretion may not be mediated by VDCCs in the pancreatic 
iff-cells (Hill et al., 1987). In addition, protein kinase A closes ATP-sensitive K"*" 
channels (Holz et al., 1993) and/or directly interacts with the secretory machinery 
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(Ammala et al., 1993). In HIT cells, changes in cAMP content and the subsequent 
effect on [Ca^*^]! appears to be dependent on glucose, suggesting that an unidentified 
glucose-generated signal is required for the action of cAMP (Rajan et al., 1989). 
There are contradictory observations regarding cAMP/protein kinase A-mediated 
insulin release. An increase in cAMP concentration can potentiate, but does not initiate 
secretion from the pancreatic l3-cel\s. This suggests that an elevation in intracellular 
cAMP concentration is an insufficient stimulus for the initiation of insulin secretion and 
cAMP plays a potentiating role in the secretory processes (Persaud et al., 1990). In 
addition, cAMP can act through mechanisms other than the activation of protein kinase 
A. The regulatory subunit of protein kinase A containing bound cAMP can function 
independently to interact with the catalytic subunit of protein kinase A. An 
unidentified cAMP-binding protein may mediate cAMP effects without interacting with 
protein kinase A (Weber et al., 1987). Furthermore, cAMP may act by binding to 
cGMP-dependent protein kinase or ion channels (Ludwig et al., 1990; Jiang et al., 
1992; Holz, 4th. et al., 1995). 
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CHAPTER II RATIONALE 
Since a rat clonal insulin-secreting cell line RINmSF was established from rat 
insulinoma, RINmSF cells have facilitated numerous studies on i^-cell functions such as 
receptors, the regulation of [Ca^"^], and insulin release. However, their utilization has 
been limited because insulin secretion gradually is decreased and the morphology is 
changed from differentiated to undifferentiated state as the culture ages. Our 
preliminary studies showed that the effect of epinephrine on insulin release was 
inhibitory in differentiated cells and stimulatory in undifferentiated cells. The effect of 
KCl and Bay K 8644 increased [Ca^"^]! and insulin release more in differentiated cells 
than in undifferentiated cells. Although insulin secretion was greater in differentiated 
cells than in undifferentiated cells, a novel insulin-like immunoreactivity was 
demonstrated only in undifferentiated cells. Therefore, we were interested in 
characterizing RINmSF cells in a passage- and morphology-dependent manner to 
determine whether these changes are a genuine feature of the cells or merely a 
consequence of long-term maintenance. 
In rat pancreatic )8-cells and RINmSF cells, information has accumulated on the 
heterogeneity and structure of insulin. Rat pancreas secretes 2 types of insulin {rat 
insulins I and II), but RINmSF cells express only rat insulin type I. In chapter III, we 
first demonstrated a novel insulin-like immunoreactivity in undifferentiated RINmSF cells 
which was attributable to neither rat insulin I nor II by using radioimmunoassay (RIA), 
immunocytochemistry (ICC) and immunoblot assay. 
Specific tools for the investigation of insulin have been RIA, ICC, and immunoblot 
assay. The measurement of insulin is relatively simple, precise and rapid when 
measured by RIA. Insulin measurement by RIA techniques is based on specific binding 
of an anti-insulin antibody to insulin (Parker, 1981). RIA techniques require insulin 
labelled with ^^^1 and depend on the ability of the unlabeled insulin to inhibit binding of 
the radioactive insulin by antibody. To maximize sensitivity, the assay is carried out in 
the presence of only enough antibody to achieve substantial radioactive insulin binding. 
In this study, the dilutions of antibodies selected gave approximately 30% binding of 
radioactive insulin when unlabeled insulin is absent. The process is a simple 
competition in which insulin occupies a portion of the antibody-combining sites 
47 
reducing the free antibodies available to radioactive insulin. Fixed concentrations of 
antibody and labeled '"l-insulin are incubated in the absence and in the presence of the 
unknown amounts of insulin. Once adequate binding of labeled ^^^l-insulin has been 
established, free and antibody-bound ^^^l-insulin are separated and measured by a y-
counter. The unknown concentration of insulin is determined by comparing the 
decrease of ^^^l-insulin binding with a standard curve obtained by adding known 
amounts of insulin to the assay system. 
Localization of insulin within cells can be determined by ICC. After the cells are 
permeabilized by Triton-X 100, the ceils are preincubated with normal goat serum to 
minimize nonspecific staining, and subsequently incubated with a primary antiserum vs. 
insulin. After removal of the primary antiserum, the cells are treated with biotinylated 
secondary antibodies and an avidin-biotinylated peroxidase complex (ABC). Peroxidase 
staining is obtained by incubating the ceils in diaminobenzidine (DAB) and HjOj. In 
addition to ICC, sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) 
and immunoblot are sensitive and capable of a high degree of resolution for insulin. A 
SDS-PAGE system separates proteins in a M.W. range from 1 to 100 KDa. The use of 
tricine as a trailing ion allows a resolution of insulin at lower acrylamide concentrations 
than in glycine-SDS-PAGE systems (Schagger and Jagow, 1987). Samples are 
electrophoresed on an SDS-PAGE and transferred to a nitrocellulose paper for reaction 
with a subsequently added antiserum vs. insulin. The insulin-antibody vs. insulin on 
the sheet is incubated with biotinylated secondary antibodies and ABC. Peroxidase 
generates a colored product after incubating the sheets in DAB. 
Epinephrine potentially modulates insulin release through ARs, with ctj-ARs 
inhibiting and a,- and jS-ARs stimulating insulin release. The presence of a^, P2-
ARs has been demonstrated in pancreatic j8-ceils and ;8-cell lines including RINmBF 
cells. In pancreatic )9-cells and RINmSF cells, the crj'^ctions on the effect of 
epinephrine in insulin release have been relatively well demonstrated; however, a,- and 
i^z-actions have not. RINmSF cells are useful in classifying and characterizing ARs and 
signal transduction mechanisms through their receptors. Furthermore, alterations of 
functional distributions of ARs can be studied when the morphology of the cells is 
changed from differentiated to undifferentiated state as the culture ages. The 
efficiency of the stimulus through ARs is influenced by the density of the receptors and 
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the nature of the signal transduction mechanisms which translate external signals into 
the cell responses. Therefore, specific AR-agonists and -antagonists can demonstrate 
the functional involvement of ARs on the cells, and specific enzyme activators and 
inhibitors can provide information on the contribution of signal transduction 
mechanisms through the receptors. In chapter IV, we characterized a passage- and 
morphology-dependent change of ARs with regard to their relative contributions to 
cAMP production and insulin release. In addition, in chapter V, we further 
demonstrated the possible contribution of G-protein, adenylyl cyclase, PDE and protein 
kinase A for the action mediated by ARs. These studies identify the distinct 
distribution of ARs between differentiated and undifferentiated cells and provide 
information for further utilization of RINm5F cells in characterizing the function of ARs 
and adenylyl cyclase in the cells. 
An increase in [Ca^"^], induces insulin release in pancreatic jff-cells. Stimulus-
secretion coupling in pancreatic ^ff-cells, therefore, refers primarily to the membrane and 
intracellular events that mediate an increase in [Ca^"^]i sufficient to modulate insulin 
release in the cells. In RINmBF cells, the contribution of VDCCs to increases in [Ca^"^], 
and insulin release has been studied; however, the relative distribution of VDCC 
subtypes is still controversial. In chapter VI, we employed RINmSF cells with two 
morphological features to further characterize the subtypes of VDCCs with regards to 
their voltage dependency, kinetics, and pharmacology. This study provides information 
to better understand the functional roles of VDCCs in electrophysiological and chemical 
signallings. The functional role of VDCCs is important as they are frequent targets for 
modulation by hormone, neurotransmitter, and drugs. 
A fluorescent probe, Fura-2, allows reliable quantitification of intracellular free Ca^^ 
concentration from a resting level of approximately 100 nM to a maximal level of 
several micromolar. Fura-2 is a Ca^"^-chelating dye that changes its fluorescent 
properties after binding to free Ca^*. Fura-2 has an excitation wavelength between 
340 and 380 nm, and the emission of the two wavelengths is monitored at 510 nm. 
An increase in ICa^"^]! results in an increase in the ratio of 340/380 nm. An advantage 
of Fura-2 is that some variabilities from nonuniform dye concentrations, probe leakage, 
dye bleaching and cell thickness do not affect the ratio measurements. In addition, the 
ratio measurement has time resolution to the millisecond, which allows for recording of 
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[Ca^"^]i in real time. 
conductance tlirough its channels is directly proportional to the activity of the 
channel. The whole-cell patch-clamp technique makes it possible to study Ca^* 
channels. The patch-clamp technique provides an electrical isolation of a small 
membrane patch from the rest of the cell membrane. The patch pipette is pressed 
against the cell membrane and a slight negative pressure forms a seal with high 
resistance on the order of 10® ohm (Gigaohm), a so called gigaohm seal. After the 
gigaohm seal is established, the membrane is permeabilized by amphotericin B to 
eliminate "run-down" (diminution of Ca^^ currents without apparent reason) and the 
dialysis of cytoplasmic constituents with the pipette solution leading to the loss of 
regulatory second messengers. When stimulated by voltage or ligands, the Ca^"^ 
channels in the plasma membrane open and the charged ions move through the channel 
due to an electrical gradient. The movement of the charged ions is called current, 
which passes through the wire, is amplified, and then recorded by the amplifier. 
The methodology and techniques described above can be used to characterize 1) a 
novel insulin-like immunoreactivity, 2) the effect of epinephrine on cAMP production 
and insulin release, 3) the effect of Gs-protein, adenylyl cyclase, PDE, and protein 
kinase A, and 4) a characterization of VDCCs in differentiated and undifferentiated 
RINmSF cells. 
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CHAPTER III CHARACTERIZATION OF A NOVEL INSULIN-LIKE 
IMMUNOREACTIVITY IN A RAT CLONAL BETA-CELL LINE, RINM5F 
IN A PASSAGE- AND MORPHOLOGY-DEPENDENT MANNER 
A paper to be submitted to American Journal of Physiology 
Bum-sup Lee, Chi Yang, H-. Dieter Dellmann, Carol D. Jacobson, 
Richard L. Engen, Cheryl Clark, Ter-Hsin Chen and Walter H. Hsu 
ABSTRACT 
A rat clonal yff-cell line, RINmBF, is derived from a radiation-induced insulinoma and 
secretes insulin. We have utilized radioimmunoassay, immunocytochemistry and 
immunoblotting by using antisera vs. rat, porcine and bovine insulins to characterize a 
novel insulin-like immunoreactivity in undifferentiated RINmBF cells. Antisera vs. rat 
and porcine insulins recognized all rat, porcine and bovine insulins. However, the 
antiserum vs. bovine insulin did not recognize rat insulin but did recognize porcine and 
bovine insulins. 
The RINmBF cells exhibited one of two morphological features; the differentiated 
state with long neuron-like processes and the undifferentiated state without the 
processes. As the morphologies of the cells were changed from differentiated to 
undifferentiated cells, the amount of secreted insulin decreased. By applying antisera 
vs. rat and porcine insulins in RIA, the amount of secreted insulin from RINmBF cells 
was gradually decreased; however, it was gradually increased by antiserum vs. bovine 
insulin. Transmission electron microscopy revealed that more dense core secretory 
vesicles were contained in differentiated cells than in undifferentiated cells. 
Examination by immunocytochemistry and immunoblot demonstrated that antisera vs. 
rat and porcine insulins reacted with insulin in both differentiated and undifferentiated 
cells. However, antiserum vs. bovine insulin reacted with insulin in undifferentiated 
cells, but not with insulin in differentiated cells. In immunoblotting, insulin from cell 
homogenate was found as a single band at a M.W. of 6 KDa. Antiserum vs. porcine 
insulin reacted with insulin from both differentiated and undifferentiated cell 
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homogenate. However, antiserum vs. bovine insulin reacted with insulin from 
undifferentiated cell-homogenate, but not with insulin from differentiated cell-
homogenate. These results suggested that a novel insulin-like peptide (NIP) is present 
in undifferentiated RINm5F cells, which is not attributable to rat insulin I nor II. In 
addition, NIP secreted from undifferentiated cells was neither rat insulin I and II nor 
insulin like growth factor (IGF)-I and -11. 
INTRODUCTION 
Insulin, with a 5.6 KDa and 51 amino acids, is composed of two amino acid chains 
joined together by two disulfide linkages (Miaza and Wilkin, 1989). The two chains 
are compactly arranged, with the A chain positioned above the central helical portion of 
the B chain. Pancreatic ;ff-cells synthesize insulin from a single-chain precursor called 
proinsulin. On conversion of proinsulin to insulin, four basic amino acids and the 
remaining connector or C-peptide are removed by proteolysis. Preproinsulin has been 
identified as the precursor of proinsulin. Preproinsulin is synthesized and cleaved to 
proinsulin in the endoplasmic reticulum, and is therefore not a product that is 
accumulated in theyff-cell (Chan et al., 1976). 
In contrast to the majority of mammals, not one but two different insulins are 
present in the pancreas of rats (Smith, 1964; Clark and Steiner, 1969) and mice 
(Balant et al., 1971). In the rat, these insulins are nonallelic and coded by two distinct 
genes, with the corresponding mRNAs showing about 93% homology (Ullrich et al., 
1977; Villa-Komaroff et al., 1978). The primary translation products, rat preproinsulin I 
and II, differ by 3 amino acid substitutions in the signal peptide sequence, 2 in the C-
peptide region and 2 in the B-chain (Cordell et at., 1979; Villa-Komaroff et al., 1978). 
Many species variations of insulin are known and the major sites of structural 
difference among porcine, bovine, and rat insulins are in positions 8, 9, and 10 of the 
A chain (Rathjen et al., 1986). The structural differences of bovine, porcine and rat (I 
and II) insulins are shown in figure 1. 
The rat insulinoma cell line RINm5F is derived from a radiation-induced insulinoma 
transplanted for further growth in nude mice. The expression of the two nonallelic 
genes in rat insulinoma cells has been found to be 10-fold higher for rat insulin I than 
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rat insulin II (Cordell et al., 1982). it also has been demonstrated that only the rat 
insulin type I gene is expressed despite the presence of the rat insulin II gene in rat 
insulinoma cells (Fiedorek Jr. et al., 1990). These differences in insulin production 
rates could be the result of differences in transcription of either of the two nonallelic 
genes present in rats (Lomedico et al., 1979) or subsequent steps involving processing 
and stability of either of the two gene products (Fiedorek Jr. et al., 1990). 
In a preliminary study, we observed that the amount of secreted insulin from 
RlNmBF cells was decreased as the morphologies of the cells were changed from 
neuron-like processed (differentiated) cells to non-processed (undifferentiated) cells. 
Furthermore, antiserum vs. rat insulin could recognize insulin secreted by both cell 
types but antiserum vs. bovine insulin recognized insulin secreted only by 
undifferentiated cells. These findings suggested that a novel insulin-like 
immunoreactivity was present in undifferentiated cells and prompted us to further 
characterize the novel insulin-like immunoreactivity in undifferentiated RlNmBF cells. 
We hypothesized that undifferentiated RlNmBF cells secrete a novel insulin-like peptide 
(NIP) that is different from the insulin secreted by differentiated RlNmBF cells. 
Therefore, this study was performed to characterize the novel insulin-like 
immunoreactivity in undifferentiated RlNmBF cells. 
MATERIALS AND METHODS 
Materials 
The following materials were used: RPMI-1640, fetal bovine serum, IGF-I, IGF-II, 
and poly-L-lysine (all from Sigma Chemical,St. Louis, MO), 24-well culture plate 
(Corning Glass Works, Corning, NY), rat insulins I and II, porcine insulin and bovine 
insulin (Eli Lilly, Indianapolis, IN), antiserum vs. rat insulin (Linco Research Inc., St 
Louis, MO), antiserum vs. porcine insulin (a gift from Dr. Joseph Dunbar, Wayne State 
University, Detroit, Ml), antiserum vs. bovine insulin (a gift from Dr. Allen Trenkle, Iowa 
State University, Ames, lA), secondary biotinylated anti-guinea pig IgG antibody and 
avidin-biotin complex kit (all from Vector, Burlingham, CA), Tricine (Fisher, Pittsburgh, 
PA), Tricine-gel (Jule Inc., New Haven, CT), nitrocellulose paper (Bio-Rad, Hercules, 
CA), and a low molecular marker (Novex, San Diego, CA). 
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Cell culture 
RINmBF cells were obtained from Dr, S.B. Pek (University of Michigan Medical 
Center, Ann Arbor, Ml). The cells were maintained in RPMI-1640 medium with 10% 
fetal bovine serum as described previously (Chen et al., 1994). The cells were 
subcultured every 7 days and the medium was changed at day 3 and day 5 after 
subculture. All experiments were performed by use of cells from passages 28-40. No 
antibiotics were used. 
Insulin secretion 
Static incubations were performed to study insulin release as previously described 
(Hsu et al., 1991). Briefly, RINmBF ceils were plated into 24-well Corning plates and 
grown for 5 days. For experiment, every other passage from 28 to 40 was used. For 
passages from 28 to 32, the cells were plated at 0.2 million cells/well and for passages 
after 34, the cells were plated at 0.1 million cells/well. Growth medium was removed 
and the monolayer cells were washed with modified Krebs-Ringer bicarbonate buffer 
(KRB) containing (in mM): 136 NaCI, 4.8 KCI, 2.5 CaClz, 1.2 KH2PO4, 1.2 MgSO^, 5 
NaHCOg, 10 HEPES, 1.67 glucose and 0.1 % bovine serum albumin at pH 7.4. The 
cells were preincubated for 15 min, and incubated for 15 min at 37 °C. After 
experiments, the cells were detached by using trypsin-EDTA and the cell numbers were 
counted in each well. Insulin in the media was measured by radioimmunoassay (RIA) 
as previously described (Hsu et al., 1991). 
Immunocytochemistry 
The cells were seeded into Petri dishes with histological cover slides that were 
previously coated with poly-L-lysine and then cultured for 5 days. The cells were then 
fixed with 4% paraformaldehyde and stained for insulin by an avidin-biotin complex 
method described previously (Hill et al., 1987). Briefly, the cells were treated with 
0.3% H2O2 to block endogenous peroxidase activity and permeabilized with 0.4% 
Triton-X 100. The cells were incubated with antiserum vs. rat or bovine insulin for 
24 h at room temperature. The secondary biotinylated anti-guinea pig IgG antibody 
(0.02%) was applied for 2 h, followed by an incubation with 1 % avidin-biotin-
horseradish-peroxidase complex. Immunologically bound peroxidase was visualized 
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with 0,4 mg/ml diaminobenzidine and 3% HjOj. The cells were counterstained with 
Neutral Red and dehydrated with ethanol series from 70% to 100%. 
Electron microscopy 
The cells were grown on poly-L-lysine coated coverslides for 5 days and fixed in 
phosphate-buffered 5% glutaraldehyde. The cell were processed as previously 
described (Dellmann and Stahl, 1984). Briefly, the ceils were postfixed in 1 % OsO^ 
plus 1.5% potassium ferricyanide in veronal acetate buffer for 1 h, stained ert bloc for 
2 h in uranyl acetate in the same buffer, dehydrated and embedded in an epon-araldite 
mixture for transmission electron microscopy. Following orientation in semi-thin 
sections, thin sections were examined at 50 KV with a Hitachi HU 12 A electron 
microscope. 
Immunoblo tting 
RINmSF cells in suspension were homogenized with a tissue homogenizer and the 
cell debris was pelleted by 30 min of centrifugation at 10,000 x g. Insulin was 
separated by tricine-SDS-gel electrophoresis as previously described (Schagger H., and 
von Jagow, G., 1987). Briefly, a tricine buffer system with stacking and spacing gels 
and a separating gel of 16.5% polyacrylamide was applied. The running time was 2 h. 
The proteins separated were transferred to nitrocellulose paper. For immunoblotting, 
the nitrocellulose paper was blocked by incubation in 2% nonfat dried milk in Tris-
buffered saline (50 mM Tris, 150 mM NaCI, pH 7.4) for 1 h as described previously 
(Fiedorek Jr. and Parkinson, 1992). The antiserum vs. porcine or bovine insulin were 
applied for 24 h followed by applying biotinylated anti-guinea pig secondary antibody 
for 1 h. The avidin-biotin-horseradish-peroxidase complex was applied and 
immunologically bound peroxidase was visualized with diaminobenzidine and H^Oj. 
Statistical analysis 
All values were expressed as the mean ± S.E. Results were analyzed by using 
analysis of variance (ANOVA). The least significance test was used to test for 
differences between means of end points for which the ANOVA indicated a significant 
(P <0.05) F ratio. 
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RESULTS 
Changes in morphology of RINmSF cells 
RINmSF cells exhibited one of two morphological features; the differentiated state 
with neuron-like processes and the undifferentiated state without the processes (Fig. 
2). Transmission electron microscopy revealed the presence of dense core secretory 
granules typical for vesicles in unstimulated RINmBF cells (Fig. 3). RINm5F cells 
contained scattered dense-core secretory granules which exhibited variable 
morphologies. Some cells exhibited the characteristic clear halo of islet /9-cell granules 
and others displayed a more immature, halo-devoid appearance. The dense core 
secretory granules were heterogeneously dispersed predominantly along plasma 
membranes and cellular processes. The dense core secretory vesicles were more 
numerous in the differentiated cells than undifferentiated cells. In differentiated cells, 
the endoplasmic reticulum (ER) was composed of elongated cisternae and occurred in 
stacks. In contrast, in undifferentiated cells the ER was composed of short or 
elongated cisternae and dispersed in a poorly organized way (Fig. 3). More than 80% 
of the cells between passages 28 and 32 had neuron-like processes. However, the 
cells gradually lost processes to become non-processed cells with more than 99% of 
the cells after passage 35 not exhibiting processes (Fig. 4). We defined a passage 
which had >90% of neuron-like processes as differentiated cells, and a passage which 
had < 1 % of the processes as undifferentiated cells. Therefore, the passages 28 - 30 
were differentiated cells and the passages ^ 35 were undifferentiated cells (Fig. 4). 
Specificities of antisera vs. rat-, porcine- and bovine-insulins on rat, porcine and bovine 
insulins and insulin-like growth factors 
Experiments were performed by incubating antiserum vs. rat, porcine or bovine 
insulin with ^^^l-porcine insulin and increasing concentrations of rat, porcine or bovine 
insulin from 31.25 to 8000 pg/ml. The binding affinities of antiserum vs. rat, porcine 
or bovine insulin were calculated from the concentration of the insulins required to 
inhibit the binding of ^^®l-porcine insulin by 50% (ICgo). ICgo's of rat, porcine, and 
bovine insulins to antiserum vs. rat insulin were 362, 387 and 241 pg/ml, respectively. 
Fig. 2. Phase-contrast photographs of differentiated (A) and undifferentiated (B) 
RINmSF cells. Magnification 400 X. These pictures were taken 48 h after 
subculture. (C) Change of the percentage of cells with processes with passage-
dependent manner in RINmBF cells. One representative result out of 5 observations. 
The cells were counted 48 h after subculture. 
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Rg. 3. Ultrastructures of differentiated (left panel) and undifferentiated (right panel) 
RINmBF cells. A and B are representatives of most fields from differentiated cells. 
C and D are representatives from undifferentiated cells. Dense core secretory vesicles 
(It) and endoplasmic reticulum (t) are more apparent in differentiated cells than in 
undifferentiated cells. The secretory granules are found along with plasma membrane 
(i^), mitochondria (A), endoplasmic reticulum (t) and Golgi apparatus (:*•). 
Magnifications; A and B 3,750 X, C and D 15,000 X. 
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Differentiated cells Undifferentiated cells 
Fig. 4. Specificities of antisera vs. rat (A), porcine (B) and bovine (C) insulins. Insulin 
labelled with '^'1 was incubated in the presence of rat {•), porcine (7) or bovine (•) 
insulin. Once adequate binding of labelled '"l-insulin was established, free and 
antibody-bound '^®l-insulin was separated and measured by a K-counter. Mean ± S.E. 
(n = 4) are shown. 
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The ICso values of rat, porcine, and bovine insulins to antiserum vs. porcine insulin 
were 1907, 474 and 982 pg/ml, respectively. The IC50 values of porcine and bovine 
insulins to antiserum vs. bovine insulin were 688 and 545 pg/ml, respectively. 
However, The IC50 values of rat insulin to antiserum vs.bovine insulin could not be 
determined because rat insulin only inhibited the binding of ^^®l-porcin8 insulin by 14% 
at a maximal concentration of rat insulin at 8000 pg/ml (Fig. 5). Furthermore, even a 
high concentration of 64 ng/ml, rat insulin inhibited the binding of '^®l-porcine insulin to 
antiserum vs. bovine insulin only by 20%. Rat insulins I and II (8000 pg/ml) inhibited 
the binding of '^®l-porcine insulin to antiserum vs. bovine insulin by only 15% (Fig. 5A). 
Since IGFs have considerable homology with insulin and proinsulin, the specificity of 
antiserum vs. bovine insulin on IGF-I and -II was determined. The antiserum was 
incubated with ^"l-porcine insulin and increasing concentrations of IGF -I and -II from 2 
to 64 ng/ml and even a single high concentration of 512 ng/ml. IGF -I and -II at 2 to 
64 ng/ml and 512 ng/ml did not significantly inhibit the binding of 1251-porcine insulin 
to antiserum vs.bovine insulin (Fig. 58). 
Changes in insulin release and a novel insulin-like immunoreactivity in RINmSF cells 
The cells secreted insulin in all passages studied (28 - 40). When antisera vs. rat 
or porcine insulins were used to recognize the insulin, the amount of basal release of 
insulin was gradually decreased as morphologies of the cells were changed from 
differentiated to undifferentiated cells. However, when antiserum vs. bovine insulin 
was used, the amount of insulin secreted was gradually increased from nearly 
undetectable concentrations, as the morphology of the cells changed from the 
differentiated state to undifferentiated state (Fig. 6). 
To further characterize a novel insulin-like peptide (NIP) secreted from 
undifferentiated cells, competitive inhibition of the peptide for the binding of ^^®l-
porcine insulin to antiserum vs. insulin was compared with the inhibition of insulin for 
the binding of ^^®l-porcine insulin. The experiment was performed by incubating 
antiserum vs. rat, porcine or bovine insulin with '"l-porcine insulin and NIP from 
undifferentiated cell homogenate. NIP (31.25 - 8000 pg/ml) dose-dependently inhibited 
Fig. 5. (A) Specificities of antisera vs. rat (a and 0) and bovine (• and O) insulins on 
rat insulin I (• and A) and II {O and O). ^^®l-insulin was incubated with rat insulin I 
and II. (B) Specificity of antiserum vs. bovine insulin on IGF-I (•) and IGF-II (V) and 
bovine insulin (T). '"l-insuiin was incubated in the presence of IGF-I, IGF-II, and bovine 
insulin. Mean ± S.E. (n = 4) are shown. 
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Fig. 6. Passage dependency of basal insulin secretion in RINm5F cells. The basal 
insulin was measured by antiserum vs. rat insulin (O) and by antiserum vs. bovine 
insulin (•). After KRB buffer was removed, the cells were detached by using trypsin-
EDTA and the cell numbers were counted in each well. Mean ± S.E. (n = 16) are 
shown. 
Fig. 7. Dose-dependent inhibition by a novel insulin-like peptide (NIP) from 
undifferentiated cell-homogenate for the binding of ^^®I-insulin. Rat insulin (A and B) 
and porcine insulin (C) were used as a standard with antisera vs. rat (A), porcine (B), 
and bovine insulin (C). '"l-insulin was incubated with NIP (•) and insulin (O). Once 
adequate binding of labelled ^^®l-insulin was established, free and antibody-bound 
'"l-insulin was separated and measured. Mean (n = 4) is shown. 
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the binding of ^^®l-porcine insulin to antisera vs. rat, porcine, and bovine insulins (Fig. 
7). In addition, the pattern of dose-dependent inhibition by NIP paralleled the pattern of 
the inhibition by rat and porcine insulins. This suggested that NIP contained in 
undifferentiated RINm5F cells was most likely insulin. 
To determine whether all of NIP secreted by undifferentiated cells was 
immunoreactive to antiserum vs. bovine insulin, two standard systems were applied by 
using porcine insulin with antiserum vs. porcine insulin, and by using porcine insulin 
with antiserum vs. bovine insulin. The amount of NIP recognized by a standard of 
porcine insulin with antiserum vs. porcine insulin was 2.6 ± 0.1 and 3.0 ± 0.2 
ng/min/million cells in passages 38 and 40, respectively. The amount of NIP 
recognized by a standard of porcine insulin with antiserum vs. bovine insulin were 2.9 
± 0.2 and 3.3 ±0.1 ng/min/million cells in passages 38 and 40, respectively. 
Between these standard systems, the amount of NIP was not significantly different 
between two standard systems in passages 38 and 40. This suggested that all of the 
NIP secreted in undifferentiated cells was immunoreactive to antiserum vs. bovine 
insulin. 
Localization of insulin using immunocytochemistry and immunoblot analysis in RINmSF 
cells 
Immunoreactive insulin was localized in RINmSF cells using immunocytochemistry. 
Insulins, which were not treated with antisera vs. rat and bovine insulins, were not 
immunostained in either differentiated or undifferentiated cells (Figs. 8A and SB), in 
addition, insulins, which were not treated with biotinylated anti-guinea pig antibody, 
were not immunostained in either differentiated or undifferentiated cells (data not 
shown). Both differentiated and undifferentiated cells were immunostained for insulin 
with antiserum vs. rat insulin (Figs. 8C and 8D). However, with antiserum vs. bovine 
insulin, insulin was immunostained in undifferentiated cells (Fig. BF) but not in 
differentiated cells (Fig. 8E). To further characterize a novel insulin-like 
immunoreactivity, immunoblotting was applied (Fig. 9). Antiserum vs. porcine insulin 
reacted with rat insulin I [lane 2), however, antiserum vs. bovine insulin did not [lane 
5). In addition, antiserum vs. porcine insulin recognized insulin from both cell 
homogenates {lanes 3 and 4), however, antiserum vs. bovine insulin recognized insulin 
Fig. 8. Localizations of insulin by immunocytochemistry in differentiated (left panel) 
and undifferentiated (right panel) RlNmBF cells. As a negative control (A and B), 
antiserum vs. insulin or biotinylated anti-guinea pig antibody was omitted. Antiserum 
vs. rat insulin (C and D) or antiserum vs. bovine insulin (E and F) were treated to stain 
insulin. The cells were counterstained with Neutral Red. These pictures are 
representatives of most fields from differentiated and undifferentiated RlNmBF cells. 
Magnification 128 X. 
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only from the undifferentiated cell homogenate (lanes 6 and 7). Insulin from cell 
homogenates were not immunostained when they were not treated with either 
antiserum vs. insulin or biotinylated anti-guinea pig antibody (data not shown). In 
immunoblotting, insulins from both cell homogenates and rat insulin I had same 
mobility and a single band. M.W of insulin from both cell homogenates and rat insulin 1 
were near 6 KDa (Fig. 10). 
DISCUSSION 
We have characterized a novel insulin-like immunoreactivity in undifferentiated 
RINm5F cells, which does not represent either rat insulins I or II. As the morphology of 
the cells changed from the differentiated state to undifferentiated state, the amount of 
secreted insulin was decreased; however, the immunoreactivities of antiserum vs. 
bovine insulin were increased from nearly undetectable concentrations. Studies from 
immunocytochemistry and immunoblot further confirmed that insulins from the 
undifferentiated cells were immunoreactive with all antisera vs. rat, porcine and bovine 
insulins, although insulins from the differentiated cells were immunoreactive with both 
antisera vs. rat and porcine insulins but not with antiserum vs. bovine insulin. 
Previous investigations have demonstrated the presence of rat insulins I and II in 
pancreatic y?-cells and insulinoma derived cell lines (Smith, 1966; Clark and Steiner, 
1969; Cordell et al., 1982; Gross et al., 1988; Fiedorek Jr. et al., 1990). The 
expression of two insulin genes I and II in a transplantable /?-cell tumor has been found 
to be 10-fold higher for rat insulin I than rat insulin II, while in normal pancreatic islets 
there are approximately equal amounts of each insulin (Cordell et al., 1982). In 
contrast, it has also been demonstrated that RINmSF cells contain only rat insulin I 
mRNA and selective expression of the insulin I gene is a relatively general characteristic 
of all RIN cells (Fiedorek Jr. et al., 1990). However, a novel insulin-like 
immunoreactivity in RINmSF cells, which was not due to rat insulin I and II, has not 
been previously demonstrated. 
Electron microscopic study revealed that more insulin secretory vesicles were 
contained in differentiated than undifferentiated cells. These findings are consistent 
with a report that sodium butyrate, an inducer of cellular differentiation, induces 
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Antiserum vs. PI 
Antiserum vs. Bl 
Fig. 9. Immunoblot of rat insulin I and cell homogenates from differentiated and 
undifferentiated RlNmBF cells. Lane 1, a M.W. marker; lanes 2 and 5, rat insulin i; 
lanes 3 and 6, cell-homogenate from differentiated RINmSF cells, and lanes 4 and 7, 
cell-homogenate from undifferentiated RINmSF cells. Lanes 2, 3, and 4 were reacted 
with antiserum vs. porcine insulin (PI) and lanes S, 6, and 7 with antiserum vs. bovine 
insulin (Bl). The position of a M.W. marker is given on the left. 
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changes in the morphology of RIN cells to differentiated features and increases insulin 
mRNA 10 fold over control levels (Philippe et al., 1987; Bartholomeusz et a!., 1990). 
Thus, there is a possibility that decreased insulin release is related to the morphological 
differentiation or is the result of the long-term culture in vitro. 
It is likely that antigenic determinants of the insulin secreted in undifferentiated cells 
are changed because the amino acid residue(s) are changed. Antigenic specificity to a 
species-specific insulin is dependent on the presence of a suitable antigenic 
determinant on the molecule even though insulins of mammals show a high degree of 
homology (Bullesbach and Schwabe, 1994). Thus, anti-insulin antibody formation is 
initiated through recognition of the conformation of specific loops by changes in the 
amino acid sequence (Sasaki et al., 1988). The interaction between A- and B-chains is 
necessary for spatial configuration of the molecule and for the integrity of most 
antigenic determinants of insulin (Arquilla and Bromer, 1967). The antibody specificity 
of antiserum vs. bovine insulin was a major finding of this study. Porcine and bovine 
insulins differ by only two amino acids; however, antibody specificities between 
antisera vs. porcine and bovine insulins were distinct. The only differences between 
porcine and bovine insulins are amino acids in A8 and A10. A8 is alanine and A10 is 
valine in bovine insulin, while threonine and isoleucine are located in these positions in 
porcine insulin as shown in Figure 1. In addition, the amino acids in A8 and A10 in rat 
insulins I and II are identical to those in porcine insulin. Therefore, it is most likely that 
the amino acids in A8 and A10 contribute the specificity of antisera vs. rat and bovine 
insulins. This is supported by the findings that A8 - 10 may play an important role in 
insulin antigenicity and receptor binding ability because of differences in primary 
structure and a high degree of mobility (Sasaki et al., 1988; Bullesbach and Schwabe, 
1994). Therefore, the changes in antigenic determinant of the insulin secreted by 
undifferentiated RINmSF cells might contribute to the novel insulin-like 
immunoreactivity. This can be confirmed by identifying the amino acid sequence of 
NIP by using molecular cloning technique in the future. 
The implication of our present findings remains to be established. However, 
RINmSF cells do not share surface features in common with native )ff-cells 
(Bartholomeusz et al., 1990) and are relatively undifferentiated in comparison with 
normal adult islet cells (Gazdar et al., 1980). In addition, RINmSF cells have frequently 
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been employed as a model of islet cell growth and an early stage in pancreatic P-ceW 
differentiation (Philippe et al., 1987; Bartholomeusz et al., 1990; polak et al., 1993). 
Therefore, we speculate that the third gene which produce the novel insulin-like 
immunoreactivity may serve as an ancestral gene, although insulin gene II has been 
known as an ancestral gene in normal pancreatic )8-ceils (Bell et al., 1980). This should 
be further tested by molecular cloning techniques. 
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CHAPTER IV ALTERATIONS OF ADRENERGIC RECEPTORS IN RESPONSE 
TO EPINEPHRINE ON INSULIN RELEASE FROM RINM5F CELLS IN A PASSAGE-
AND MORPHOLOGY-DEPENDENT MANNER 
A paper to be submitted to Journal of 
Pharnnacology and Experimental Therapeutics 
Bum-sup Lee, Dong-Ho Shin, Ter-Hsin Chen, Chi Yang and Walter H. Hsu 
ABSTRACT 
The o,-, 02- and yff-adrenergic receptors (ARs) are present in pancreatic /ff-cells. In 
the present study, the functional distributions of these receptors were investigated in 
RINm5F cells, a cloned P-cqW line, in conjunction with the changes of morphologic 
features from differentiated to undifferentiated states. Thus, the cells in passages 
between 28 and 30 were differentiated and the cells after passage 35 were 
undifferentiated. Epinephrine (1 - 10/yM) significantly decreased cAMP production and 
insulin release in differentiated cells; however, epinephrine (10 nM - 10//M) dose-
dependently increased cAMP production and insulin release in undifferentiated cells. In 
addition, epinephrine (1 //M) decreased forskolin-induced intracellular cAMP 
concentration in differentiated cells but not in undifferentiated cells. In differentiated 
cells, epinephrine (1 //M) decreased KCI (30 mM)-induced insulin release but RX 
821002 (0.1 //M), an aj-AR antagonist, abolished the epinephrine-induced inhibition. 
Prazosin (0.1 a/M), an a^-AR antagonist, and propranolol (1 /;M), a/?-AR antagonist, 
failed to alter the effect of epinephrine. In undifferentiated cells, however, epinephrine 
(1 /iM) increased insulin release and enhanced KCI (30 mM)-induced insulin release. RX 
821002 further potentiated the effect of epinephrine on KCI's action. Propranolol (1 
A/M) abolished the effect of epinephrine on KCI's action but prazosin (0.1 //M) did not. 
In addition, when Oj-ARs were blocked, cirazoline (10 and methoxamine (lOOyt/M), 
a^-AR agonists, did not increase insulin release in either differentiated or 
undifferentiated cells. Medetomidine (0.001-1 //M), a specific Oj-AR agonist, inhibited 
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KCI (30 mM)-incluced insulin release in a dose-dependent manner in differentiated cells, 
but did not in undifferentiated cells. Isoproterenol, a 0-AR agonist (1 /wM), failed to 
increase intracellular cAMP concentration and insulin release in differentiated cells but 
increased them in undifferentiated cells. Taken together, these results suggested that 
in RINm5F cells, 1) the differentiated states are functionally equipped with more O2-, 
but fewer )ff-adrenergic receptors, than the undifferentiated states, and 2) o,-adrenergic 
receptors do not participate in insulin release in either differentiated or undifferentiated 
RINmBF cells. 
INTRODUCTION 
The islets of Langerhans are richly vascularized and both the islet cells and blood 
vessels are intimately associated with autonomic nerves. In general, stimulation of 
parasympathetic nerves increases insulin secretion (Kaneto et al., 1967), whereas 
stimulation of the sympathetic nerve decreases insulin release (Miller, 1981). 
Norepinephrine and epinephrine inhibit insulin release by activating aj-ARs of the /?-
cells. When oTj-ARs are blocked, norepinephrine and epinephrine increase insulin release 
by activating/ffj-adrenergic receptors (Miller, 1981). Activation of aj-ARs decreases 
insulin release by inhibiting adenylyl cyclase activity (Thomsen and Neubig, 1989). 
However, activation of y^j-^^^renergic receptors stimulates insulin release by activating 
adenylyl cyclase activity (Ross and Oilman, 1980). A clonal i^-cell line, RINmSF cells, 
have a,-, iff-ARs and have been widely used as a model to characterize the 
cellular mechanisms of these receptors in pancreatic ^ff-cells (Ullrich and Wollheim, 
1985; Ullrich and Wollheim, 1989; Aicardi et al., 1991; Chan et al., 1991; Suzuki et 
al., 1992). 
RINm5F cells change their morphology from a differentiated state (with a few 
neuron-like processes) to an undifferentiated state (without the processes) during long-
term culture (Polak et al., 1993). In a preliminary study, we found that when RINmSF 
cells changed from the differentiated to the undifferentiated state, the effect of 
epinephrine on insulin release was changed from inhibitory to stimulatory. The 
morphological changes of RINmSF cells after long-term culture have been noticed in 
many laboratories (Polak et al., 1993), but the functional changes in conjunction with 
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morphological changes have not been reported. 
In the present study, we characterized the a,-, 02-, and ^-ARs mediating insulin 
release in differentiated and undifferentiated cells. We performed the experiment in 
passages 28 - 40 because these passages presented a marked contrast between 
differentiated and undifferentiated cells. Our results suggested that differentiated 
RINmSF cells possess more a2-adrenergic receptors than the undifferentiated cells but 
undifferentiated cells possess more functional j9-adrenergic receptors than differentiated 
cells. In addition, a^adrenergic receptors did not participate in insulin release in either 
differentiated or undifferentiated RINmBF ceils. 
MATERIALS AND METHODS 
Materials 
The following materials were used: RPMI-1640, fetal bovine serum, epinephrine, 
isoproterenol, propranolol and forskolin (all from Sigma Chemical,St. Louis, MO), 24-
well culture plate (Corning Glass Works, Corning, NY), medetomidine HCI (Farmos, 
Turku, Finland), Prazosin HCI (Pfizer Inc., Groton, CT), RX 821002 (Research 
Biochemicals Inc., Natick, MA), antiserum vs. rat insulin (Linco Research Inc., St Louis, 
MO). 
Cell culture 
RINmSF cells were obtained from Dr. S.B. Pek (University of Michigan Medical 
Center, Ann Arbor, Ml). The cells were maintained in RPMI-1640 medium with 10% 
fetal bovine serum as described previously (Chen et al., 1994). The cells were 
subcultured every 7 days and the medium was changed at day 3 and day 5 after 
subculture. All experiments were performed by use of cells from passages 28-40. No 
antibiotics were used. 
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Insulin release 
Static incubations were perfornned to study insulin release in response to test 
agents as previously described (Hsu et al., 1991b). Cells from later passages grew 
more rapidly; consequently, the cells were plated onto 24-well plates at 2 x 10^ 
cells/well for passages 28-32 and at 7 x 10^ cells/well for passages 34-40 and grown 
for 5 days. The growth medium was then removed, and the cells were washed with 
Krebs-Ringer buffer (KRB) containing (in mM): 136 NaCI, 4.8 KCI, 2,5 CaClj, 1.2 
KH2PO4, 1.2 MgS04, 5 NaHCOg, 10 HEPES, 1.67 glucose and 0.1 % bovine serum 
albumin, pH 7.4. The cells were then preincubated for a 15-min basal period at 37''C, 
followed by 15-min incubation in KRB with test agents. When needed, the antagonist 
was given 5 min before the administration of the agonist to ensure blockade of the 
receptors before the addition of the agonist. Insulin in the media was measured by 
radioimmunoassay (RIA) as previously described (Hsu et al., 1991). 
Statistical analysis 
All values were expressed as the mean ± S.E. Analysis of variance (ANOVA) was 
used to determine the treatment or dose effect. The least significance test was used to 
test for differences between means of end points for which the ANOVA indicated a 
significant (P<0.05) F ratio. 
RESULTS 
Effects of epinephrine on intracellular cAMP concentration and insulin release in 
differentiated and undifferentiated FINmSF cells 
In the differentiated state, RINm5F cells had a few neuron-like processes. However, 
in the undifferentiated state, the cells did not exhibit morphological features of neuron­
like processes. More than 90% of the cells between passages 28 and 30 were 
differentiated. However, the cells gradually lost processes to become undifferentiated 
cells and > 99% of the cells after passage 35 were undifferentiated (Fig. 1. in chapter 
III). 
To demonstrate the effects of epinephrine on insulin release, epinephrine was 
tested on every other passage between 28 and 40. Since cAMP has been implicated 
as a second messenger mediating Oj'Sdrenergic effects, intracellular cAMP 
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concentrations were also measured in parallel to insulin release. In passages 28 and 
30, epinephrine (1 //M) significantly inhibited basal insulin release by 12% and 
intracellular cAMP concentration by 14 - 17%. However, in passages after 35, 
epinephrine (1 //M) significantly increased basal insulin release by 28 - 39% and 
intracellular cAMP concentration by 20 - 37% (Fig. 1). Dose-dependent effects of 
epinephrine were studied between differentiated and undifferentiated cells. Epinephrine 
(1 - 10//M) significantly decreased basal cAMP production and insulin release, but 
epinephrine (10 nM - lOyuM) increased basal cAMP production and insulin release in a 
dose-dependent manner (Fig. 2). 
Since the effect of an inhibitor on intracellular cAMP is best demonstrated in 
stimulated cells, forskolin, an adenylate cyclase activator, was used to increase 
intracellular cAMP concentration. The intracellular cAMP concentration after the 
administration of forskolin was set at 100%, and changes were expressed as a 
percentage of the forskolin control value. Forskolin (5 //M) markedly increased 
intracellular cAMP concentration by 85.7-fold in differentiated cells and forskolin (0.5 
fjM) increased it by 98.5-fold in undifferentiated cells (Fig. 3A). Epinephrine (1 JJM) 
significantly inhibited forskolin (5 /uM)-stimulated intracellular cAMP concentration by 
86% in differentiated cells but did not inhibit forskolin (0.5 //M)-stimulated intracellular 
cAMP concentration in undifferentiated cells (Fig, 3A). With a blockade of ^z-ARs by 
RX 821002 (0.1 //M), the inhibitory effect of epinephrine on cAMP in differentiated 
cells was abolished (data not shown). Furthermore, when the effect of epinephrine on 
the forskolin-stimulated intracellular cAMP production was tested on every other 
passage between 28 and 40, epinephrine (1 //M) significantly inhibited the forskolin (10 
A/M)-stimulated intracellular cAMP concentration by 68 - 86% in differentiated cells but 
did not in undifferentiated cells (Fig. 3B). 
Effects of prazosin, propranolol and RX 821002 on KCI-stimulated Insulin release in 
differentiated and undifferentiated RINm5F cells 
The functional receptors which mediated the inhibitory and stimulatory effects of 
epinephrine on insulin release were further characterized by applying KCI with a number 
of AR antagonists in both differentiated and undifferentiated RINm5F cells. In 
differentiated cells, epinephrine (1 )uM) significantly inhibited KCI (30 mM)-induced 
Fig. 1. Passage-dependent responses of RINm5F cells to epinephrine (1 //M) on cAMP 
production (A) and insulin release (B). After each experiment, the cells were detached 
by using trypsin-EDTA and the cell numbers were counted in each well. The basal 
insulin release was 6.9 - 8.9 ng/min/million cells in differentiated cells and 2.9 - 3.4 
ng/min/million cells in undifferentiated cells. Mean ± S.E, (n = 16) are shown. 
*P<0.05, compared with basal control group. 
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are shown. */'<0.05, compared with forskolin-stimulated group. (B) The passage-
dependent effect of epinephrine (1 //M) on forskolin (10 //M)-induced cAMP production. 
Mean ± S.E. (n = 12) are shown. •/'<0.05, compared with basal control group. 
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insulin release by 86% (Fig. 4A). An Oj-AR antagonist, RX 821002 (0.1 /yM), 
abolished the epinephrine-induced inhibition. However, Prazosin (0.1 //M), an a^-AR 
antagonist, and propranolol (1 //M), a /3-AR antagonist, failed to alter the effect of 
epinephrine (1 yuM) (Fig. 4A). In undifferentiated cells, epinephrine (1 /yM) increased 
insulin release by 40% and enhanced KCI (30 mM)-stimulated insulin release (Fig. 4B). 
In the presence of aj-AR blockade by RX 821002 (0.1 /^M), epinephrine further 
potentiated KCI (30 mM)-induced insulin release by 51%. Propranolol (1 //M) abolished 
the stimulatory effect of epinephrine on KCI's action but prazosin (0.1 //M) did not (Fig. 
4B). With a blockade of Oj-AR by RX 821002 (0.1 //M) and a, -AR by prazosin (0.1 
yuM), epinephrine (1 //M) potentiated KCI-induced insulin release by 47%, but with a 
blockade of Oj-AR by RX 821002 (0.1 //M) and yS-AR by propranolol (1 //M), 
epinephrine failed to change it. 
Effects of cirazoHne, methoxamine and medetomidine on insulin release in differentiated 
and undifferentiated RINmSF cells 
Since we demonstrated the insignificant participation of ffi-AR in insulin release by 
using its antagonist, prazosin, other a^-AR agonists were tested to support these 
findings. Cirazoline (lOyuM) and methoxamine (100//M), a^-AR agonists, in the 
presence of otj-AR antagonist, RX 821002 (0.1 //M), did not significantly increase 
insulin release in either differentiated or undifferentiated RINmSF cells. Medetomidine 
(0.001 - 1 //M), a potent and specific aj'AR agonist (Virtanen et al., 1988), inhibited 
KCI (30 mM)-stimulated insulin release in a dose-dependent manner (IC50 of 48.5 ± 0.9 
nM) in differentiated cells but not in undifferentiated cells (Fig. 5). In this experiment, 
insulin release after the administration of KCI was set at 100%, and all changes are 
expressed as a percentage of the KCI-stimulated value. 
Effect of isoproterenol on intracellular cAMP concentration and insulin release in 
differentiated and undifferentiated RINmSF cells 
Since the significant participation of 0-AHs was demonstrated by the antagonism 
study, the effect of its agonist, isoproterenol, was further tested on every other 
passage between 28 and 40 to determine if there was a passage-dependent effect. 
Fig. 4. Effect of epinephrine (1 /;M) on KCI (30 mM)-induced insulin release and effects 
of adrenergic receptor antagonists (0.1 ;uM prazosin, 1 /jM propranolol and 0.1 jjM RX 
821002) on epinephrine-induced insulin release in differentiated cells (A), and 
undifferentiated RINmBF cells (B). The antagonists were given 5 min before 
epinephrine. Mean ± S.E. (n = 8) are shown. The different letters in the same panel 
indicate a significant difference (P<0.05) between the treatment groups. 
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Fig. 6. Passage-dependent responses of RlNmSF cells to isoproterenol (1 fjM) on cAMP 
production (A) and insulin release (B), Mean ± S.E. In = 16) are shown. *P<0,05, 
compared with basal control group. 
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isoproterenol (1 yuM) failed to change insulin release in differentiated cells but increased 
it by 55-65% in undifferentiated cells (Fig. 6A). In addition, isoproterenol failed to 
change intracellular cAMP concentration in differentiated cells but increased it by 52-
74% in undifferentiated cells (Fig. 6B). Dose-dependent increases of intracellular cAMP 
and insulin release by isoproterenol (1 nM-10 //M) were higher in undifferentiated cells 
than in differentiated cells (Fig. 7). 
DISCUSSION 
This study was undertaken to characterize the functional ARs which mediate the 
inhibitory and stimulatory effects of epinephrine on insulin release in differentiated and 
undifferentiated RINm5F cells. In differentiated cells, ctj-ARs mediated the inhibitory 
effect of epinephrine on KCl- and forskolin-induced insulin release and cAMP 
production. In undifferentiated cells, fi-ARs mediated the stimulatory effect of 
epinephrine or isoproterenol on insulin release and cAMP production. However, a,-ARs 
did not mediate the effect of epinephrine on insulin release in either differentiated cells 
or undifferentiated RINm5F cells. 
Our findings in the differentiated cells were consistent with the observation that 
epinephrine inhibits basal cAMP concentration and insulin release by activating aj-ARs 
in RINmSF cells (Ullrich and Wollheim, 1988). In addition, forskolin-stimulated cAMP 
production is lowered by epinephrine and clonidine, an aj-AR agonist, in rat pancreatic 
islets and RINmSF cells (Garcia-Morales et al., 1984; Ullrich and Wollheim, 1988). In a 
clonal p-ceW line HIT-T15 (derived from hamster islets with Simian virus-40 infection), 
isoproterenol causes more dramatic increase in intracellular cAMP concentration in the 
later passages, although HIT-T15 cells are morphologically undifferentiated in all the 
passages studied (Zhang et al., 1989). Thus, it has to be further tested whether 
passage numbers or morphology plays a role in the effect of epinephrine on insulin 
release in RINmSF cells. 
There are inconsistencies in the literatures regarding the a^-adrenergic effects on 
insulin release. An a,-AR agonist, amidephrine mesylate (1 ;c/M), failed to affect 
glucose-stimulated insulin release in rat pancreatic /ff-cells (Malaisse and Moratinos, 
1986), but an a,-AR agonist, phenylephrine (100//M), caused a slight increase of 
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insulin release from RINm5F cells (Ullrich and Wollheim, 1985). In porcine pancreatic 
islets, an a^-AR agonist, phenylephrine (0.1 //M), inhibited insulin release, and the 
inhibitory effect of epinephrine was abolished by an o,-AR antagonist, prazosin, but not 
by an Ca-AR antagonist, idazoxan (Gregersen et al., 1991). The reason for these 
discrepancies is unclear. 
The functional distribution of ARs was distinct between differentiated and 
undifferentiated RINm5F cells. Functional studies are based on the receptor occupation 
theory which states that the occupation of a receptor by a drug leads to a stimulus and 
a subsequent response (Kenakin, 1984). In our studies, insulin release and cAMP 
production were used to test the potency of epinephrine on a- and )?-ARs and to 
distinguish the subtypes of ARs. The lack of agonistic activity of epinephrine through 
a, and /?-ARs may be a result of the low concentration of these ARs in differentiated 
RINm5F cells. Similarly, the lack of epinephrine's action through <7,- and ffz-ARs in 
undifferentiated RlNm5F cells may also be a result of low density of these ARs. Our 
speculation on the density of ARs which mediate the dual inhibitory and stimulatory 
effects of epinephrine in RINmBF cells should be further tested by radioligand binding 
studies. 
Alterations in affinity of ARs to G-proteins and in the quantities of G-proteins may 
be secondary to differences in receptor numbers and subtypes. Epinephrine inhibits 
adenylyl cyclase and insulin release through otj-ARs coupled to PTX-sensitive Gj-
proteins (Katada and Ui, 1979; Hsu et al., 1991a), but stimulates them through yS-ARs 
coupled to CTX-sensitive Gg-proteins (Sharp, 1979). Five PTX substrates are found as 
three forms of G, (G,,, Gjz and Gq) and two forms of Go (G^, and G^j) in RINm5F cells 
(Gillison and Sharp, 1994). Two molecular forms of G^-proteins are present in RINm5F 
cells: one form with 39 KDa and the other form with 42 KDa (Gillison and Sharp, 
1994). Two molecular forms of Gs„-proteins are present in HIT cells: one form with 45 
KDa and the other form with 52 KDa. The 45 KDa form is more efficacious than the 
52 KDa form as an activator of cAMP (Walseth et al., 1989). In addition, greater 
quantities of the 45 KDa forms than 52 KDa forms of Ggg-proteins are present with 
increasing passages in HIT-15 cells (Walseth et al., 1989) and this contributes to a 
more marked increase in isoproterenol-induced cAMP production in the later passages 
of HIT-T15 cells (Zhang et al., 1989). In RINm5F cells, it remains to be determined 
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whether changes in Gi- or Gs-proteins are responsible for the epinephrine-effect on 
insulin release, which is inhibitory in differentiated cells and stimulatory in 
undifferentiated cells. 
Greater P- than Oa-adrenergic activity in undifferentiated cells and greater Oz- than yff-
adrenergic activity in differentiated cells can be associated with the development of 
fetal pancreatic ^ff-ceils. We speculate that dedifferentiation during oncogenesis 
resembles the morphological and functional changes of RINm5F cells towards the early 
stage of embryonic /ff-cells. In fact, RINmBF cells are less differentiated than their 
native counterparts in several key respects and represent the fetal iff-cells (Gazdar et al., 
1980; Halban et al., 1983; Polak et al., 1993). The undifferentiated RINmBF cells 
might represent more primitive fetal )8-cells than the differentiated cells. Comparison 
between differentiated and undifferentiated RINmBF cells may provide information on 
the alteration of adrenergic receptors in the embryonic development of pancreatic /S-
cells. In some cases, immature tissues contain higher receptor concentrations that 
subsequently decline with development. This pattern of fetal receptor overexpression 
is found for Cj- and /ff-ARs in the liver (McMillian et al., 1983), for yff-ARs in the thymus 
(Rossi, 1987), and for Oj-ARs in the heart (Lin et al,, 1992). The ;?-receptor 
overexpression in fetal rat is a widespread phenomenon and receptor subtype 
selectivities (yffj liver, in heart, predominantly whole fetus) have been 
confirmed (Slotkin and Seidler, 1994). 
The tissue distribution of yff-ARs during fetal life is more clearly defined than their 
functional significance. The activation of yffz-ARs elicits a program of growth and 
differentiation in thyroid cell line FTRL (Hen et al., 1989), human lung adenocarcinoma 
cell line (Schuller and Cole, 1989), mouse T lymphoma TL 2-9 (Buscail et al., 1990), 
and human submandibular cell line A253 (Marmary et al., 1989). jffj'ARs are also 
involved in regulating the growth and differentiation of tumor cells such as rat 
hepatoma (Miyamoto, et al., 1985), rat mammary tumor (Marchetti et al., 1989), and 
in neoplastic human thyroid tissues (Ling et al., 1992). In addition, undifferentiated 
keratinocytes in vitro expresses more ySj-adrenergic receptors than differentiated ones 
(Schallreuter et al., 1993). 
Fetal tissues can be exposed to catecholamines via two sources. First, 
norepinephrine and epinephrine are released by the fetal adrenal medulla into the 
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circulation, but these effects are more prominent toward the end of gestation and 
during parturition {Lagercrantz and Bistoletti, 1973; Jones et al., 1988). Second, a 
variety of different cell types can express adrenergic phenotype and the ability to 
synthesize catecholamines transiently during development (Cochard et al., 1978; 
Jonakait et al., 1979). The cellular processes in developing pancreatic /?-cells might 
alter the sensitivity or selectivity of target cells to catecholamines to increase or 
decrease insulin release depending on whether p- or a-ARs are activated (Poiak et a!., 
1993). Greater functional involvement of ^ff-ARs in undifferentiated cells than in 
differentiated cells might represent the development of early fetal pancreatic yS-cells and 
contribute to the growth and differentiation of fetal /?-cells. 
In conclusion, our present findings suggested that differentiated RINm5F cells 
possess more functional Oz-, but fewer )?-ARs, than the undifferentiated cells. In 
addition, a^ARs apparently do not participate in insulin release in either differentiated 
or undifferentiated RINmBF cells. The implication of our present findings remains to be 
established. However, since RINmBF cells functionally express a^- and ;ff-ARs in 
differentiated and undifferentiated states, respectively, the cells can be used as a 
model for cellular mechanisms of these receptors in pancreatic /?-cells. Our present 
findings might also be useful in studying the early development of pancreatic )?-cells in 
conjunction with distribution of ARs. 
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CHAPTER V ELEVATED ACTIVITY OF ADENYLYL CYCLASE IN 
UNDIFFERENTIATED RINM5F CELLS IN A PASSAGE- AND 
MORPHOLOGY-DEPENDENT MANNER 
A paper to be submitted to Journal of 
Pharmacology and Experimental Therapeutics 
Bum-sup Lee, Chi Yang, Ter-Hsin Chen and Walter H. Hsu 
ABSTRACT 
We have demonstrated that undifferentiated RINm5F cells have greater activity of 
/ff-ARs than differentiated cells {in Chapter IV). In the present study, we further 
characterized a cAMP-dependent signalling pathway which may contribute to the 
elevated activity of yff-ARs in undifferentiated cells. Activities of Gj-protein, adenylyl 
cyclase, phosphodiesterase (PDE) and cAMP-dependent protein kinase (protein kinase 
A) were characterized in a clonal p-ceW line, RINmSF. The cells were equipped with 
two morphological features; the cells with neuron-like processes (differentiated cells) in 
passages between 28 and 30 and the cells without processes (undifferentiated cells) in 
passages after 35. Cholera toxin (CTX, 1 //g/ml), an activator of Gg-proteins, increased 
intracellular cAMP concentration in both differentiated and undifferentiated cells 
without significant differences between these cells. CTX also increased insulin release 
in both cell types but was 2.6-fold more potent in undifferentiated cells than in 
differentiated cells. The effect of forskolin (10/yM) on cAMP production and insulin 
release was 2- and 6-fold more potent, respectively, in undifferentiated cells than in 
differentiated cells. The phosphodiesterase inhibitor, IBMX (100 /yM), significantly 
increased intracellular concentration of cAMP in differentiated and undifferentiated cells 
without significant differences between these cells. The stimulatory effect of IBMX on 
insulin release, however, was 6-foId greater in undifferentiated cells than in 
differentiated cells. 
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Isoproterenol, a yff-adrenergic agonist, significantly potentiated forskolin-induced 
cAMP production and insulin release in undifferentiated cells, but not in differentiated 
cells. CTX (1 //g/ml) significantly potentiated forskolin-induced cAMP production and 
insulin release in undifferentiated cells, but not in differentiated cells. In addition, 
forskolin potentiated KCl-induced insulin release in undifferentiated cells, but not in 
differentiated cells. There were no significant differences in intracellular cAMP 
concentrations or [Ca^"^]j between the forskolin alone group and forskolin + KCI group. 
The activity of protein kinase A was not significantly different between differentiated 
and undifferentiated cells. Taken together, these results suggested that the activity of 
adenylyl cyclase is higher in undifferentiated cells than in differentiated cells, and this 
may be partly responsible for the elevated activity of ^ff-ARs in undifferentiated cells. 
The activities of Gj-protein, PDE and protein kinase A were similar in differentiated and 
undifferentiated RlNmBF cells. However, the Gj-protein- and protein kinase A-
dependent exocytotic apparatus may be more functional in undifferentiated cells than in 
differentiated cells, which may partly contribute to the elevated activity of ^-ARs in 
undifferentiated cells. 
INTRODUCTION 
GTP binding proteins (G-proteins) consist of three subunits named a, p and y in 
order of decreasing molecular size. The a-subunits have a single, high affinity binding 
site for GTP or GDP. The P- and K-subunits are tightly associated and function as a 
unit. G-proteins link many hormone receptors to adenylyl cyclase, ion channels, 
phospholipase C, and exocytotic apparatus in pancreatic i?-cells. ^-ARs are coupled to 
the Gg-proteins to stimulate adenylyl cyclase and increase cAMP and insulin release 
(Sharp, 1979). Two molecular forms of Gjo-proteins are present in HIT cells: one form 
with 45 KDa and the other form with 52 KDa (Walseth et al., 1989). Cholera toxin 
(CTX), an 87 KDa protein with one A and five B subunits, covalently modifies the a-
subunit of CTX-sensitive-G-proteins (G, and Gg,,) amplifying hormonal mechanisms. 
The ADP-ribosylation of CTX-sensitive-G-proteins block their capacity to hydrolyse 
bound GTP to GDP, consequently activating adenylyl cyclase and increasing 
intracellular concentration of cAMP (Birnbaumer, 1990). 
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Both forskolin, an adenylyl cyclase activator, and IBMX (3-isobutyl-1-
methylxanthine), a phosphodiesterase (PDE) inhibitor, increase insulin release through 
elevating intracellular concentration of cAMP in pancreatic )?-cells and clonal yff-cell lines 
including RINmBF (Wiedenkeller and Sharp, 1981; Hermansen, 1985; Suzuki, et al., 
1992; Chen and Hsu, 1994). cAMP activates primarily protein kinase A, to control 
diverse phenomena such as metabolism, gene transcription, and memory (Krebs and 
Bevo, 1979). In pancreatic ^-ceWs, protein kinase A increases Ca^"^ influx through 
voltage-dependent Ca^"^ channels (Rajan et al., 1989), closes ATP-sensitive K"^ 
channels (Holz et al., 1993) and/or directly interacts with the secretory machinery 
(Ammala et al., 1993), However, cAMP may act through mechanisms other than 
activation of protein kinase A. An unidentified cAMP-binding protein may mediate 
cAMP effects without interacting with protein kinase A (Weber et al., 1987). In 
addition, cAMP may act by binding to the cGMP-dependent protein kinase or ion 
channels (Jiang et al., 1992; Holz, IV. et al., 1995). 
The clonal insulin-secreting cell line RINm5F is derived from NEDH rat insulinoma 
with X-ray irradiation (Gazdar et al., 1980). Numerous studies of the physiology and 
pathophysiology of pancreatic /9-cells have been facilitated by RINm5F cells which have 
a virtually pure population of jff-cells unlike pancreatic islets which have various types of 
endocrine cells. However, insulin secretion and the response to secretagogues of the 
cell line have been observed to vary with passage number (passage is defined as a 
subculture of cells from one culture vessel to another in 7 days). In addition, RINm5F 
cells change their morphology from the differentiated to undifferentiated state after 
long-term culture. 
We have demonstrated that undifferentiated cells are functionally equipped with 
more iS-ARs than differentiated RlNm5F cells. However, differentiated cells are 
functionally equipped with more Cj-ARs than undifferentiated RlNmSF cells. Therefore, 
we further characterized cAMP-dependent signal transduction pathways responsible for 
the action mediated by Oj' ^"^1 jff-ARs. In the present study, we evaluated the activities 
of G,-proteins, adenylyl cyclase, PDE and protein kinase A in a passage- and 
morphology-dependent manner in RINm5F cells. To perform these studies, we used 
the cells from passage 28 to 40 because the cells in the passages before 30 were 
differentiated and gradually changed to become undifferentiated state after passage 
35. 
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MATERIALS AND METHODS 
Materials 
The following materials were used: RPMI-1640, fetal bovine serum, HEPES, BSA 
(fraction V), isoproterenol, IBMX, leupeptin, and forskolin (all from Sigma Chemical,St. 
Louis, MO), 24-well culture plate (Corning Glass Works, Corning, NY), colorimetric 
protein kinase A assay kit (Pierce, Rockford, IL), and cholera toxin (ICN Biochemicals, 
Aurora, OH). 
Cell culture 
RINmSF cells were obtained from Dr. S.B. Pek (University of Michigan Medical 
Center, Ann Arbor, Ml). The cells were maintained in RPMI-1640 medium with 10% 
fetal bovine serum as described previously (Chen and Hsu, 1994). The cells were 
subcultured every 7 days and the medium was changed at day 3 and day 5 after 
subculture. All experiments were performed by use of cells from passages 28-40. No 
antibiotics were used. 
Insulin release 
Static incubations were performed to study insulin release in response to test 
agents as previously described (Hsu et al., 1991). Cells from later passages grew more 
rapidly; consequently, the cells were plated onto 24-well plates at 2 x 10^ cells/well for 
passages 28 - 32 and at 7 x 10* cells/well for passages 34 - 40 and grown for 5 days. 
The medium was changed at the day before the experiment. The growth medium was 
then removed, and the cell monolayer was washed with Krebs-Ringer buffer (KRB) 
containing (in mM): 136 NaCI, 4.8 KCI, 2.5 CaClj, 1.2 KH2PO4, 1.2 MgS04, 5 NaHCOg, 
10 HEPES, 1.67 glucose and 0.1 % bovine serum albumin, pH 7.4. The cells were then 
preincubated for a 15-min basal period at 37°C, followed by 15-min incubation in KRB 
with test agents. Insulin in the media was measured by radioimmunoassay (RIA) as 
previously described (Hsu et al., 1991). 
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cAMP measurement 
Intracellular cAMP concentrations were measured after 15 min of static 
incubations with test agents. Cells were treated with cholera toxin (CTX) to study 
ADP ribosylation of the Gs-proteins. After CTX holoenzyme was activated at 30 °C for 
20 min in 5 mM dithiothreitol and 20 mM Tris at pH 7.4 as described previously 
(Gillison and Sharp, 1994), cells were treated with CTX (1 //g/ml) for 5 h. After the 
experiment, cells were scraped from the plates in 0.01 N HCI and incubated in a water 
bath at 75 °C for 20 min to heat-inactivate PDE. After centrifugation, the cell extracts 
were neutralized by 0.01 N NaOH and resuspended in the assay buffer. cAMP 
concentrations were measured by RIA as previously described (Chen and Hsu, 1994). 
[Ca^*]j measurement 
The cells were loaded with 2 //M fura-2 acetoxymethylester (AM) in KRB for 30 
min at 37 "C. The loaded cells were washed with KRB and kept at room temperature. 
The cells were resuspended in a concentration of 10® cells/ml and 1.5 ml of aliquot 
was used for measuring [Ca^^],. The 340/380 nm fluorescence ratios were monitored 
in a SLM-8000 fluorescence spectrophotometer (SLM, Urbana, IL). The [Ca^^], was 
calibrated after cell lysis as described previously (Hsu et al., 1991). 
Protein kinase A assay 
Cells were grown for 5 days, harvested and washed with ice-cold homogenization 
buffer containing 5 mM K2HPO4, 5 mM KH2PO4, 1 mM EDTA, 0.1% Triton-X 100, 0.1 
mM dithiothreitol, lOy^g/ml leupeptin, and 50 mM NaF at pH 6.8 as previously 
described (Flockhart and Corbin, 1984). The homogenate was centrifuged at 20,000 x 
g for 30 minutes at 4 °C. After centrifugation, the soluble fraction was retained for 
further treatment and assay, and the particulate fraction was discarded. The activity of 
protein kinase A was determined by a colorimetric protein kinase A assay (Pierce, 
Rockford, IL). 
The soluble fraction and pre-mixed reaction mixture including reaction buffer, protein 
kinase A substrate, and activator solution were incubated for 45 minutes at 30 °C. 
After incubation, each sample was transferred directly onto the affinity membrane. 
Phosphopeptide binding buffer was applied to the affinity membrane and centrifuged at 
I l l  
3,450 X g for 1 minute. Phosphopeptide elution buffer was applied and the samples 
were centrifuged. Enzyme protein in the eluted fractions was measured by Spectronic 
spectrophotometer (Milton Roy, Rochester, NY) at 570 nm. 
Statistical analysis 
All values were expressed as the mean ± S.E. Data were analyzed with Student's 
unpaired f test (two-tail) or one way analysis of variance (ANOVA). The least 
significance test was used to test for differences between means of end points for 
which the ANOVA indicated a significant (P<0.05) f ratio. 
RESULTS 
Effects of CTX, forskolin, and IBMX on cAMP production and insulin release in RINmSF 
cells 
More than 90% of the cells had neuron-like processes (differentiated) in passages 
between 28 and 30 . However, the cells gradually lost processes to become round 
cells (undifferentiated) and > 99% of the cells were undifferentiated in passages after 
35 (Fig. 1 in chapter III). CTX (1 //g/ml) significantly increased intracellular cAMP 
concentration in both differentiated and undifferentiated cells. The increases of 
intracellular cAMP by CTX were 73.6 ± 6.6% in differentiated cells and 80.5 ± 4.5% 
in undifferentiated cells (Fig. 1 A). Basal cAMP concentrations were 961 - 1112 
/mol/million cells without significant differences among all passages studied (28 - 40). 
However, insulin release in response to CTX was greater in undifferentiated cells 
(105.4 ± 2.1%) than in differentiated cells (39.9 ±1.0 %) (Fig. IB). 
Forskolin (10/yM), an activator of adenylyl cyclase, significantly increased 
intracellular cAMP concentration by 150 - 186 fold in differentiated cells and by 311 -
370 fold in undifferentiated cells (Fig. 2A). Forskolin (lOyuM) significantly increased 
insulin release by 15 - 32% in differentiated cells and by 104 - 130% in 
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Fig. 1. Effect of CTX on cAMP production (A) and insulin release (B) in RINm5F cells. 
Mean ± S.E. (n = 4) for cAMP production and insulin release are shown. *P<0.05, 
compared with differentiated cells. 
Fig, 2. Passage-dependent effect of forskolin (10;l/M) on cAMP production (A) and 
insulin release (B) in RINmBF cells. Passage-dependent effect of IBMX (100 fjM) on 
cAMP production (C) and insulin release (D) in RINm5F cells. Mean ± S.E. (n = 16) are 
shown for both intracellular cAMP concentration and insulin release.. Intracellular cAMP 
concentrations and insulin release by forskolin (10 fjM) and IBMX (100//M) were 
significantly increased in all the passages studied (28 - 40) at ^<0.05, compared with 
basal control group. The intracellular concentrations of cAMP in control group were 
961 -1112 /mol/million cells in differentiated and undifferentiated cells, without 
significant differences at P<0.05. The insulin release of control group were 6.9 - 8.9 
ng/min/million cells in differentiated and 2.9 - 3.4 ng/min/million cells in 
undifferentiated cells. 
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release (B) in differentiated (O)and undifferentiated (•) RINmSF cells. Dose-dependent 
response of IBMX on cAMP production (C) and insulin release (D) in differentiated 
{0)and undifferentiated (•) RINmSF cells. Mean ± S.E. for insulin release (n = 8) and 
for intracellular cAMP concentration (n = 4) are shown. *F<0.05, compared with 
basal control group. 
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undifferentiated cells (Fig. 2B). IBMX (100 //iVI) significantly increased intracellular 
cAMP concentration without significant differences between differentiated and 
undifferentiated cells, in which the increases were 63 - 86% (Fig. 2C). Furthermore, 
IBMX (0.1 mM) significantly increased insulin release by 11 - 48% from differentiated 
cells and by 110 - 132% from undifferentiated cells (Fig. 2D). 
Forskolin (0.01 - 10 //M) increased intracellular cAMP concentration and insulin 
release in a dose-dependent manner in both differentiated and undifferentiated cells 
(Figs. 3A and 3B). However, increases in intracellular cAMP concentration and insulin 
release were higher in undifferentiated cells than differentiated ceils. In addition, dose-
dependent increases of insulin release by IBMX (0.1 - 100 yuM) was higher in 
undifferentiated cells than in differentiated cells. However, the IBMX-induced cAMP 
increase was not significantly different between differentiated cells and undifferentiated 
cells (Figs. 3C and 3D). 
Effects of isoproterenol and CTX on forskolin-induoed cAMP production and insulin 
release in RINmSF cells 
To study the effect of isoproterenol on forskolin-induced cAMP production and 
insulin release, various concentrations of isoproterenol and forskolin were applied to 
determine the concentrations of isoproterenol and forskolin that cause equal 
intracellular cAMP concentrations in differentiated and undifferentiated cells. 
Isoproterenol at 10//M in differentiated cells and 0.1 pM in undifferentiated cells 
increased intracellular cAMP concentration by 30.4 ± 3.1% and 32.5 ± 2.6%, 
respectively. In addition, forskolin at 1 pM in differentiated cells and 0.3 pM in 
undifferentiated cells increased intracellular cAMP concentration by 509 ±32% and 
485 ± 29%, respectively. In differentiated cells, isoproterenol (10 pM) did not 
significantly potentiate forskolin (1 /iM)-induced cAMP production or insulin release 
(Fig. 4). However, in undifferentiated cells, isoproterenol (0.1 //M) potentiated forskolin 
(0.3 A/M)-induced cAMP production and insulin release by 355% and 135%, 
respectively. 
Fig. 4. Effect of isoproterenol on forsicoiin-stimuiated cAMP production (A) and insulin 
release (B) in RINmBF cells. Closed bar; isoproterenol, open bar; forskolin, and hatched 
bar, isoproterenol + forskolin. Isoproterenol at 10 //M in differentiated cells and 0.1 
JJM in undifferentiated cells increased intracellular cAMP concentration equally in 
differentiated and undifferentiated ceils. In addition, to equally increase intracellular 
cAMP concentration, forskolin at 1 JJM and 0.3 JJM was applied in differentiated and 
undifferentiated cells, respectively. Mean ± S.E. (n = 4) for intracellular cAMP 
concentration and {n = 8) insulin release are shown. '^<0.05, compared with the 
combined value from each forskolin and isoproterenol value. 
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Fig. 5. Effect of CTX on forskolin-stimulated cAMP production (A) and insulin release 
(B) in RINnnSF cells. Closed bar; CTX, open bar; forskolin, and hatched bar, CTX and 
forskolin. CTX (1 //g/ml) was used to ADP-ribosylate Gj-proteins in both differentiated 
and undifferentiated cells. However, forskolin at 1 //M in differentiated cells and 0.3 
//M in undifferentiated cells increased intracellular cAMP concentration equally in 
differentiated and undifferentiated cells. Mean ± S.E. (n = 4) for intracellular cAMP 
concentration and insulin release are shown. *P<0.05, compared with the combined 
value from each forskolin and isoproterenol value. 
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Fig. 6. Effect of forskolin on KCI (30 mM)-stimulated insulin release in RINmBF cells. 
Closed bar; forskolin, open bar; KCI, and hatched bar, forskolin and KCI. Forskolin at 
10 JJM and 0.3 PM was applied to equally increase insulin release in differentiated and 
undifferentiated cells, respectively. Mean ± S.E. (n = 8) for insulin release are shown. 
*P<0.05, compared with the combined value from each forskolin and KCI value. 
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To study the effect of ADP ribosylation of Gj-protein by CTX on forskolin-induced 
cAMP production and insulin release, forskolin at 1 /JM in differentiated ceils and 0.3 
JJM in undifferentiated cells was used to obtain similar increase in intracellular cAMP 
concentration in differentiated cells (549 ± 46%) and in undifferentiated cells (488 ± 
10%). In undifferentiated cells, CTX (1 //g/ml) significantly potentiated forskolin-
induced cAMP production and insulin release by 326% and 152% (n = 4), respectively. 
In differentiated cells, CTX, however, did not potentiate forskolin-induced cAMP 
production and insulin release (Fig. 5). 
Effect of forskolin on KCf-stimulated cAMP production and insulin release in RINnnSF 
cells 
To study the effect of forskolin on KCI-induced insulin release, concentrations of 
forskolin were applied to equally increase insulin release, as described above. Forskolin 
at 10;cyM in differentiated cells and 0.3//M in undifferentiated cells equally increased 
insulin release by 60.3 ± 3.6% and 47.2 ± 5.5%, respectively. In undifferentiated 
cells, forskolin (0.3//M) potentiated KCI (30 mM)-induced insulin release by 102% but 
in differentiated cells forskolin (10//M) failed to do so (Fig. 6). In undifferentiated cells 
there were no significant differences in intracellular cAMP concentrations between the 
forskolin alone group and the forskolin + KCI group (557 ±43% and 479 ± 38%, 
respectively;{n = 4)). In addition, there was no significant differences in the increase of 
ICa^^li between KCI alone group and forskolin + KCI group (data not shown). 
Activity of protein kinase A in RINmSF cells 
To study the activity of protein kinase A in differentiated and undifferentiated cells, 
100 JJM cAMP was added to 10 /yl soluble fractions of cell homogenate from 1 million 
cells. Activity of protein kinase A was not significantly different between differentiated 
c e l l s  a n d  u n d i f f e r e n t i a t e d  c e l l s .  T h e  c o n c e n t r a t i o n s  o f  p r o t e i n  k i n a s e  A  w e r e  1 9 1  ± 9  
U/mg protein in differentiated cells (n = 4) and 181 ±4 U/mg protein in 
undifferentiated cells (n = 4). 
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DISCUSSION 
This study was undertal<en to characterize cAMP-dependent signal transduction 
pathways mediating the action of ;S-ARs in RINm5F cells. Our findings demonstrated 
that activity of adenylyl cyclase is higher in undifferentiated cells than in differentiated 
RINmBF cells. However, the activities of Gg-proteins, PDE and protein kinase A remain 
unchanged between differentiated and undifferentiated RINmSF cells. Our results 
further suggested that elevated activity of adenylyl cyclase and sensitivity of G^-
protein- and protein kinase A-dependent exocytosis may be responsible for the higher 
activities of J3-M\s in undifferentiated cells than in differentiated cells. 
CTX, which causes ADP-ribosylation of Gj-proteins, equally increased intracellular 
cAMP concentrations suggesting the presence of equal activity of Gg-proteins in 
differentiated and undifferentiated cells. In HIT-T15 cells (derived from hamster islets 
with Simian virus-40 infection), increased potency of isoproterenol and forskolin in the 
later passages is responsible for greater quantities of 45 KDa subunit of G„-protein 
between 45 and 52 KDa subunits (Zhang et al., 1989; Walseth et al., 1989). In 
addition, CTX stimulated more cAMP production, suggesting that these are greater 
quantities of Gg,-proteins in the later passages than in earlier passages (Walseth et al., 
1989). Whether the quantity and/or subunit of Gs-proteins contribute to the activity of 
Gg-proteins in RINm5F cells requires further study. 
CTX increased more insulin release in undifferentiated cells than in differentiated 
cells. CTX activates Gj-proteins and increases intracellular cAMP concentration. 
Increased intracellular cAMP activates protein kinase A which may increase insulin 
release partly through elevating [Ca^"^], via opening of VDCCs, and partly through some 
unknown mechanisms. Our results showed that the activity of protein kinase A was 
not significantly different and forskolin (10 //M) caused an insignificant increase in 
[Ca^'^l, compared to its effect on insulin release (unpublished observations) in both cell 
types. Therefore, Gg-proteins may be directly coupled to the exocytotic apparatus, if 
so, are more involved in undifferentiated cells than in differentiated cells. In fact, the 
presence of G^j-proteins, which may be directly involved in the activation of 
exocytosis, has been suggested in RINmSF cells (Ullrich and Wollheim, 1988). 
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Forskolin stimulated more cAMP production and insulin release in undifferentiated 
cells, which indicates that the activity of adenylyl cyclase is greater than in 
differentiated cells. The activity of adenylyl cyclase in pancreatic islets is regulated by 
Ca^'^-calmodulin (Thams et al., 1982), In the absence of calmodulin, Ca^"^ inhibits 
adenylyl cyclase activity but in the presence of calmodulin, Ca^"" stimulates adenylyl 
cyclase in RINmBF cells (Caldwell et al., 1992). In addition, p-AR- and forskolin-
stimulated activation of adenylyl cyclase is enhanced by Na^ suggesting that Na*^ can 
play a role in regulating the Gs-proteins/adenylyl cyclase system (Watson et al., 1989). 
In our findings, the effect of forskolin on cAMP production and insulin release was 
further potentiated by isoproterenol and CTX in undifferentiated cells, but not in 
differentiated cells suggesting that Gg-proteins may be directly associated with the 
activity of adenylyl cyclase. In fact, the affinity of forskolin is higher for adenylyl 
cyclase (types II, V and Vl, but not type I) which is associated with the a-subunit of Gj-
proteins than for adenylyl cyclase alone (Alousi et al., 1991; Sutkowski et al., 1994). 
Therefore, our findings suggested that greater association of Goj-protein with adenylyl 
cyclase may contribute to an increased activity of adenylyl cyclase on cAMP 
production in undifferentiated than differentiated cells, although equal activity of Gg-
proteins is present in both cell types. 
Intracellular cAMP concentration is determined not only by the rate of cAMP 
production through the activation of adenylyl cyclase but also by the rate of hydrolysis 
through the activation of PDE. IBMX, a PDE inhibitor, primarily increases intracellular 
cAMP concentration (Wiedenkeller and Sharp, 1981), although IBMX may have other 
cAMP-independent mechanisms such as a promoter for release of Ca^"^ stores 
(Shemesh et al., 1984) and an inhibitor of the sustained calcium current in RINmBF 
cells (Simasko and Yan, 1993). According to the current guidelines for PDE 
nomenclature (Beavo and Reifsnyder, 1990), cAMP is hydrolyzed to 5'-AMP by at least 
four classes of PDE isozymes: (1) a Ca^'^-calmodulin-dependent PDE (PDE I), (2) a 
cGMP-stimulated PDE (PDE II), (3) a cGMP-inhibited PDE (PDE 111), and (4) a cAMP-
specific PDE (PDE IV). Since these studies were performed with IBMX which is a 
nonselective PDE inhibitor (Akita et al., 1994), the possible changes of PDE isotypes 
were not evaluated and remain to be further characterized. 
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Increased intracellular cAMP concentrations primarily activate protein kinase A and 
stimulate insulin release in pancreatic p-ceWs and clonal y?-cell lines including RINmSF 
(Wiedenkeller and Sharp, 1981; Hermansen, 1985; Suzuki, et al., 1992; Chen and Hsu, 
1994). cAMP-dependent phosphorylation may be responsible for insulin release by 
increasing Ca^"^ entry into the yff-cells (Eddlestone et al., 1985) or by releasing Ca^"^ 
from intracellular stores (Mandarine et al., 1980; Hahn et al., 1979). In our findings, 
total (activated and inactivated) activity of protein kinase A vt/as not significantly 
different between differentiated and undifferentiated RINm5F cells. However, insulin 
release containing equal, amounts of cAMP was greater in undifferentiated cells than in 
differentiated cells. The greater insulin release in undifferentiated cells may be due not 
only to more sensitivity of protein kinase A to cAMP but also by more binding of cAMP 
to a target such as a channel other than activation of protein kinase A (Weber et al., 
1987; Jiang et al., 1992; Holz, 4th. et al., 1995). Further studies are required to test 
these hypotheses. 
The precise relationship of cAMP to ion channels in pancreatic ^-cells is still 
controversial. Ca^^-activated nonselective cation channels are activated by cAMP to 
generate which is an inward Na'^ current induced by cAMP, results in 
membrane depolarization and raises [Ca^'^], by activation of VDCCs. I^amp niay also 
increase [Na^lj which slows Na'^/Ca^^ exchange which, in turn, increases [Ca^^],. An 
increase in ICa^"^], promotes Ca^"^-induced Ca^'^ release (CICR) from intracellular Ca^^ 
stores (Sturgess et al., 1986; Reale et al., 1994; Holz, 4th. et al., 1995). In addition, 
cAMP increases [Ca^^li not only through VDCCs, but also through an uncharacterized 
voltage-independent process (Holz, 4th. et al., 1995). However, forskolin potentiated 
KCI-induced insulin release in RINm5F cells without significantly changing [Ca^"^], (our 
unpublished observations). Based on these findings, modulation of exocytosis by 
protein kinases A, at a distal step to the elevation of Ca^"^, may also be much greater in 
undifferentiated cells than in differentiated cells. Activation of protein kinase A or 
inhibition of protein phosphatases dramatically potentiates exocytosis of insulin without 
an enhancement of Ca^'^ influx in pancreatic /9-cells. This suggests that protein kinase 
A is of greater quantitative importance than Ca^*^ (Ammala et al., 1993; Gillis and 
Misler, 1993; Ammala et al., 1994). 
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RINm5F cells may be valuable tools for further studies on the relationship between 
changes in insulin release and ;S-ARs/cAMP metabolism during the differentiation of 
fetal pancreatic yff-cells. In fact, RINmSF cells resemble incompletely differentiated fetal 
pancreatic )9-cells (Gazdar et al., 1980; Halban et al., 1983; Polak et al., 1993). By 
comparing the morphologic and physiologic changes which occur when the cells 
change from differentiated to undifferentiated state during oncogenesis, RINm5F cells 
may provide useful information on the embryonic development of pancreatic /?-cells. 
Since the morphologically undifferentiated RINmBF cells might represent more poorly 
differentiated fetal yff-cells than the differentiated cells. The yff-adrenoceptor/adenylyl 
cyclase system is well characterized in embryonic development (Maier et al., 1989). In 
rats, basal and forskolin-stimulated activities of adenylyl cyclase show a developmental 
spike by gestational day 18 (Slotkin et al., 1994) and are greater in the fetus and 
neonate than in the adult (Katz et al., 1985; Tobise et al., 1994). Stimulation of 
adenylyl cyclase by GTP also decreases during development suggesting that 
developmental alterations of the nucleotide regulatory component and/or its interaction 
with the catalytic component occur (Katz et al., 1985). Altered plasma membrane 
fluidity has been reported during development (Kutchai et al., 1976), and fluidity of the 
membrane in turn modulates coupling of G-proteins to adenylyl cyclase (Salesse et al., 
1982). Developmental changes of membrane lipid content may also exert a regulatory 
influence on the enzyme (Kalish et al., 1977). In addition, in the ventricle, a decrease 
in the content of the type VI, but not type V, isoform of adenylyl cyclase correlates 
with a decrease in catalytic activity with development and aging (Tobise et al., 1994). 
For insulin secretion, aged rats (2 years old) do not show a response to forskolin in a 
cAMP- dependent pathway, whereas, young rats (12 weeks old) do (Aizawa et al., 
1994). Similarly, IBMX stimulates cAMP production and insulin release in 4 - 6 day old 
rats but does not stimulate insulin release in 12 day or 3 month old rats (although 
cAMP concentration is significantly enhanced) (Ziegler et al., 1982). In rabbit 
ventricular cells, the PDE isoenzyme changes from PDE IV to PDE III to increase 
calcium currents during the postnatal period (Akita et al., 1994). Activation of adenylyl 
cyclase stimulates differentiation and growth, gene expression, the response to in utero 
stress and the adaptation of organs to birth (Slotkin et al., 1987; Odom et al., 1987; 
Jones and Ritchie, 1983; Curtis and Zaiin, 1985; McDonald et al., 1986). Therefore, 
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we speculate that the activity of adenylyl cyclase is higher early in embryonic and fetal 
pancreatic /ff-cells in order to contribute to cell migration and differentiation, and 
RINmSF cells may be a useful model to study development in this tissue. 
In conclusion, our present findings suggested that the activity of adenylyl cyclase 
is greater in undifferentiated cells than in differentiated RINm5F cells and this may be 
due, in part, to a greater association of G^-proteins with adenylyl cyclase. The 
activities of Gj-proteins, PDE and protein kinase A remain unchanged between 
differentiated and undifferentiated RINmSF cells. However, it is possible that Gj-
protein- and protein kinase A-dependent exocytosis of insulin is more functional in 
undifferentiated cells than in differentiated cells. 
ACKNOWLEDGEMENTS 
We thank Mr. Lavern Escher for technical assistance. RINmSF cells were donated 
by Dr. Sumer Pek. The antiserum against cAMP was a gift of the National Institute of 
Diabetes and Digestive and Kidney Diseases, National Hormone and Pituitary Program, 
and the University of Maryland, School of Medicine. Porcine insulin was a gift of Eli 
Lilly Laboratories. The antiserum against porcine insulin was donated by Dr. Joseph 
Dunbar of Wayne State University. 
REFERENCES 
Aizawa, T., Komatsu, M., Sato, Y., Ishihara, F., Suzuki, N., Nishii, N., Hashizume, K. 
and Yamada, T. (1994) Insulin secretion by the pancreatic beta cell of aged rats. 
Pancreas 9, 454-459. 
Akita, T., Joyner, R.W., Lu, C., Kumar, R. and Hartzell, H.C. (1994) Developmental 
changes in modulation of calcium currents of rabbit ventricular cells by 
phosphodiesterase inhibitors. Circulation 90, 469-478. 
Alousi, A.A., Jasper, J.R., Insel, P.A. and Motutsky, H.J. (1991) Stoichiometry of 
receptor-Gs-adenylate cyclase interactions. FASEB J. 5, 2300-2303. 
Ammala, C., Ashcroft, F.M. and Rorsman, P. (1993) Calcium-independent potentiation 
of insulin release by cyclic AMP in single beta-cells. Nature 363, 356-358. 
129 
Ammala, C., Eliasson, L., Bokvist, K., Berggren, P.O., Honkanen, R.E., Sjoholm, A, and 
Rorsnnan, P. (1994) Activation of protein kinases and inhibition of protein 
phosphotases play a central role in the regulation of exocytosis in mouse 
pancreatic beta cells. Proc. Natl. Acad. Sci. USA 91, 4343-4347. 
Beavo, J.A. and Reifsnyder, D.H. (1990) Primary sequence of cyclic nucleotide 
phosphodiesterase isoenzymes and the design of selective inhibitors. Trends 
Pharmacol. Sci. 11, 150-155. 
Birnbaumer, L (1990) G proteins in signal transduction. Ann. Rev. Pharmacol. Toxicol. 
30, 675-705. 
Caldwell, K.K., Boyajian, C.L. and Cooper, D.M.F. (1992) The effects of Ca^^ and 
calmodulin on adenylyl cyclase activity in plasma membranes derived from neural 
and non-neural cells. Cell Calcium 13, 107-121. 
Chen, T.-H. and Hsu, W.H. (1994) Inhibition of insulin release by a formamidine 
pesticide amitraz and its metabolites in a rat beta-cell line: An action mediated by 
alpha-2 adrenoceptors, a GTP-binding protein and a decrease in cyclic AMP. J. 
Pharmacol. Exp. Ther. 271, 1240-1245. 
Curtis, D.H. and Zalin, R.J. (1982) Regulation of muscle differentiation: Stimulation of 
myoblast fusion in vitro by catecholamines. Science 214, 1355-1357. 
Eddlestone, G.T., Oldham, S.B., Upson, L.G., Premdas, F.H. and Beigelman, P.M. 
(1985) Electrical activity, cAMP concentration, and insulin release in mouse islets 
of Langerhans. Am. J. Physiol., 248, CI45-153. 
Flatt, P.R., DeSilva, M.G., Swanston-Flatt, S.K., Powell, C.J. and Marks, V. (1988) 
Tumor formation and insulin secretion by clonal RlNm5F cells following repeated 
subcutaneous transplantation in NEDH rats. J. Endocrinol. 118, 429-437. 
Flockhart, D.A. and Corbin, J.D. (1984) Preparation of the catalytic subunit of cAMP-
dependent protein kinase. Brain receptor methodologies (A), Academic press, pp 
209-215. 
Gazdar, A.F., Chick, W.L., Oie, H.K., Shims, H.L., King, D.L., Weir, G.C. and Laurie, V. 
(1980) Continuous, clonal, insulin- and somatostatin-secreting cell lines established 
from a transplantable rat islet cell tumor. Proc. Natl. Aced. Sci. USA 77, 3519-
3523. 
130 
Gillison, S.L. and Sharp, G.W.G. (1994) ADP ribosylation by cholera toxin identifies 
three G-proteins that are activated by the galanin receptor. Diabetes 43, 24-32. 
Gillis, K.D. and Misier, S. (1993) Enhancers of cytosolic cAMP augment depolarization-
induced exocytosis from pancreatic ^-cells: evidence for effects distal to Ca^"^ 
entry. Pflugers Arch. 424, 195-197. 
Hahn, H,-J. Gylfe, E. and Hellman, B. (1979) Glucose-dependent effect of 
methylxanthines on the distribution in pancreatic/ff-cells. FEBS lett. 103, 
348-351. 
Halban, P.A., Praz, G.A. and Wollheim, C.B. (1983) Abnormal glucose metabolism 
accompanies failure of glucose to stimulate insulin release from a rat pancreatic 
cell line. Biochem J. 212,439-443. 
Hepler, J.R. and Gillman, A.G. (1992) G proteins. Trends Biochem. Sci. 17, 383-387. 
Hermansen, K. (1985) Forskolin, an activator of adenylate cyclase, stimulates 
pancreatic insulin, glucagon, and somatostatin release in the dog: studies in vitro. 
Endocrinology 116, 2251-2258. 
Holz, G.G. 4th., Kuhtreiber, W.M. and Habener, J.F. (1993) Pancreatic beta-cells are 
rendered glucose-competent by the insulinotropic hormone glucagon-like peptide-
1(7-37). Nature, 361, 362-365. 
Holz, G.G. 4th., Leech, C.A. and Habener, J.F. (1995) Activation of a cAMP-regulated 
Ca^^-signalling pathway in pancreatic yff-cells by the insulinotropic hormone 
glucagon-like peptide-1. J. Biol. Chem. 270, 17749-17757. 
Hsu, W.H., Xiang, H.D., Rajan, A.S., Kunze, D.L., Boyd, A.E. Ill (1991) Somatostatin 
inhibits insulin secretion by a G-protein-mediated decrease in Ca^^ entry through 
voltage-dependent Ca^"^ channels in the beta cells. J Biol. Chem. 266:837-843 
Jiang, H., Colbran, J.L., Francis, S.H. and Corbin, J.D. (1992) Direct evidence for 
cross-activation of cGMP-dependent protein kinase by cAMP in pig coronary 
arteries. J. Biol. Chem. 267, 1015-1019. 
Jones, C.T. and Knox Ritchie, J.W. (1983) The effect of adrenergic blockade on fetal 
response to hypoxia. J. Dev. Physiol. 5, 211-222. 
Kalish, M.I., Katz, M.S., Pineyro, M.A. and Gregerman, R.I. (1977) Epinephrine- and 
glucagon-sensitive adenylate cyclase of rat liver during. Evidence for membrane 
instability associated with increased enzymatic activity. Biochem. Biophys. Acta 
483, 452-466. 
Katz M.S., Boland, S.R. and Schmidt, S.J. (1985) Developmental changes of P-
adrenergic receptor-linked adenylate cyclase of rat liver. Am. J. Physiol. 248(6 pt 
1), E712-718. 
Krebs, E.G. and Bevo, J.A. (1979) Phosphorylation-dephosphorylation of enzymes. 
Annu. Rev. Biochem. 48, 923-950. 
Kutchai, H., Barenholz, Y., Ross, T.F. and Wermer, D.E. (1976) Developmental 
changes in plasma membrane fluidity in chick embryo heart. Biochem. Biophys. 
Acta 436, 101-112. 
Maier, J.A., Roberts, J.M. and Jacobs, M.M. (1989) Ontogeny of fetal adenylate 
cyclase; mechanisms for regulation of ^ff-adrenergic receptors. J. Dev. Physiol. 12, 
249-261. 
Mandarino, L., Itoh, M., Blanchard, W., Patton, G. and Gerich, J. (1980) Stimulation of 
insulin release in the absence of extracellular calcium by isobutylmethylxanthine 
and its inhibition by somatostatin. Endocrinology 106, 430-433. 
McDonald, J.V., Gonzales, L.W., Ballard, P.L., Pitha, J. and Roberts, J.M. (1986) Lung 
beta-adrenoceptor blockade affects peripheral surfactant release but not lung 
water. J. Appl. Physiol. 60, 1727-1733. 
Odom, M., Snyder, J.M. and Mendleson, C.R. (1987) Adenosine 3',5'-monophosphate 
analogs and beta-adrenergic agonists induce the synthesis of the major surfactant 
apoprotein in human fetal lung in vitro. Endocrinology 121, 1155-1163. 
Polak, M., Scharfmann, R., Seilheimer, B., Eisenbarth, G., Dressier, D., Verma, I.M. and 
Potter, H. (1993) Nerve growth factor induces neuron-like differentiation of an 
insulin-secreting pancreatic beta cell line. Proc. Natl. Aced. Sci. USA 90, 5781-
5785. 
Rajan, A.S.,Hill, R.S. and Boyd, A.E. III. Effect of rise in cAMP levels on Ca^^ influx 
through voltage-dependent Ca^^ channels in HIT cells. Second-messenger synarchy 
in beta-cells. Diabetes, 38, 874-880. 
132 
Salesse, R., Gamier, J, and Daveloose, D. (1982) Modulation of adenylate cyclase 
activity by the physical state of pigeon erythrocyte membrane. 2. Fluidity-
controlled coupling between the subunits of the adenylate cyclase system. 
Biochemistry 21, 1587-1590. 
Sharp, G.W.G. (1979) The adenylate cyclase-cyclic AMP system in islets of 
Langerhans and its role in the control of insulin release. Diabetologica 16, 287-
296. 
Shemesh, M., Hansel, W. and Strauss, J.F. (1984) Calcium-dependent, cyclic 
nucleotide-independent steroidogenesis in the bovine placenta. Proc. Natl. Acad. 
Sci. USA 81, 6403-6407. 
Simasko, S.M. and Yan, S. (1993) 3-lsobutyl-1-methylxanthine inhibits sustained 
calcium current independently of cyclic AMP in neuronal and endocrine cells. Mol. 
Pharmacol. 44, 622-627. 
Slotkin, T.A., Whitmore, W.L., Orb-Miller, L., Queen, K.L. and Haim, K. (1987) Beta-
adrenergic control of macromolecule synthesis in neonatal rat heart, kidney and 
lung: relationship to sympathetic neuronal development. J. Pharmacol. Exp. Ther. 
243, 101-109. 
Slotkin, T.A., Lau, C. and Seidler, F.J. (1994) Beta-adrenergic receptor overexpression 
in the fetal rat: distribution, receptor subtypes, and coupling to adenylate cyclase 
activity via G-proteins. Toxicol. Appl. Pharmacol. 129:223-234. 
Sturgess, N.C., Hales, C.N. and Ashford, M.L. (1986) Inhibition of a calcium-activated, 
non-selective cation channel, in a rat insulinoma cell tine, by adenine derivatives. 
FEBS Lett. 208, 397-400. 
Sutkowski, E.M., Tang, W.J., Broome, C.W., Bobbins, J.D. and Seamon, K.B. (1994) 
Regulation of forskolin interactions with type I, II, V, and VI adenyly! cyclase by Gs 
alpha. Biochemistry 33, 12852-12859. 
Suzuki, S., Murakami, M., Abe, S., Satoh, Y., Shintani, S., Ishizuka, J., Suzuki, K., 
Thompson, J.C. and Toyota, T. (1992) The effects of amylin on insulin secretion 
from RlNm5F cells and glycogen synthesis an lipogenesis in rat primary cultured 
hepatocytes. Diabetes Res. Clin. Pract. 15, 77-84. 
133 
Thams, P., Capito, K. and Hedeskov, C.J. (1982) Differential effects of Ca^*-
calmodulin on adenylate cyclase activity in mouse and rat pancreatic islets. 
Biochem. J. 206, 97-102. 
Tobise, K., Ishikawa, Y., Holmer, S.R., Im, M-.J., Newell, J.B., Yoshie, H., Fujita, M., 
Susannie, E.E. and Homey, C.J. (1994) Changes in type VI adenylyl cyclase 
isoform expression correlate with a decreased capacity for cAMP generation in the 
aging ventricle. Circulation Res. 74, 596-603. 
Ullrich, S. and Wollheim, C.B. (1988) GTP-dependent inhibition of insulin secretion by 
epinephrine in permeabilized RINmSF cells. J. Biol. Chem. 263, 8615-8620. 
Walseth, T.F., Zhang, H-.J., Olson, L.K., Schroeder, W.A. and Robertson, R.P. (1989) 
Increase in Gj and cyclic AMP generation in HIT cells. J. Biol. Chem. 264, 21106-
21111. 
Walsh, D.A., Perkins, J.P. and Krebs, E.G. (1968) An adenosine 3'.5'-monophosphate-
dependent protein kinase from rabbit skeletal muscle. J. Biol. Chem. 243, 3763-
3765. 
Watson, E.L., Jacobson, K.L. and Singh, J.C. (1989) Monovalent ion enhancement of 
beta-adrenergic-stimulated adenylate cyclase activity in mouse parotid gland. 
Biochem. Pharmacol. 38, 1069-1074. 
Weber, I.T., Steitz, T.A., Bubis, J. and Taylor, S.S. (1987) Predicted stuctures of 
cAMP binding domains of type I and 11 regulatory subunits of cAMP-dependent 
protein kinases. Biochemistry 26, 343-351. 
Wiedenkeller, D.E. and Sharp, G.W. (1981) Insulin release. Demonstration of a priming 
effect of 3-isobutyl-1-methyl-xanthine (IBMX) on islets of Langerhans. Diabetes 
754-756. 
Zhang, H. -J., Walseth, T.F. and Robertson, R.P. (1989) Insulin secretion and cAMP 
metabolism in HIT cells: reciprocal and serial passage-dependent relationships. 
Diabetes 38, 44-48. 
Ziegler, B. Kohnert, K.D., Noack, S. and Hahn, H.J. (1982) Effects of 3-isobutyl-1-
methylxanthine on secretory response, cAMP accumulation and DNA synthesis of 
islets from postnatal and adult Wistar rats. Acta. Biol. Med. Ger. 41, 1171-1177. 
134 
CHAPTER VI CHARACTERIZATION OF VOLTAGE-DEPENDENT 
CALCIUM CHANNELS IN RINM5F CELLS IN A PASSAGE-
AND MORPHOLOGY-DEPENDENT MANNER 
A paper to be submitted to the Cell Calcium 
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ABSTRACT 
Changes in intracellular Ca^"^ concentrations have a major role in the regulation of 
insulin release from pancreatic yff-cells. In the present study, voltage-dependent calcium 
channels (VDCCs) were characterized in a passage-and morphology-dependent manner 
in a clonal iff-cell line RINmBF. Passages from 28 to 40 were employed to contrast two 
morphological features; the differentiated cells with neuron-like processes and the 
undifferentiated cells without the processes. Passages < 30 were differentiated cells 
and passages ^ 35 were undifferentiated cells. The effect of KCI (15 mM) on [Ca^^], 
and insulin release was 3-fold higher and Bay K 8644 (1 //M) was 6-fold higher in 
differentiated cells than in undifferentiated cells. Furthermore, the dose-dependent 
increases in [Ca^^], and insulin release by the L-type Ca^"^ channel agonist. Bay K 8644 
(1 nM - 1 //M), were higher in differentiated cells than in undifferentiated cells. 
However, dose-dependent increases in [Ca^*^], and insulin release induced by low 
concentrations of KCI (7.5 - 30 mM) were greater in differentiated cells than in 
undifferentiated cells but the results were reversed in the presence of higher 
concentrations of KCI (30 - 45 mM). In addition, the inhibitory effect of nimodipine on 
KCI and Bay K 8644 was studied by equally increasing [Ca^*^], and insulin release in 
differentiated and undifferentiated cells. Thus, 12 mM and 15 mM KCI was used in 
differentiated and undifferentiated cells, respectively, and 0.1 //M and 1 yi/M Bay K 
8644 was used in differentiated and undifferentiated cells, respectively. Dose-
dependent inhibitions in KCI- and Bay K 8644-induced [Ca^"^], and insulin release by 
nimodipine (1 nM - 1 //M) were greater in differentiated cells than in undifferentiated 
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cells. 
In whole-cell patch-clamp recordings, with a holding potential of -80 mV, inward 
Ca^"^ currents were first observed during a depolarization to -50 mV in both 
differentiated cells and undifferentiated cells. However, the maximal Ca^'^ current was 
higher in undifferentiated cells than in differentiated cells. Bay K 8644 (1 /yM) 
increased Ca^"^ currents by 74 ± 13% in differentiated cells and 20 ± 7 % in 
undifferentiated cells. Nimodipine (1 //M) caused an inhibition of control Ca^^ currents 
by 48 ± 17% in differentiated cells and failed to inhibit them in undifferentiated cells. 
In addition, nimodipine (1 inhibited Bay K 8644-induced Ca^"^ current by 83 ± 8 
% in the differentiated cells, but failed to inhibit them in undifferentiated cells. 
Since nimodipine did not totally inhibit control Ca^^ currents and Bay K 8644-
induced increases in [Ca^"^]i and insulin release in undifferentiated cells, it was further 
studied for two possibilities: 1) the functional involvement of other VDCCs such as N-, 
P- and Q-type and 2) the voltage-dependence of L-type Ca^"^ channels. An N-type 
channel blocker, w-conotoxin GVIA (1 //M), and a P- and Q-type channel blocker, u)-
agatoxin IVA (300 nM), did not inhibit basal Ca^^ currents nor did they inhibit KCI- and 
Bay K 8644-induced increases in [Ca^^lj and insulin release in both differentiated and 
undifferentiated cells. The voltage-dependence of L-type channels was studied by 
using nimodipine, whose binding could be enhanced by prolonged membrane 
depolarization. KCI (30 mM)-induced increases in [Ca^'*'], and insulin release was dose-
dependently inhibited by nimodipine (0.1 nM - 1 yuM) in both differentiated and 
undifferentiated cells. The potency of nimodipine on [Ca^^], and insulin release by 30 
mM KCI was 17- to 22-fold higher than by 15 mM KCI in undifferentiated cells. 
However, in differentiated cells, there were no significant differences in the potency of 
nimodipine on [Ca^*^]! and insulin release induced by 12 and 30 mM KCI. In addition, in 
undifferentiated cells, the potency of nimodipine in inhibiting control Ca^"^ currents was 
compared by holding membrane potentials at -80 mV and 0 mV in the whole-cell patch-
clamp recordings. Nimodipine (1 //M) failed to inhibit control Ca^'^ currents at the 
holding potentials of -80 mV, but inhibited them by 70.3 ± 7.7% at the holding 
potentials of 0 mV. The current-voltage relationship shifted to more negative potentials 
in differentiated cells than in undifferentiated cells. The voltage at which one-half of 
Ca^^ currents was activated was -24.3 ± 3.6 mV in differentiated cells and -10.6 ± 
136 
2.5 mV in undifferentiated cells. The prepulse potential at which one-half of the 
maximal Ca^"^ currents was inactivated shifted from -21.4 ± 3.9 mV in differentiated 
cells to 1.8 ± 4.3 mV in undifferentiated cells. Taken together, these results 
suggested that differentiated RINmSF cells are functionally equipped with more L-type 
Ca^"^ channels than the undifferentiated cells, and the voltage-dependence of L-type 
Ca^"^ channels was different between differentiated and undifferentiated cells. 
However, N-, P- and Q-type VDCCs were not detected in differentiated and 
undifferentiated RINmSF cells. 
INTRODUCTION 
Intracellular serves as a major signal for insulin release (Smith et al, 1993). 
Ca^"^ entry through voltage-dependent Ca^'^ channels (VDCCs) is a major pathway for 
raising the intracellular Ca^^ concentration in most of living cells Including ;9-cells 
(Ashcroft et al., 1990). As Ca^"^ entry in jff-cells is primarily controlled by VDCCs, the 
identification and characterization of these channels are of importance for 
understanding )9-cell stimulus-secretion coupling. VDCCs are primarily categorized as T 
(transient)-, N (neither L nor T)-, L (long-lasting)- and P (Purkinje)-types. In addition, the 
Q-type channel has been characterized in the brain (Hofmann et a!., 1994). The T-type 
(low voltage-activated or slow-deactivating) channel is activated at membrane 
potentials of around -50 mV and exhibits a voltage-dependent inactivation. The L-type 
(high-voltage activated or fast-deactivating) channel of ;9-cells is activated at membrane 
potentials of around -40 mV, and the inactivation of calcium current is Ca^"^-dependent 
(Polio et al., 1993). The L-type channel is distinguished by its sensitivity to 
dihydropyridines (DHP), being inhibited by DHP antagonists such as nimodipine and 
activated by DHP agonists such as Bay K 8644 (Smith et al., 1993). The N- and P-
type channels are blocked by w-conotoxin GVIA and a;-agatoxin IVA, respectively. The 
Q-type channel is blocked by higher concentrations (300 nM) of w-agatoxin IVA than 
the P-type channel (30 nM). In addition, the Q-type channel is blocked by eu-conotoxin 
MVIIC (Hofmann et al., 1994). 
There is growing evidence that the pancreatic ^ff-cell possesses a heterogeneity of 
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Ca^"^ channels and that the expression of the different channel types may vary among 
species (Ashcroft et al., 1994). In mouse /ff-cells, the L-type Ca^"^ channel accounts for 
most of the Ca^"^ influx (Smith et al., 1993), and both L- and T-type channels have 
been identified in rat and human yff-cells (Ashcroft et al., 1990) and RINm5F cells 
(Velasco, 1987). Recently, the presence of multiple types of high voltage-activated 
(HVA) channels has been suggested in pancreatic l3-ce\\s and RINm5F cells 
(Aicardi et a!., 1991; Sher et al., 1992; Polio et al., 1993; Magnelli et al,, 1995). 
DHPs inhibit the HVA current by 55%, w-conotoxin GVIA by 10-20%, a/-agatoxin IVA 
by 24%, and oz-conotoxin MVIIC by 45% in RINm5F cells suggesting that N-, P- and Q-
type VDCCs in addition to L-type may be present (Aicardi et al., 1991; Sher et al., 
1992; Polio et al., 1993; Magnelli et al., 1995). 
In a preliminary study, we observed that RINmSF cells had neuron-like long 
processes (differentiated cells) and lost them to become round cells (undifferentiated 
cells) after a long-term {> 8 weeks) culture . As the cells changed their morphologies, 
the functional responses to Bay K 8644 and KCI for insulin release and intracellular 
calcium ([Ca^^];) were distinct between differentiated and undifferentiated cells. These 
findings led us to further characterize the role of VDCCs on increases in [Ca^'^], and 
insulin release by applying a number of calcium channel agonists and antagonists in 
differentiated and undifferentiated RINm5F cells. The present findings indicated that L-
type Ca^"^ channels are functionally more predominant in differentiated cells than in 
undifferentiated cells, whereas, the voltage-dependency of L-type Ca^'^ channels was 
different between differentiated cells and undifferentiated RINmSF cells , However, N-, 
P- and Q-type calcium channels were not evident in either differentiated or 
undifferentiated RINm5F cells. 
MATERIALS AND METHODS 
Materials 
The following materials were used: RPMI-1640, fetal bovine serum, and cj-
conotoxin GVIA (Sigma Chemical,St. Louis, MO), 24-well culture plate (Corning Glass 
Works, Corning, NY), Bay K 8644 and nimodipine (Research Biochemicals International, 
Natic, MA), CGP 28392 (Ciba-Geigy Limited, Basel, Switzerland), and a;-agatoxin IVA 
(Pfizer Inc., Groton, CT). 
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Cell culture 
RiNm5F ceils were obtained from Dr. S. B. Pek (University of Michigan Medical 
Center, Ann Arbor, Ml). The cells were maintained in RPMI-1640 medium with 10% 
fetal bovine serum as described previously (Chen et al., 1994), The cells were 
subcultured every 7 days and the medium was changed at day 3 and day 5 after 
subculture. All experiments were performed by use of cells from passages 28-40. No 
antibiotics were used. 
measurement 
Intracellular Ca^* concentration ([Ca^"^],) was monitored as previously described 
(Hsu et al., 1991a). Briefly, the cells were loaded with 2 JJM fura-2 
acetoxymethylester (AM) in KRB for 30 min at 37 °C. The loaded cells were washed 
with KRB and kept at room temperature. The cells were resuspended in a 
concentration of 10® cells/ml and 1.5 ml of aliquot was used for measuring [Ca^"*"]). 
The 340/380 nm fluorescence ratios were monitored in a SLM-8000 fluorescence 
spectrophotometer (SLM, Urbana, IL). The [Ca^^], was calibrated after cell lysis as 
described previously (Hsu et al., 1991a). 
Ca^* current recordings 
The perforated patch clamp was performed as described previously (Horn and 
Marty, 1988) using an Axopatch-ID clamp amplifier (Axon Instruments, Foster City, 
CA). Patch pipettes (3-5 MO) were made on a micropipette puller (Narishige 
Instruments, Tokyo) by using disposable glass pipettes (VWR Scientific, West Chester, 
PA), and were polished on a custom-made microforge. A high-resistant seal between 
the edge of the electrode and the membrane was obtained by applying slight suction to 
the pipette after gently pushing it on to the surface of the cell. The liquid junction 
potentials were nullified with an offset circuit before the high-resistance seal formed. 
Ca^"^ currents were evoked by depolarizing pulses from a holding potential of -80 mV to 
a potential between -60 to + 50 mV at 10 mV increments. Data were collected and 
analyzed using an IBM-PC computer with an analogue-digital interface board and 
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pClamp software 5.5. (Axon Instruments, Foster city, CA). The patch pipette was 
filled with a solution containing 120 mM glutamic acid, 130 mM CsOH, 250//g/ml 
amphotericin B and 10 mM Hepes (pH 7.2). The bath solution contained in mM: 140 
tetraethylammonium chloride, 5 4-aminopyridine, 2 CaClj, 1.67 glucose, 5.4 KCl and 
10 Hepes (pH 7.4). Agents were applied to the bath solution directly and all 
experiments were performed at room temperature. 
Insulin release 
Static incubations were performed to study insulin release in response to test 
agents as previously described (Hsu et al., 1991b). Cells from later passages grew 
more rapidly; consequently, the cells were plated onto 24-well plates at 2 x 10® 
cells/well for passages 28-32 and at 7 x 10* ceils/well for passages 34-40 and grown 
for 5 days. The growth medium was then removed, and the cells were washed with 
Krebs-Ringer buffer (KRB) containing (in mM): 136 NaCI, 4.8 KCl, 2.5 CaClz, 1.2 
KH2PO4, 1.2 MgS04, 5 NaHCOg, 10 HEPES, 1.67 glucose and 0.1% bovine serum 
albumin, pH 7.4. The cells were then preincubated for a 15-min basal period at 37°C, 
followed by a 15-min incubation in KRB with test agents. When needed, the 
antagonist was given 5 min before the administration of the agonist to ensure blockade 
of the receptors before the addition of the agonist. Insulin in the media was measured 
by radioimmunoassay (RIA) as previously described (Hsu et al., 1991b). 
Statistical analysis 
All values were expressed as mean ± S.E. Analysis of variance (ANOVA) was 
used to determine the treatment or dose effect. The least significance test was used to 
test for differences between means of end points for which the ANOVA indicated a 
significant (P<0.05) F ratio. 
RESULTS 
Effects of KCl and Bay K 8644 on fCa^*],- and insulin release in differentiated and 
undifferentiated RINmSF cells 
In the differentiated state, RINm5F cells had neuron-like processes; however, in the 
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undifferentiated state, the cells did not possess neuron-like processes. More than 90% 
of the cells were differentiated in passages < 30. However, the cells gradually lost 
processes to become undifferentiated cells and > 99% of the cells were 
undifferentiated after passage 35 (Fig. 1 in Chapter III). 
KCI (15 mM) and Bay K 8644 (1 yuM) caused a rapid transient increase in [Ca^^]| 
which was followed by a slowly decaying plateau in both differentiated and 
undifferentiated cells, but increases were greater in differentiated cells than in 
undifferentiated cells (Fig. 1). KCI was 3-fold more potent and Bay K 8644 6-fold more 
potent in producing a [Ca^^], increase in differentiated cells than in undifferentiated 
cells (Fig. 2). Similarly, KCI (15 mM) and Bay K 8644 (1 //M) induced insulin release in 
both differentiated and undifferentiated cells but KCI was 3-fold more potent and Bay K 
8644 6-fold more potent on insulin release in differentiated cells than in 
undifferentiated cells (Fig. 2). Bay K 8644 (1 nM - 1 //M) dose-dependently increased 
[Ca^"^]i and insulin release in both cell types, but increases were greater in differentiated 
cells than in undifferentiated cells (Fig. 3). KCI (7.5 - 45 mM) increased [Ca^"^], and 
insulin release in a dose-dependent manner in both differentiated and undifferentiated 
cells, but patterns of the increases were distinct (Fig. 4). At lower concentrations of 
KCI (10-30 mM), the dose-dependent increases were greater in differentiated cells 
while at higher concentrations of KCI (30 - 45 mM) the increases were greater in 
undifferentiated cells. These findings suggested that differentiated cells are 
functionally equipped with more L-type channels than undifferentiated cells. In 
addition, the voltage-dependence of the HVA-Ca^"^ channels may be different between 
differentiated and undifferentiated cells because KCI, which depolarizes membrane 
potentials and opens VDCCs, increased [Ca^^], and insulin release in a discrete manner 
between differentiated and undifferentiated cells (Fig. 4). 
Effects of depolarization and Bay K 8644 on Ca'* currents in RINmSF cells 
In the whole-cell patch-clamp recordings, after blocking K"^ currents by adding a 
high concentration of Cs"^ (30 mM) to the pipette solution, and tetraethylammonium 
(TEA) and 4-aminopyridine (4-AP) to the bath solution to block K^ channels, inward 
Ca^"^ currents were elicited by depolarizing from -60 to +50 mV from a holding 
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Fig. 1. Effects of KCI (15 mM) and Bay K 8644 (1 //M) on [Ca^"^], in differentiated (left 
panel) and undifferentiated (right panel) RINmSF cells. Arrowheads show the times 
when the agents were added. One representitive result out of 8 observations. 
Fig. 2. (A and C) Passage-dependent effects of KCI (15 mM) on [Ca^^lj (A) and insulin 
release (C) in RINm5F cells. Percentage of increase of [Ca^'^l, was calculated from the 
changes between basal and peak concentration. Basal concentration of [Ca^*], was 
105 - 134 nM in passages between 28 and 40. (B and D) Passage-dependent effect 
of Bay K 8644 (1 //M) on (B) and insulin release (D) in RiNm5F cells. Mean ± 
S.E. (n = 8) for [Ca^"*"], and In = 16) for insulin release are shown. 
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differentiated (O) and undifferentiated (•) RINmSF cells. Percentage of increase of 
[Ca^"^], was calculated from the changes between basal and peak concentration. Mean 
± S.E. for [Ca^*]i (n=4) and for insulin release {n = 8) are shown. 
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potential of -80 mV {Fig. 5) in the presence of 2 mM in the bath solution. Under 
control conditions, inward Ca^"^ currents were first observed during a depolarization to 
-50 mV and reached maximum at membrane potentials of about 0 mV in the 
differentiated cells and 20 mV in the undifferentiated cells (Fig. 5). The currents 
were typically biphasic, consisting of a sustained and an inactivating component. The 
maximal amplitude was 103 ± 22 pA (n = 10) in the differentiated cells and 386 ± 90 
pA (n = 12) in the undifferentiated cells. The activation of both currents was fast while 
inactivation developed slowly and was largely incomplete after 300 ms depolarizing 
pulses. Bay K 8644 (1 ;t/M) increased the peak amplitude by 74 ± 13% (n = 6) in the 
differentiated cells and 22 ± 5% (n = 8) in the undifferentiated cells. The Ca^"^ 
currents recovered after the washout. 
Effects of DHP antagonists on the KCI- and Bay K 8644-stimulated [Ca^*], and insulin 
release in RINm5F cells 
To further evaluate the activity of L-type Ca^"^ channels, the inhibitory effects of 
two DHP antagonists, nimodipine and nifedipine, on [Ca^'^]{ and insulin release were 
studied in differentiated and undifferentiated RINmSF cells. In this experiment, [Ca^'^li 
and insulin release were equally elevated by 12 and 15 mM KCI in differentiated and 
undifferentiated cells, respectively, and 0.1 and 1 JJM Bay K 8644 in differentiated and 
undifferentiated cells, respectively. Nimodipine {1 nM - 1 ;/M) dose-dependently 
inhibited KCI- and Bay K 8644-induced [Ca^^], and insulin release in both differentiated 
and undifferentiated cells (Fig. 6), iCgo of nimodipine on the KCI-induced [Ca^'^lj were 
5 ± 1 nM (n = 4) in differentiated cells and 41 ± 4 nM (n = 4) in undifferentiated cells. 
ICgo of nimodipine on the KCI-induced insulin release were 3 ± 3 nM (n = 8) in 
differentiated cells and 30 ± 3 nM (n = B) in undifferentiated cells. IC50 nimodipine 
on the Bay K 8644 (0.1 /yM)-induced [Ca^^l, and insulin release in the differentiated 
cells were 13 ± 4 nM (n = 4) and 5 ± 2 nM {n = 8), respectively. However, IC50 of 
nimodipine on the Bay K 8644 (1 )uM)-induced [Ca^"^], and insulin release in 
undifferentiated cells was not estimated because of poor inhibitory effect of nimodipine 
in the cells. Therefore, by comparing IC50 values of nimodipine on KCI-induced [Ca^"^], 
and insulin release, nimodipine was 8- to 10-fold more potent in differentiated cells 
than in undifferentiated cells. 
Fig. 4. Dose-dependent effect of KCI on (A) and insulin release (B) in 
differentiated (O) and undifferentiated (•) RINnn5F cells. Percentage of increase of 
[Ca^"^]! was calculated from the changes between basal and peak concentration. Mean 
± S.E. for [Ca^'*"]j {n = 4) and for insulin release (n = 8) are shown. 
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Fig. 5. Effect of Bay K 8644 (1 pM) on evoking calcium current in differentiated (A) 
and undifferentiated (B) RINmBF cells. (Aa) Superimposed current traces obtained in 
the absence (O) and presence of Bay K 8644 (•) in differentiated cells. The holding 
potential and test potential were -80 mV and +0 mV, respectively. (Ab) The voltage-
current relationship. (Ba) Superimposed current traces obtained in the absence (O) and 
presence of Bay K 8644 (•) in undifferentiated cells. The holding potential and test 
potential were -80 mV and +20 mV, respectively. (Bb) The voltage-current 
relationship. |C) Average increase of Ca^* currents by Bay K 8644. Mean ± S.E. for 
Ca^* currents in differentiated cells (n = 6) and in undifferentiated ceils In = 8) are 
shown. 
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(A) and insulin release (C) in differentiated (O) and undifferentiated (•) RINmSF cells. 
(B and D) The effect of nimodipine (1 nM - 1 fjM) on KCI -induced [Ca^"^], (8) and insulin 
release (D) in differentiated (O) and undifferentiated (•) RINmBF cells. 12 and 15 mM 
KCI was applied to equally increase [Ca^"^], and insulin release in differenatiated and 
undifferentiated cells, respectively. In addition, to equally increase [Ca^*], and insulin 
release, 0.1 and 1 //M Bay K 8644 was applied in differentiated and undifferentiated 
cells, respectively. Mean ± S.E. for (n = 4) and for insulin release (n = 8) are 
shown. 
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Effect of nimodipine on depolarization- and Bay K 8644-induced Ca^* currents in 
RINmSF cells 
Ca^"^ currents were activated at about -50 mV in both differentiated and 
undifferentiated cells reaching maximal amplitude at 0 mV in the differentiated cells 
and 20 mV in the undifferentiated cells. The activation of these currents was rapid 
while inactivation developed slowly and was largely incomplete after 300 ms of 
depolarizing pulses. The maximal Ca^"^ current was 123 ± 25 pA (n = 5) in the 
differentiated cells and 446 ± 111 pA (n = 5) in the undifferentiated cells. The addition 
of nimodipine (1 pM) produced a reduction of maximal control Ca^"^ currents by 47.6 ± 
17% {n = 5) in differentiated cells and 8 ± 3% (insignificant changes at P<0.05; n = 5) 
in undifferentiated cells (Fig. 7). The currents recovered after the washout. 
To further evaluate the relative contribution of nimodipine and Bay K 8644-
sensitive Ca^'*" channels in both differentiated and undifferentiated cells, the effect of 
nimodipine on Bay K 8644-activated Ca^"^ currents was studied. The maximal 
amplitude was 128 ± 18 pA (n = 5) in the differentiated cells and 422 ± 85 pA (n = 5) 
in the undifferentiated cells. Bay K 8644 (1 /yl\/I)-induced Ca^^ currents were inhibited 
by nimodipine (1 //M) by 83 ± 8% (n = 5) in differentiated cells, but not in 
undifferentiated cells (at P<0.05 compared with controls; n = 5) (Fig. 8). Ca^^ currents 
also recovered after the washout. 
Effects of uj-conotoxin GVIA and oj-agatoxin IVA on Ca^"^ currents, [Ca^*]i, and insulin 
release in RINmSF cells 
To test the possibility that other Ca^'^ channels besides the L-type may be involved 
in RINm5F cells, oz-conotoxin GVIA and a/-agatoxin IVA were applied to both 
differentiated and undifferentiated cells. oz-Conotoxin GVIA (1 //M), an N-type channel 
blocker, failed to change KCI (30 mM)-induced insulin release in differentiated and 
undifferentiated cells, which were 103 ± 3% and 102 ± 1%, respectively (n = 4). w-
Agatoxin IVA (300 nM), a P- and Q-type calcium channel blocker, did not significantly 
inhibit KCI (30 mM)-induced insulin release in differentiated and undifferentiated cells, 
which were 99 ± 4% and 90 ± 5%, respectively (n = 8). w-Agatoxin IVA (300 nM) 
failed to change KCI (15 and 30 mM)-induced increase in [Ca^*^], in differentiated and 
undifferentiated cells. In addition, w-conotoxin GVIA (1 //M) and w-agatoxin IVA (300 
Fig. 7. Effects of nimodipine (Nim, 1 juM) and w-conotoxin (1 fjM) on Ca^"^ currents in 
differentiated cells (A) and undifferentiated (B) RINmSF cells. (Aa) Superimposed 
current traces obtained in the absence (O) and presence of nimodipine {9), uj-
conotoxin GVIA (V), and Cd^"*" {•) in differentiated ceils. The holding potential and test 
potential were -80 mV and +10 mV, respectively. (Ab) The voltage-current 
relationship. (Ba) Superimposed current traces obtained in the absence (O) and 
presence of nimodipine (•), w-conotoxin GVIA (V), and Cd^"^ (•) in undifferentiated 
cells. The holding potential and test potential were -80 mV and + 20 mV, respectively. 
(Bb) The voltage-current relationship. (C) Average inhibition of Ca^'^ currents by 
nimodipine. Mean ± S.E. (n = 5) for Ca^* currents in differentiated cells and in 
undifferentiated ceils are shown. 
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nM) failed to inhibit the control Ca^"^ currents and KCl (15 and 30 mM)-induced 
increase in [Ca^^lj in both differentiated cells and undifferentiated cells. 
Voltage-dependence of L-type channels on Ca'* currents, ICa^*], and insulin release in 
RINmSF cells 
To test the possibility that the affinity of nimodipine might be lowered in 
undifferentiated cells and it can be enhanced by prolonged depolarization (Catterall and 
Striessnig, 1992; Hille, 1992), 30 mM KCl was applied to equally elevate [Ca^^], and 
insulin release (Fig. 4) in differentiated and undifferentiated RINmSF cells. Nimodipine 
(0.1 nM - 1 //M) dose-dependently inhibited KCl (30 mM)-induced [Ca^^], and insulin 
release in both differentiated and undifferentiated cells (Fig. 9). ICgj, of nimodipine on 
KCI-induced [Ca^'^], were 6.0 ± 2.2 nM (n = 4) in differentiated cells and 1.8 ± 0.6 
nM (n = 4) in undifferentiated cells. In addition, ICgo of nimodipine on KCI-induced 
insulin release was 2.5 ± 0.1 nM (n = 8) in differentiated cells and 1.8 ± 0.1 nM 
(n = 8) in undifferentiated ceils. The potency of nimodipine on ICa^"^], and insulin 
release induced by 30 mM KCl was 17- to 22-fold higher than by 15 mM KCl in 
undifferentiated RINmBF cells. However, in differentiated RINm5F cells, there were no 
significant differences in the potency of nimodipine on [Ca^"^]! and insulin release 
induced by 12 and 30 mM KCl. Therefore, these findings suggested that the greater 
inhibitory effect of nimodipine resulted from a further decrease in membrane potentials 
in undifferentiated cells, but not in differentiated cells. The voltage-dependence of 
RINmBF cells may be different between differentiated and undifferentiated cells, 
since the change of membrane potentials produced by 15 mM to 30 mM KCl affected 
the potency of nimodipine in undifferentiated cells, but not in differentiated cells. 
We further studied the voltage-dependence of RINm5F cells, particularly in 
undifferentiated cells. In the whole-cell patch-clamp recordings, the potency of 
nimodipine in inhibiting control Ca^'^ currents was further compared by applying two 
different membrane holding potentials (-80 mV and 0 mV) in undifferentiated cells, 
because the resting membrane potentials of RlNm5F cells were -80 mV and 50% of 
the Ca^"^ channels was inactivated at membrane potentials of 0 mV. With a holding 
potential of -80 mV, inward Ca^^ currents were first observed during a depolarization 
Fig. 9. Effect of nimodipine (0,1 nM - 1 //M) on KCI (30 mM)-induced [Ca^*], (A) and 
insulin release (B) in differentiated (O) and undifferentiated (•) RINmSF cells. 30 mM 
KCI was applied to equally elevate [Ca^""], and insulin release. Mean ± S.E. for (Ca^*], 
{n = 4) and for insulin release (n = 8) are shown. 
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to -50 mV, reaching maximum at membrane potentials of 20 mV. With a holding 
potential of 0 mV, inward Ca^* currents were first observed during a depolarization to 
+ 5 mV, reaching maximum at membrane potentials of 20 mV. In both holding 
potentials, the Ca^^ currents were also typically biphasic, consisting of a sustained and 
an inactivating component. The maximal Ca^"^ current was approximately 121 ±24 
pA (n = 5) in the holding potential of -80 mV and 39 ± 9 pA (n = 4) in the holding 
potential of 0 mV (Fig. 10a). The activation of both currents was fast while 
inactivation developed slowly and was largely incomplete after 300 ms depolarizing 
pulses in both holding potentials. Nimodipine (1 //M) failed to inhibit control Ca^^ 
currents at the holding potentials of -80 mV (n = 5), but inhibited them by 70.3 ± 
7.7% {n = 4) at the holding potentials of 0 mV in undifferentiated ceils {Fig. 10b). The 
Ca^^ currents recovered after the washout. 
Voltage dependence of activation and steady-state inactivation of Ca^"^ currents in 
RINmSF cells 
Analysis of voltage-dependent activation and inactivation is one approach to 
differentiate L-type Ca^"^ currents. The activation (la,ep/lmax) was estimated by 
normalizing the currents evoked by test potentials to the maximal current. The average 
data were fitted to the Boltzmann equation: Istep/'max = 1/[1 exp{(Vi/2 - V)//r}] where 
is the half-activation potential and k is the slope factor, a measure of the steepness 
of the voltage dependence of activations. By fitting to the Boltzmann equation, V1/2 for 
activation of Ca^'*' currents was -24.3 ± 3.6 mV in differentiated cells (n=4) and -10.6 
± 2.5 mV in undifferentiated cells (n=5) (Fig. 11a). The steady-state inactivation was 
characterized using the two-pulse protocol consisting of a long prepulse (5 s) and a 
300 ms test pulse where the peak current is produced. The average values were fitted 
well by the following function: Ijtep/lma* = 1/[1 + exp{{V - V^j)/^}! where V is the 
prepulse, V„2 is the potential required for half inactivation of the currents, and k is the 
slope factor. The inactivation was measured by the ratio of is,ep/ln,ax which 's the 
maximum current amplitude evoked during the test pulse after the most hyperpolarizing 
prepulse and ls,ap is the currents evoked by test pulse. V,/2 for inactivation of Ca^^ 
currents was -21.4 ± 3.9 mV in differentiated cells (n = 4) and 1.8 ± 4.3 mV in 
undifferentiated cells {n = 4) (Fig. 11b). These findings suggested that the current-
Fig. 10. Effect of nimodipine (1 )i;M) on control Ca^"' currents with holding potentials at 
-80 mV and 0 mV in undifferentiated RINmBF cells. Superimposed traces (A and B) of 
currents elicited by 300 ms depolarizing pulses (amplitude indicated on each pair from 
holding poteintials of -80 mV (A) and 0 mV (B) for Ca^"^ currents). Note in B the 
change in holding potential altered the currents significantly. (C) Average changes of 
Ca^'^ currents by nimodipine. Mean ± S.E. ((n = 5) for the holding potentials at -80 
mV; (n = 4) for the holding potentials at -10 mV) are shown . 
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Fig. 11. (A) Voltage dependence of activation of L-type Ca^"^ currents in differentiated 
(O) and undifferentiated (•) RINmSF ceils. The activation of Ca^^ currents was 
measured at a variety of test potentials and was normalized to the maximum 
current (/^.x)- Data points are means from differentiated ceils (n = 4) and 
undifferentiated cells {n = 5). (B) Steady-state inactivation of L-type currents in 
differentiated (O) and undifferentiated (•) RINmBF cells. Data points are means from 
differentiated cells (n = 4) and undifferentiated cells {n = 5). 
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voltage relationship of activation and inactivation of L-type channels shifted to more 
negative membrane potentials in differentiated cells than in undifferentiated cells. 
DISCUSSION 
Although VDCCs are known to play a crucial role in stimulus-secretion coupling in 
pancreatic P cells, little is known about their molecular properties and pharmacology. 
This is of interest in light of increasing evidence of the coexpression of multiple 
subtypes of VDCCs in pancreatic /S-cells and RINm5F cells (Aicardi et al., 1991; Polio 
et al., 1993; Magnelli et al., 1995). In the present study, we performed a long-term 
culture of RINm5F cells which led to morphologic changes possibly linked to the 
concomitant changes in the VDCC physiology. Our results demonstrated that 
predominantly L-type Ca^^ channels are functionally involved in both the differentiated 
cells and undifferentiated cells. However, differentiated cells are functionally equipped 
with more L-type channels than undifferentiated RINm5F cells. In addition, voltage 
dependence of activation and steady-state inactivation of Ca^"^ currents were shifted to 
more negative membrane potentials in undifferentiated cells than in differentiated 
RlNmBF cells. The possible involvements of N-, P- and Q-type Ca^"^ channels were 
excluded from both differentiated and undifferentiated RlNmBF cells. 
Differentiated cells showed greater response to depolarization- and Bay K 8644-
induced increase in Ca^"^ currents and [Ca^"^]! than undifferentiated cells. In addition, 
voltage dependence of activation and steady-state inactivation of Ca^"^ currents in 
differentiated cells were shifted to more negative potentials than those in 
undifferentiated RINm5F cells. Since the a, subunit of L-type channel contains the 
binding sites for DHPs and is the pore-forming subunit, increases in Ca^^ currents and 
ICa^"^!) are directly associated with the a, subunit (Singer et al., 1991). In Xenopus 
oocytes. Bay K 8644 induces Ca^"^ currents with the expression of or, subunit alone, 
but does not with the expression of y subunit or the coexpression of both 02/6 and P 
subunits. However, Bay K 8644 enhances Ca^'^ currents with the coexpression of 
aJS or P subunit with o, subunit, and further potentiates Ca^"^ currents with the 
coexpression of OzIS and P subunit with subunit (Singer et al., 1991). In addition, 
activation and inactivation kinetics of VDCCs are slow when only a•^ subunit of Ca^"^ 
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channels is expressed. With the coexpression of a, and ^ subunits of L- or T-type Ca^"" 
channels, however, voltage dependence of activation and steady-state inactivation of 
currents are normal and are shifted to more negative membrane potentials than 
with the expression of cr, subunit alone (Lacerda et al., 1991; Singer et al., 1991; 
Soong et al., 1993). Therefore, our findings suggested that smaller number of L-type 
channels or fewer cr, and yff subunits are expressed in undifferentiated cells than in 
differentiated cells. However, further studies are required to confirm this hypothesis. 
Although Bay K 8644 and nimodipine are DHP agonist and antagonist, 
respectively, their effects on L-type Ca^^ channels were not consistent between 
differentiated and undifferentiated RINmBF cells. Nimodipine at the highest dose 
studied (1 //M) abolished Bay K 8644-induced Ca^"^ currents, [Ca^"*"]! and insulin release 
in differentiated cells but only partially inhibited those in undifferentiated cells. These 
findings raised the possibility that the binding sites for Bay K 8644 and nimodipine are 
different. In fact, it has been suggested that there are two DHP binding sites in L-type 
Ca^*^ channels: one is close to the SS1-SS2 region of repeat III (Striessnig et al, 1991; 
Nakayama et al., 1991) and the other is close to a sequence following IVS6 segment 
of the a•^ subunits of L-type Ca^"^ channels (Regulla et al., 1991). Another possibility is 
that the affinity of nimodipine might be lowered in undifferentiated cells. The affinity of 
a DHP antagonist is enhanced by prolonged depolarization (Catterall and Striessnig, 
1992; Hille, 1992) and binds far more tightly to the inactivated state than to the 
resting state of the Ca^^ channel (Bean, 1984). Thus, the properties of the DHP 
receptor depend on the gating state of the Ca^"^ channels (Hill, 1992). We 
demonstrated that nimodipine was a more potent inhibitor of currents and [Ca^"^], 
increases and insulin release when membrane potentials were decreased or membrane 
holding potentials were increased. These findings suggested that the gating state of 
DHP-sensitive Ca^"*^ channels are different and this contributes to the different effect of 
nimodipine between differentiated and undifferentiated RINmSF cells. 
RINmSF cells have been suggested to possess at least three HVA Ca^*^ channels; 
an L-type channel that contributes to about 50% of the total current, an N-type (10-
20%) and other non-L-, non-N-type channels contributing to the slowly inactivating 
current («35%) (Polio et al., 1993). In addition, HVA Ba^"^ currents in the whole-cell 
patch clamp of RINmSF cells are partially blocked by both a/-agatoxin IVA and a/-
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conotoxin MVIIC (Magnelli et al., 1995), in tliat 30 nM and 300 nM i(;-agatoxin IVA 
block P- and Q-type channels, respectively, and micromoiar concentrations of w-
conotoxin MVIIC blocks Q-type channels (Mintz et al., 1992; Wheeler et al., 1994). 
Therefore, the presence of "Q-like" channels, kineticaliy more similar to the P- and N-
type channels than to the Q-type, have been suggested in RINmSF cells (Magnelli et 
al., 1995). However, in our findings, N-, P- and Q-type Ca^^ channels were not 
involved in either differentiated or undifferentiated RINm5F cells. Therefore, it is likely 
that in differentiated and undifferentiated RINm5F cells, only L-type Ca^"^ channels are 
involved in the increase in Ca^^ currents, [Ca^^liand KCI-mediated insulin release. This 
is in accordance with the observations that KCI-induced net uptake into RINm5F 
cells are completely inhibited by {-t-)-PN 200-110, a DHP Ca^^ channel blocker (Quar et 
al., 1988). Depolarization-induced insulin release from rat pancreatic )9-cells (Komatsu 
et al., 1989) and RINmSF cells (Roenfeldt et al., 1992) is not attenuated by u-
conotoxin GVIA. The complete inhibition of KCI-induced insulin release by nimodipine 
(0.1 )uM) in our study and by PN 200-110 (0.1 //M) from Roenfeldt et al. (1992) 
suggests that in RINm5F cells, irrespective of the presence of other types of VDCCs or 
hormone regulated Ca^^ channels, only the L-type channel is involved in the 
mechanism of depolarization-induced insulin release (Roenfeldt et al., 1992). 
The increased activity of L-type Ca^^ channels in differentiated RINm5F cells may 
be directly associated with differentiation of the normal pancreatic /ff-cell. Decreased 
activity of L-type Ca^^ channels may occur when the cells undergo undifferentiation 
during oncogenesis. In fact, RINm5F cells resemble the incompletely differentiated 
fetal y9-cells in that they contain and secrete minimal amounts of insulin and respond 
only weakly to glucose. They also secrete small amount of glucagon and somatostatin 
(Gazdar et al., 1980; Halban et al., 1983). The morphologically undifferentiated 
RINmSF cells may represent more poorly differentiated fetal iff-cells than the 
differentiated cells. In this aspect, the comparison between differentiated and 
undifferentiated RINm5F cells may provide information on the embryonic development 
of VDCCs in pancreatic /9-cells. In rat skeletal muscle, the levels of a, subunits of L-
type VDCCs are quite low during the first 10 days after birth, then rise dramatically 
and, by day 20, approach those found in adult muscle (Morton and Froehner, 1989). 
VDCC mRNA is not detectable in the myoblast form of C2C12 cells while its 
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expression is induced in differentiated myotubules (Varadi et al., 1989). It has been 
suggested that the VDCC or, subunit is also expressed in pancreatic /ff-cells and RINmSF 
cells (Seine et al., 1992). In addition, the Bn,„ value for [^H]-nitrendipine, a DHP 
antagonist, increases with age between fetal and neonatal ages in rat ventricular 
muscles {Kojima et al., 1990). Altogether, poorly undifferentiated fetal pancreatic P-
cells may have a lower activity of L-type channels than differentiated /3-cells, but by 
progressive cell differentiation, pancreatic ;S-cells might have a higher activity of L-type 
channels than undifferentiated y?-cells. 
In neuroblastoma x glioma hybrid NG 108-15 cells and neuroblastoma x Chinese 
hamster brain NCB-20 cells, the differentiated cells show a marked response to 
depolarization- and Bay K 8644-induced increases in Ca^"^ currents and [Ca^"^], but the 
undifferentiated cells do not (Mienville, 1992; Jin et al., 1994). Sodium butyrate 
(NaB), an inducer of cell differentiation, decreases cell growth and increases insulin 
release and the expression of ganglioside which represents i?-cell differentiation 
(Bartholomeusz et al., 1990). In addition, NaB decreases the cellular content of 
polyamine (Sjoholm, 1993) which also can be depleted by the ornithine decarboxylase 
inhibitor, difluoromethylornithine (DFMO), in RINmBF cells (Sjoholm et al., 1993). In 
DMFO-treated RINmSF cells, [Ca^*^], and insulin release are markedly enhanced after 
KCl (25 mM)-induced depolarization. Furthermore, the behavior of the stimulus-
secretion coupling of polyamine-depleted RINm5F cells changes towards that of native 
jS-cells (Sjoholm et al„ 1993). Nerve growth factor (NGF) is a good candidate for 
comparing morphologic changes to the changes in the VDCC physiology because NGF 
has been reported to induce differentiation in RlNm5F cells (Polak et al., 1993). 
However, we could not induce differentiation from the undifferentiated state by using 
NGF in RINmSF cells. The relationship between morphology and VDCC physiology in 
RINmSF cells should be further studied. 
In conclusion, our present findings suggested that for increases in [Ca^"^!) and 
insulin release, the activity of L-type Ca^"^ channels is predominant in both 
differentiated cells and undifferentiated cells and there is no involvement of N-, P- or Q-
type Ca^^ channels. However, differentiated cells are functionally equipped with more 
L-type channels than undifferentiated RINmSF cells. In addition, voltage dependence of 
activation and steady-state inactivation of Ca^*^ currents in differentiated cells were 
171 
shifted to more negative membrane potentials than in undifferentiated cells than in 
differentiated RINmBF cells. Therefore, we suggest that differentiated RINm5F cells 
have higher density of L-type channels and/or more functional a•^ and p subunits than 
undifferentiated cells. The density of L-type channels which mediate the effects of L-
type channel agonist and antagonist in RINmSF cells should be further evaluated by a 
radioligand binding studies. 
The physiological implication of our present findings remains to be established. 
However, as discussed above, we speculate that both cell migration and differentiation 
are influenced by changes in [Ca^*^], through L-type channels and, as a consequence, 
the modulation of [Ca^"^], is important in^-cell differentiation (Moran, 1991). Neurite 
outgrowth and cell adhesive function are dependent upon Ca^^ (Lankford and 
Letourneau, 1989) and maintenance of the differentiated state also requires regulation 
at the L-type Ca^^ channels (Moran, 1991). It is conceivable that, as the cells migrate 
and differentiate, they encounter stimuli that may promote the clustering of L-type 
channels. In this context, VDCCs are believed to provide more Ca^"^ to the specific cell 
region undergoing the cytomorphological change (i.e. the growth of cellular processes) 
(Silver et al., 1990). 
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CHAPTER VII GENERAL DISCUSSION 
Detailed discussion of the results obtained in this dissertation may be found in the 
Discussion section of each chapter. This chapter will outline the major conclusions 
derived from the presented data and discuss possible physiological implications and 
mechanisms underlying our experimental findings. 
A novel insulin-like immunoreactivity in RINmBF cells 
Based on the specificity of antiserum vs. bovine insulin, we suggest that 
undifferentiated RINm5F cells have a novel insulin-like peptide (NIP), which is most 
likely insulin. Changes in the antigenic determinant of the insulin secreted by 
undifferentiated RINmBF cells may contribute to the specificity of antiserum vs. bovine 
insulin producing a novel insulin-like immunoreactivity. The amino acid sequence of 
NIP may be very similar to porcine and bovine insulins, but not to rat insulin, especially 
at residues A8 and A10 which may act as antigenic determinants in insulin (Sasaki et 
al., 1988; Bullesbach and Schwabe, 1994). However, we speculate that amino acids 
A8 and A10 may not significantly contribute to the antigenic determinant between 
bovine and porcine insulins. Although these insulins only exhibit differences at the A8 
and A10 residues, antisera vs. bovine and porcine insulin cross-react to recognize 
either insulin. The possible antigenic determinants of rat insulin are amino acids at A4, 
B3, 89, 829 and 830 based on these residues being the only differences between rat 
and bovine insulin. Rat insulin differs from bovine and porcine insulin at A4 (Glu -> 
Asp), 83 (Asn -» Lys), 89 (Ser -• Pro), 829 (Lys Met) and 830 (Thr -» Ser). 
However, the changed amino acid residues of NIP are most likely at AS and A10. The 
significance of the changes at A4, 83, 89, 829 and 830 can be ruled out, because 
antiserum vs. porcine insulin recognizes rat insulin even though amino acid residues of 
porcine insulin are different from rat insulin at these residues. Therefore, we speculate 
that the amino acid sequence of NIP should be similar to that of bovine insulin and 
major changes occur at A8 and A10. Antibody specificities between antisera vs. 
porcine and bovine insulins may be attributable to these two residues; and may also 
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contribute to the specificity of antiserum vs. bovine insulin to rat insulin. Furthermore, 
it is possible that antibody vs. bovine insulin is heteroclitic. The antibody vs. bovine 
insulin vtfith low affinity to rat insulin fits loosely to the epitope of rat insulin I and 11. 
This increases the possibility of its being heteroclitic, and permits greater binding to 
cross-reacting epitopes of NIP (Mirza and Wilkin, 1989). 
In addition, the changed affinity of insulin to antibody vs. bovine insulin may 
contribute to the novel insulin-like immunoreactivity. Since the gaps and holes that 
exist between the antibody and the antigen may be filled by water molecules, hydrogen 
bonding and other charge-charge interactions may strengthen the binding (Amit et al., 
1986). 
To further characterize the insulin-like immunoreactivity, it is necessary to examine 
the relationship between morphological changes and the novel insulin-like 
immunoreactivity. It has been shown that a differentiating inducer, sodium butyrate, 
induces RINmSF cells to synthesize more insulin without demonstrating changes of 
morphology. However, sodium butyrate induces morphological changes in another 
system (Wright, 1973). Nerve growth factor (NGF), another differentiating inducer, 
changes morphology from the undifferentiated to differentiated state in RINmBF cells 
(Polak et al., 1993). Therefore, the relationship between the morphology and a novel 
insulin-like immunoreactivity requires further study, possibly using differentiating 
inducers such as sodium butyrate or NGF. To study the relationship between the 
morphology and function, we have employed NGF in serum-free condition to induce 
morphological changes from the undifferentiated state to the differentiated state. 
However, NGF did not significantly change the morphology from the undifferentiated 
state to differentiated state (unpublished observations). Therefore, other agent(s) 
except NGF should be used to test the relationship between the morphology and the 
physiology. 
It would be important to consider the long-term effect of a culture system in vitro 
without supplying physiological factors which might contribute to the unusual 
immunoreactivity of insulin. In vivo transplantation of cells enhances insulin secretion 
and responses to secretagogues, but improved responses are lost during subsequent 
subculture (Flatt et al., 1988). This suggests that long-term maintenance of the cells in 
vitro causes changes in morphology and induces a novel insulin-like immunoreactivity. 
179 
Transplantation of cells to rats may demonstrate the effect of long-term culture. 
Physiological implications of NIP remains to be determined. However, RINm5F 
cells resemble incompletely differentiated fetal /ff-cells (Gazdar et al., 1980; Halban at 
al., 1983). When the cells morphologically change from the differentiate state to the 
undifferentiated state during oncogenesis, the undifferentiated cells may represent 
more poorly differentiated fetal ;9-cells than the differentiated cells. NIP may provide 
information concerning the development of insulin gene expression. We speculate that 
during differentiation of fetal pancreatic yff-cells, the genes of insulin I and II are 
differentially expressed. The gene of insulin II is considered to be the ancestral gene in 
normal pancreatic y9-cells (Bell et al., 1980), however, the third insulin gene may serve 
as an ancestral gene. 
In summary, undifferentiated RINmSF cells produce NIP which is neither rat insulin 
I nor II and is immunoreactive to antisera vs. rat, porcine and bovine insulin.. We 
speculate that NIP may be developed and utilized as an universal insulin which does not 
produce a significant immune reaction when it is injected into either humans or 
animals. 
Adrenergic receptors and their signal transduction mechanisms in RINmSF cells 
The functional distribution of ARs was distinct between differentiated and 
undifferentiated RINmSF cells. Functional studies are based on the receptor occupation 
theory which states that the occupation of a receptor by a drug leads to a stimulus and 
a subsequent response (Kenakin, 1984). Insulin release and cAMP production were 
used to test the potency of epinephrine on a- and )ff-ARs and to distinguish the 
subtypes of ARs. The lack of agonistic activity of epinephrine through CT, and /9-ARs 
may be a result of the low concentration of these ARs in differentiated RINmSF cells. 
In addition, the lack of epinephrine's action through a,- and aj-ARs may also be a result 
of low density of these ARs in undifferentiated RINmSF cells. Our speculation on the 
density of ARs which mediate the dual inhibitory and stimulatory effects of epinephrine 
in RINmSF cells should be further tested by using a radioligand binding study. 
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Differences in tine relative potency of epinephrine and isoproterenol may result 
from differences in their relative affinity for receptors and /or their relative efficacy. 
The potency of the agonists may be affected by a number of factors such as the 
number of receptors and the second messenger system. Therefore, we speculate that 
signal transduction after plasma membrane receptor binding may play a significant role 
in the effect of epinephrine on insulin release. Heterotrimeric G-proteins play an 
essential role in linking cell-surface receptors to effector proteins at the plasma 
membrane, and in transferring the external signals to internal signals. G,- or G^-proteins, 
which are coupled to the ARs, may contribute to epinephrine's action. It is possible 
that higher quantities of G-proteins may contribute to the significant functional 
activities of Cj-ARs in differentiated cells, and higher quantities of Gg-proteins in the 
mediation of ^-ARs in undifferentiated RINmBF cells. In fact, greater quantities of the 
45 KDa subunit of G„-protein are responsible for increased activities of )9-ARs in HIT-
T15 cells (Zhang et al., 1989; Walseth et al., 1989). However, our findings 
demonstrated that the activity of Gj-proteins is not significantly different between 
differentiated and undifferentiated cells. Therefore, we speculate that the quantity of 
Gj-proteins is not different between these two types of RINmBF cells. 
Our results suggested that the activity of adenylyl cyclase is higher in 
undifferentiated cells than in differentiated cells, although the activity of Gg-proteins is 
not different between these cells. Therefore, we speculate that higher association of 
Gg-proteins with adenylyl cyclase in undifferentiated cells than in differentiated cells 
may contribute to the increased activities of adenylyl cyclase and agonistic effect of 
epinephrine. These differences may be responsible for the elevated potency of 
epinephrine and isoproterenol through /ff-ARs and elevated potency of forskolin in 
undifferentiated cells when compared to differentiated cells. 
Intracellular cAMP concentration is determined not only by the rate of cAMP 
production by adenylyl cyclase, but also the rate of hydrolysis by PDE. Activity of PDE 
remained unchanged between differentiated cells and undifferentiated cells because 
increase in intracellular cAMP by IBMX was not significantly different between these 
cells. In addition, the increased activity of protein kinase A may be responsible for the 
increased activity of 0-ARs in undifferentiated cells, although cAMP can act through 
mechanisms other than activation of protein kinase A (Weber et al., 1987; Ludwig et 
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al., 1990; Jiang et al„ 1992). However, in our study, the total (activated and 
inactivated) activity of protein kinase A was not different between differentiated and 
undifferentiated RlNmBF cells. These findings suggested that mechanisms mediated by 
cAMP other than activation of protein kinase A may be more important in yff-AR-
mediated insulin release in undifferentiated cells. The R subunit of protein kinase A 
containing bound cAMP can function independently to interact with the C subunit of 
protein kinase A. An unidentified cAMP-binding protein may mediate cAMP effects 
without interacting with protein kinase A (Weber et al., 1987). Furthermore, cAMP 
may act by binding to cGMP-dependent protein kinase or ion channels (Ludwig et al., 
1990; Jiang et al., 1992; Holz, 4th. et al., 1995). 
These findings may have physiological implications with differentiation of fetal 
pancreatic ;ff-cells because RlNmBF cells represent the early stage of embryonic /ff-cells 
(Gazdar et al., 1980; Halban et al., 1983). During oncogenesis, the morphologically 
undifferentiated RlNmBF cells might represent more poorly differentiated fetal p-ceWs 
than the differentiated cells. We speculate that /J-ARs are predominant in the early 
development of pancreatic /S-cells, decline with further development as az-ARs become 
the dominant AR's type. In fact, the ;ff-AR overexpression in the fetal rat is a 
w i d e s p r e a d  p h e n o m e n o n  a n d  r e c e p t o r  s u b t y p e  s e l e c t i v i t i e s  ( p r e d o m i n a n t l y  y f f j * h e  
whole fetus) are already in place (Slotkin et al., 1994). Fetal tissues can be exposed 
to catecholamines released by the fetal adrenal medulla and a variety of different cell 
types which synthesize catecholamines (Jonakait et al., 1979; Jones et al., 1988). 
Therefore, we speculate that ySz'ARs may elicit a program of growth and differentiation, 
a response to in utero stress and the adaptation of pancreatic i9-cells to birth as in other 
cells and cell lines (Slotkin et al., 1987; Hen et al., 1989; Schuller and Cole, 1989; 
Schallreuter et al., 1993). 
The iff-AR/adenylyl cyclase system has been characterized in the study of 
embryonic development (Maier et al., 1989). Activities of adenylyl cyclase and 
interaction between adenylyl cyclase and G-proteins are greater in the fetus and 
neonate than in the adult (Katz et al., 1985; Tobise et al., 1994). We speculate that 
changes in the cytoskeletal system and membrane fluidity between differentiated cells 
and undifferentiated cells may contribute to the coupling of G-proteins to adenylyl 
cyclase, in which G-proteins are more closely associated with adenylyl cyclase in 
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undifferentiated cells than in differentiated cells. Therefore, the cellular processes in 
developing pancreatic /ff-cells may function to increase the sensitivity or target cell 
selectivity to catecholamines leading to increases or decreases in insulin release 
depending on whether^- or ct-ARs are activated (Polak et al., 1993). However, we do 
not rule out the possibility that different isoforms of adenylyl cyclase are correlated 
with changes of activity of the enzyme. 
In summary, we suggest that the higher density of CTj-ARs and lower activities of 
adenylyl cyclase may contribute to the higher functional activity of ffj-ARs and lower 
activity of yff-ARs in differentiated cells than in undifferentiated cells. In addition, the 
higher concentration of iff-ARs, higher association of Gj-proteins with adenylyl cyclase 
and higher activities of adenylyl cyclase may contribute to the higher functional activity 
of ;ff-ARs and lower activity of Oj-ARs in undifferentiated cells than in differentiated 
cells. 
Voltage-dependent Ca^^ channels in RINmBF cells 
Based on pharmacological properties, we suggest that both differentiated and 
undifferentiated RINm5F cells have predominantly L-type Ca^"^ channels, which have 
been identified in pancreatic /ff-cells and insulin-secreting cell lines including RINmSF. 
The L-type Ca^"^ currents in RINmSF cells in the whole-cell patch-clamp recordings are 
activated at relatively high membrane potential. Activation of Ca^^ currents are fast 
with long duration and slow inactivation. In addition to being voltage-dependent, the L-
type currents are regulated by Ca^^. An increase in [Ca^"^]] induced by opening of the 
channel down-regulates the activity of the channel. The down-regulation may be due 
to the decrease in the electrochemical driving force for Ca^"^ influx. In addition, the 
binding of with the inside of the channel (S6 of o, subunit) or with extracellular 
and cytoplasmic domains may contribute to the Ca^'^-induced down-regulation of the 
channel (Zhang et al., 1994). Ca^^-activated channels and non-selective cation 
channels are also activated by an increase in [Ca^'^], and result in the repolarization of 
membrane potentials which close the L-type channels (Cole and Sanders, 1989). 
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RINm5F cells have a large conductance, long-lasting opening and high density of L-
type Ca^* channels, which are responsible for the upstroke of the action potential and 
Ca^"^ influx with membrane depolarization. In this study, we found no involvement of 
N-, P- and Q-type channels in either differentiated or undifferentiated cells, although the 
presence of these channels has been suggested in differentiated RINmBF cells (Magnelli 
et al., 1995). In addition, we were not able to identify T-type channels in RINm5F 
cells, although the T-type channels are present in rat pancreatic yff-cells. T-type 
currents may play an important physiological role in the near resting membrane 
potential to regulate excitability, as a pacemaker, due to their low threshold. 
Therefore, it is possible that T-type channels may be demonstrated when more RINm5F 
cells are studied using whole-cell patch-clamp recordings. To test this possibility, the 
percentage of cells containing T-type channels can be studied in differentiated and 
undifferentiated cells by using the properties of voltage-dependency and kinetics of T-
type channels. However, T-type channel blockers can not be used to characterize the 
channels due to the lack of specific T-type channel blockers. 
The functional distributions of L-type channels were distinct between differentiated 
and undifferentiated RINmSF cells. The low agonistic activity of Bay K 8644 in 
undifferentiated cells may be a result of the low density of L-type channels. Our 
speculation on the density of L-type channels which mediate the effects of L-type 
channel agonist and antagonist in RINmSF cells should be further tested by radioligand 
binding studies. In addition, differences in relative potency of nimodipine may result 
from differences in relative affinity for receptors. The affinity of DHP antagonist is 
enhanced by prolonged depolarization (Catterall and Striessnig, 1992) and binds far 
more tightly to the inactivated state than to the resting state of the Ca^"^ channels 
(Bean, 1984). Thus, the properties of the DHP receptor depend on the gating state of 
the Ca^'*' channels. In our findings, when membrane holding potentials were increased, 
nimodipine was more potent to inhibit Ca^"^ currents and increase [Ca^"^], and insulin 
release. These findings suggest that the gating state of L-type channels is different 
between differentiated and undifferentiated RINmSF cells. In addition, the non-
inactivating component of the Ca^"^-independent K currents are inhibited by DHP 
antagonists, nicardipine and nimodipine, but not by DHP agonist. Bay K 8644 (Valmier 
et al., 1991; Hume, 1985). This observation suggests that in RINmSF cells, nimodipine 
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may inhibit Ca^^-independent K currents, which depolarize membrane potentials and, if 
so, contribute to the inhibitory effect of nimodipine on Bay K 8644-induced [Ca^"^], and 
insulin release. However, this hypothesis remains to be tested. 
Undifferentiated RINmSF cells can be utilized as a model for the binding site of 
DHP agonists and antagonists. This model is based on the findings that nimodipine 
totally abolishes Bay K 8644-induced Ca^"^ currents, increases [Ca^"^]! and insulin 
release in differentiated cells, but not in undifferentiated cells. However, we do not 
rule out the possibility that the affinity of nimodipine is lower in undifferentiated ceils 
than in differentiated cells. Two distinct binding sites for DHPs may exist; one for 
agonists such as Bay K 8644 and another for antagonists such as nimodipine. The 
DHP binding site in L-type Ca^'^ channels is localized close to the SS1-SS2 region of 
repeat III (Striessnig et al, 1991; Nakayama et al., 1991) and to a sequence following 
the iVS6 segment of the a•^ subunits of L-type Ca^"^ channels (Regulla et al., 1991). 
The region responsible for the binding of either the agonist or antagonist has not been 
determined. 
The higher activity of L-type Ca^'^ channels in differentiated RINmSF cells may be 
directly associated with differentiation of normal pancreatic ;?-cells, because RINmSF 
cells resemble incompletely differentiated fetal ^ff-cells (Gazdar et al., 1980; Halban et 
al., 1983). Therefore, the morphologically undifferentiated RINmBF cells might 
represent more poorly differentiated fetal /?-cells than the differentiated cells. In rat 
skeletal muscle, the levels of subunits of L-type VDCCs are quite low during the first 
10 days after birth, then rise dramatically and, by day 20, approach those found in 
adult muscle (Morton and Froehner, 1989). VDCC a, mRNA is not detectable in the 
myoblast form of C2C12 cells while its expression is induced in differentiated 
myotubuies (Varadi et al., 1989). in addition, the B^a, value for [^H]-nitrendipine, a 
DHP antagonist, increases with age between fetal and neonatal ages in rat ventricular 
muscles (Kojima et al., 1990). Therefore, we speculate that the differences in changes 
of [Ca^^lj mediated through L-type channels may be attributed to the levels of or, 
subunits of L-type VDCCs between the differentiated and undifferentiated cells. It is 
conceivable that the levels of a, subunit of L-type channels are low in undifferentiated 
cells but high in differentiated RINmBF cells. Therefore, the levels of a•^ subunits of L-
type channels are quite low during early development of pancreatic iff-cells, then rise 
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dramatically and approach those found in adult pancreatic ;9-cells. The developmental 
changes of L-type channels have been demonstrated in rat skeletal muscle and 
ventricular muscles (Morton and Froehner, 1989; Kojima et al„ 1990). In addition, the 
developmental changes of L-type channels have been implicated in some cell lines 
(neuroblastoma x glioma hybrid NG 108-15 cells and neuroblastoma x Chinese hamster 
brain NCB-20 cells), which have two morphological features as RINm5F cells do 
(Mienville, 1992; Jin et al., 1994). 
In summary, differentiated cells demonstrate higher activity of L-type channels 
than undifferentiated RINm5F cells, and the voltage-dependence of activation and 
inactivation of these channels differs between differentiated and undifferentiated cells. 
N-, P- and Q-type VDCCs may not be present in differentiated and undifferentiated 
RlNmSF cells. We speculate that poorly undifferentiated fetal pancreatic /ff-cells may 
have lower activity of L-type channels than differentiated p-ceWs , but with cell 
differentiation, pancreatic yff-cells might have higher activity of L-type channel than 
undifferentiated )9-cells. 
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CHAPTER VIII GENERAL SUMMARY 
A rat clonal ^-cell line, RINm5F, is originated from rat pancreatic islets following X-
ray irradiation. The cells exhibited two morphological features: the differentiated state 
with long neuron-like processes and the undifferentiated state without the processes. 
A novel insulin-like immunoreactivity, adrenergic receptors (ARs), second messenger 
systems through ARs and voltage-dependent Ca^"^ channels (VDCCs) were 
characterized in a passage- and morphology dependent manner. 
As morphology of the cells changed from differentiated to undifferentiated cells, 
the amount of secreted insulin decreased. By applying antisera vs. rat and porcine 
insulins in RIA, the amount of secreted insulin from RINmSF cells gradually decreased; 
however, with antiserum vs. bovine insulin, it gradually increased from a barely 
detectable amount. Transmission electron microscopy revealed that dense core 
secretory vesicles were more numerous in differentiated cells than in undifferentiated 
cells. Immunocytochemistry and immunoblot analysis showed that antisera vs. rat and 
porcine insulins reacted with insulins from both cell types. There was no reaction of 
insulins with antisera vs. bovine insulin in differentiated cells, however, there was a 
reaction in undifferentiated cells. These results suggested that a novel insulin-like 
immunoreactivity was present only in undifferentiated cells. In immunoblotting, insulin 
from homogenized cells was found as a single band with a M.W. of 6 KDa. All insulins 
secreted from undifferentiated cells were neither rat insulin I and II nor insulin like 
growth factor (IGF)-I and -II. These results suggested that a novel insulin-like 
immunoreactivity is present in undifferentiated RINmBF cells, which is different from 
rat insulin I and II. 
Epinephrine (1 //M) significantly decreased basal intracellular cAMP concentration 
and insulin release in differentiated cells, but significantly increased intracellular cAMP 
concentration and insulin release in undifferentiated cells. In addition, epinephrine (1 
fjM) decreased forskolin-induced intracellular cAMP concentration in differentiated cells 
but not in undifferentiated cells. In differentiated cells, epinephrine (1 decreased 
KCI (30 mM)-induced insulin release but RX 821002 {0.1 //M), an az-AR antagonist, 
abolished the epinephrine-induced inhibition. Prazosin (0.1 //M), an a^-AR antagonist, 
and propranolol (1 //M), a P-AH antagonist, failed to alter the effect of epinephrine. In 
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undifferentiated cells, however, epinephrine (1 //M) increased insulin release and 
enhanced KCI (30 mM)-induced insulin release. RX 821002 further potentiated the 
effect of epinephrine on KCI's action. Propranolol (1 //M) abolished the effect of 
epinephrine on KCI's action but prazosin (0.1 //M) did not. In addition, under cTj-AR 
blockade, the Oi-AR agonists cirazoline (10//M) and methoxamine (100 //M) did not 
increase insulin release in either differentiated or undifferentiated cells. Medetomidine 
(0.001 - 1 //M), a potent and specific a2-AR agonist, inhibited KCI (30 mM)-induced 
insulin release in a dose-dependent manner in differentiated cells, but not in 
undifferentiated cells. Isoproterenol, a /?-AR agonist (1 //M), failed to increase 
intracellular cAMP concentration and insulin release in differentiated cells but increased 
them in undifferentiated cells. These results suggested that in RINm5F cells, 1) the 
differentiated states are functionally equipped with more 02-, but fewer )S-ARs, than the 
undifferentiated states, and 2) o,-ARs do not participate in insulin release in either 
differentiated or undifferentiated RINm5F cells. 
To further study the higher activity of yff-ARs, which may arise from higher activity 
of second messenger systems, we characterized the activities of Gg-protein, adenylyl 
cyclase, phosphodiesterase (PDE) and cAMP-dependent protein kinase (protein kinase 
A). Cholera toxin (CTX, 1 //g/ml), an activator of Gg-proteins, increased intracellular 
cAMP concentration in both differentiated and undifferentiated cells without significant 
differences between these cells. CTX also increased insulin release in these cells, 
however, CTX was 2.6-foId more potent in undifferentiated cells than in differentiated 
cells. The effect of forskolin (10//M) on cAMP production and insulin release was 2-
and 6-fold more potent, respectively, and the effect of IBMX (100 //M) on insulin 
release was 6-fold more potent in undifferentiated cells than in differentiated cells. 
IBMX, however, significantly increased the intracellular concentration of cAMP equally 
in differentiated and undifferentiated cells. Isoproterenol potentiated forskolin-induced 
cAMP production and insulin release in undifferentiated cells, but not in differentiated 
cells. CTX potentiated forskolin-induced cAMP production and insulin release in 
undifferentiated cells, but not in differentiated cells. Furthermore, forskolin potentiated 
KCI-induced insulin release in undifferentiated cells, but not in differentiated cells, 
without significant differences of intracellular cAMP concentrations and [Ca2H-]i 
between the forskolin alone group and the forskolin -f- KCI group. However, activity of 
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protein kinase A was not significantly different between differentiated and 
undifferentiated cells. These results suggested that activity of adenylyl cyclase is 
higher in undifferentiated cells than in differentiated cells, and the activities of G„-
proteins, PDE and protein kinase A remain unchanged between differentiated and 
undifferentiated RINm5F cells. Furthermore, greater association of G„-protein with 
adenylyl cyclase may contribute to the increased activity of adenylyl cyclase in 
undifferentiated RINm5F cells. 
VDCCs were characterized in a passage- and morphology-dependent manner. The 
effect of KCI (15 mM) on [Ca^"^]; and insulin release was 3-fold higher and Bay K 8644 
(1 /jM) was 6-fold higher in differentiated cells than in undifferentiated cells. 
Furthermore, the dose-dependent increases in [Ca^'^lj and insulin release by the L-type 
Ca^"^ channel agonist, Bay K 8644 |1 nM - 1 //M), was greater in differentiated cells 
than in undifferentiated cells. However, at lower concentrations of KCI (10-30 mM), 
the dose-dependent increases were greater in differentiated cells while at higher 
concentrations of KCI (30 - 45 mM) the increases were greater in undifferentiated cells. 
In addition, the inhibitory effect of nimodipine on KCI and Bay K 8644 were studied by 
equally increasing [Ca^*^], and insulin release between differentiated and 
undifferentiated cells. Thus, 12 mM and 15 mM KCI was used in differentiated and 
undifferentiated cells, respectively, and 0.1 fjM and 1 y^/M Bay K 8644 was used in 
differentiated and undifferentiated cells, respectively. Dose-dependent inhibitions in 
KCI- and Bay K 8644-induced [Ca^^lj and insulin release by nimodipine (1 nM - 1 //M) 
were greater in differentiated cells than in undifferentiated cells. 
In whole-cell patch-clamp recordings, with a holding potential of -80 mV, inward 
Ca^"^ currents were first observed during a depolarization to -50 mV in both 
differentiated cells and undifferentiated cells. However, the maximal Ca^+ current was 
greater in undifferentiated cells than in differentiated cells. Bay K 8644 (1 yuM) 
increased Ca^^ currents by 74 ± 13% in differentiated cells and 20 ± 7 % in 
undifferentiated cells. Nimodipine (1 //M) caused an inhibition of control Ca^'*^ currents 
by 48 ±'' 17% in differentiated cells and failed to inhibit them in undifferentiated cells. 
In addition, nimodipine (1 yt/M) inhibited Bay K 8644-induced Ca^"^ current by 83 ± 8 
% in the differentiated cells, but failed to inhibit them in undifferentiated cells. 
Since nimodipine did not totally inhibit control Ca^"^ currents and Bay K 8644-
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induced increases in [Ca^^], and insulin release in undifferentiated cells, it was further 
studied for two possibilities: 1) the functional involvement of other VDCCs such as N-, 
P- and Q-type and 2) the voltage-dependency of L-type Ca^^ channels. An N-type 
channel blocker, w-conotoxin GVIA (1 //M), and a P- and Q-type channel blocker, cu-
agatoxin IVA (300 nM), did not inhibit basal Ca^'^ currents nor did they inhibit KCi- and 
Bay K 8644-induced increases in [Ca^^], and insulin release in either differentiated or 
undifferentiated cells. The voltage-dependence of L-type channels was studied by 
using nimodipine, whose binding could be enhanced by prolonged membrane 
depolarization. KCI (30 mM)-induced increases in [Ca^"^], and insulin release was dose-
dependently inhibited by nimodipine (0.1 nM - 1 //M) in both differentiated and 
undifferentiated cells. The potency of nimodipine on [Ca^^lj and insulin release by 30 
mM KCI was 17- to 22-fold higher than that by 15 mM KCI in undifferentiated cells. 
However, in differentiated cells, there were no significant differences in the potency of 
nimodipine on ICa^"^], and insulin release induced by 12 and 30 mM KCI. In addition, in 
undifferentiated cells, the potency of nimodipine in inhibiting control Ca^^ currents was 
compared by holding membrane potentials at -80 mV and 0 mV in the whole-cell patch-
clamp recordings. Nimodipine (1 //M) failed to inhibit control Ca^"^ currents at the 
holding potentials of -80 mV, but inhibited them by 70.3 ± 7.7% at the holding 
potentials of 0 mV. The current-voltage relationship shifted to more negative potentials 
in differentiated cells than in undifferentiated cells. The voltage at which one-half of 
Ca^"^ currents was activated {Vi,2) was -24.3 ± 3.6 mV in differentiated cells and -
10.6 ± 2.5 mV in undifferentiated cells. The prepulse potential at which one-half of 
the maximal Ca^"^ currents was inactivated (Vi/j) shifted from -21.4 ± 3.9 mV in 
differentiated cells to 1.8 ± 4.3 mV in undifferentiated cells. These results suggested 
that differentiated RlNmBF cells are functionally equipped with more L-type Ca^"*^ 
channels than the undifferentiated cells, and the voltage-dependence of L-type Ca^^ 
channels was different between differentiated and undifferentiated cells. However, N-, 
P- and Q-type VDCCs may not be present in differentiated and undifferentiated RINmBF 
cells. 
In summary, we suggest that a novel insulin-like immunoreactivity is present in 
undifferentiated RlNmBF cells, which is not due to rat insulin 1 nor II. In addition, the 
differentiated cells are functionally equipped with more Oj-, but fewer fi-ARs, than the 
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undifferentiated cells. The increased activity of ^-ARs in undifferentiated cells is partly 
due to higher association of Ggs-protein with adenylyl cyclase and increased activity of 
adenylyl cyclase. We also suggest that RINnnSF cells have predominantly L-type 
channels with no N-, P- and Q-type channels. However, differentiated cells are 
functionally equipped with more L-type Ca^"^ channels than the undifferentiated cells 
and the voltage-dependency of L-type Ca^'*^ channels was different between 
differentiated and undifferentiated cells. 
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